review article | Q7318358 |
scholarly article | Q13442814 |
P356 | DOI | 10.1172/JCI0215593 |
10.1172/JCI15593 | ||
P3181 | OpenCitations bibliographic resource ID | 354206 |
P932 | PMC publication ID | 150968 |
P698 | PubMed publication ID | 11994399 |
P2093 | author name string | Goldstein JL | |
Brown MS | |||
Horton JD | |||
P2860 | cites work | Sterol regulatory element-binding protein-1c mimics the negative effect of insulin on phosphoenolpyruvate carboxykinase (GTP) gene transcription | Q64379685 |
Nuclear sterol regulatory element-binding proteins activate genes responsible for the entire program of unsaturated fatty acid biosynthesis in transgenic mouse liver | Q77696898 | ||
Role of AMP-activated protein kinase in mechanism of metformin action | Q22241898 | ||
Structural requirements of ligands for the oxysterol liver X receptors LXRalpha and LXRbeta | Q24553340 | ||
Differential expression of exons 1a and 1c in mRNAs for sterol regulatory element binding protein-1 in human and mouse organs and cultured cells | Q24561820 | ||
Regulation of mouse sterol regulatory element-binding protein-1c gene (SREBP-1c) by oxysterol receptors, LXRalpha and LXRbeta | Q24598068 | ||
Decreased IRS-2 and increased SREBP-1c lead to mixed insulin resistance and sensitivity in livers of lipodystrophic and ob/ob mice | Q28144106 | ||
Nonalcoholic fatty liver disease: a feature of the metabolic syndrome | Q28208772 | ||
Direct and indirect mechanisms for regulation of fatty acid synthase gene expression by liver X receptors | Q28215527 | ||
The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor | Q28238069 | ||
Sterol resistance in CHO cells traced to point mutation in SREBP cleavage-activating protein | Q28295187 | ||
SREBP cleavage-activating protein (SCAP) is required for increased lipid synthesis in liver induced by cholesterol deprivation and insulin elevation | Q28365331 | ||
ADD1/SREBP-1c is required in the activation of hepatic lipogenic gene expression by glucose | Q28583495 | ||
Elevated levels of SREBP-2 and cholesterol synthesis in livers of mice homozygous for a targeted disruption of the SREBP-1 gene | Q28584842 | ||
Identification of a mammalian long chain fatty acyl elongase regulated by sterol regulatory element-binding proteins | Q28585597 | ||
Decreased lipid synthesis in livers of mice with disrupted Site-1 protease gene | Q28588943 | ||
Sterol regulatory element-binding protein-1 as a key transcription factor for nutritional induction of lipogenic enzyme genes | Q28646399 | ||
Differential stimulation of cholesterol and unsaturated fatty acid biosynthesis in cells expressing individual nuclear sterol regulatory element-binding proteins | Q28646552 | ||
Unsaturated fatty acids down-regulate srebp isoforms 1a and 1c by two mechanisms in HEK-293 cells | Q31582971 | ||
Polyunsaturated fatty acids suppress hepatic sterol regulatory element-binding protein-1 expression by accelerating transcript decay | Q31742604 | ||
Sterol regulatory element-binding proteins: activators of cholesterol and fatty acid biosynthesis | Q33635172 | ||
Disruption of LDL receptor gene in transgenic SREBP-1a mice unmasks hyperlipidemia resulting from production of lipid-rich VLDL | Q33849024 | ||
Sterol regulatory element binding protein-1c is a major mediator of insulin action on the hepatic expression of glucokinase and lipogenesis-related genes | Q33878155 | ||
Endoplasmic reticulum localization of the low density lipoprotein receptor mediates presecretory degradation of apolipoprotein B | Q34047812 | ||
Expression of sterol regulatory element-binding protein 1c (SREBP-1c) mRNA in rat hepatoma cells requires endogenous LXR ligands | Q34083979 | ||
Regulation of gene expression by SREBP and SCAP. | Q34101197 | ||
Sterol-dependent transcriptional regulation of sterol regulatory element-binding protein-2. | Q34405624 | ||
Nutritional and insulin regulation of fatty acid synthetase and leptin gene expression through ADD1/SREBP1. | Q34451430 | ||
Mutant mammalian cells as tools to delineate the sterol regulatory element-binding protein pathway for feedback regulation of lipid synthesis | Q34497858 | ||
Unsaturated fatty acids inhibit transcription of the sterol regulatory element-binding protein-1c (SREBP-1c) gene by antagonizing ligand-dependent activation of the LXR. | Q35926317 | ||
Insulin selectively increases SREBP-1c mRNA in the livers of rats with streptozotocin-induced diabetes | Q36698641 | ||
Cholesterol feeding reduces nuclear forms of sterol regulatory element binding proteins in hamster liver | Q36806480 | ||
Nutritional regulation of the fatty acid synthase promoter in vivo: sterol regulatory element binding protein functions through an upstream region containing a sterol regulatory element | Q37254332 | ||
Overproduction of cholesterol and fatty acids causes massive liver enlargement in transgenic mice expressing truncated SREBP-1a | Q37360326 | ||
Isoform 1c of sterol regulatory element binding protein is less active than isoform 1a in livers of transgenic mice and in cultured cells | Q37364195 | ||
Regulation of sterol regulatory element binding proteins in livers of fasted and refed mice | Q37375695 | ||
Activation of cholesterol synthesis in preference to fatty acid synthesis in liver and adipose tissue of transgenic mice overproducing sterol regulatory element-binding protein-2. | Q37382401 | ||
Blunted feedback suppression of SREBP processing by dietary cholesterol in transgenic mice expressing sterol-resistant SCAP(D443N). | Q37388151 | ||
Sterol regulatory element-binding proteins induce an entire pathway of cholesterol synthesis | Q38298207 | ||
Metformin reverses fatty liver disease in obese, leptin-deficient mice | Q38308602 | ||
Increased levels of nuclear SREBP-1c associated with fatty livers in two mouse models of diabetes mellitus | Q38319698 | ||
Promoter analysis of the mouse sterol regulatory element-binding protein-1c gene | Q40864894 | ||
Sterol regulatory element binding protein-1 expression is suppressed by dietary polyunsaturated fatty acids. A mechanism for the coordinate suppression of lipogenic genes by polyunsaturated fats | Q40937102 | ||
Adenovirus-mediated overexpression of sterol regulatory element binding protein-1c mimics insulin effects on hepatic gene expression and glucose homeostasis in diabetic mice. | Q43778752 | ||
Diminished hepatic response to fasting/refeeding and liver X receptor agonists in mice with selective deficiency of sterol regulatory element-binding protein-1c | Q43848640 | ||
Functional analysis of secreted and transmembrane proteins critical to mouse development. | Q46905044 | ||
Leptin reverses insulin resistance and diabetes mellitus in mice with congenital lipodystrophy. | Q52895402 | ||
P433 | issue | 9 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | fatty acid | Q61476 |
sterol response element binding | Q21112287 | ||
P304 | page(s) | 1125-31 | |
P577 | publication date | 2002-05-01 | |
P1433 | published in | Journal of Clinical Investigation | Q3186904 |
P1476 | title | SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver | |
P478 | volume | 109 |
Q38666966 | (-)-Epicatechin regulates blood lipids and attenuates hepatic steatosis in rats fed high-fat diet |
Q57212305 | (fermented barley bran) water-soluble extracts inhibit the expression of adipogenic and lipogenic regulators in 3T3-L1 adipocytes |
Q57174719 | ,-Dimethyl-3β-hydroxycholenamide Reduces Retinal Cholesterol via Partial Inhibition of Retinal Cholesterol Biosynthesis Rather Than its Liver X Receptor Transcriptional Activity |
Q38992965 | 1-Carbon Cycle Metabolites Methylate Their Way to Fatty Liver |
Q35289357 | 2-(3-Benzoylthioureido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylic acid ameliorates metabolic disorders in high-fat diet-fed mice |
Q24644336 | 24S-hydroxycholesterol effects on lipid metabolism genes are modeled in traumatic brain injury |
Q34568079 | 25-Hydroxycholesterol increases the availability of cholesterol in phospholipid membranes |
Q37016677 | 25-Hydroxycholesterol-3-sulfate regulates macrophage lipid metabolism via the LXR/SREBP-1 signaling pathway. |
Q54568970 | 3,5,3'triiodo-L-thyronine induces SREBP-1 expression by non-genomic actions in human HEP G2 cells. |
Q43808610 | 3-Caffeoyl, 4-dihydrocaffeoylquinic acid from Salicornia herbacea attenuates high glucose-induced hepatic lipogenesis in human HepG2 cells through activation of the liver kinase B1 and silent information regulator T1/AMPK-dependent pathway |
Q53234566 | 4-1BBL signaling promotes cell proliferation through reprogramming of glucose metabolism in monocytes/macrophages. |
Q36488958 | 4-Methyl sterols regulate fission yeast SREBP-Scap under low oxygen and cell stress. |
Q36642388 | 5-cholesten-3β,25-diol 3-sulfate decreases lipid accumulation in diet-induced nonalcoholic fatty liver disease mouse model |
Q90536486 | A Component Formula of Chinese Medicine for Hypercholesterolemia Based on Virtual Screening and Biology Network |
Q42826888 | A Herbal Formula HT048, Citrus unshiu and Crataegus pinnatifida, Prevents Obesity by Inhibiting Adipogenesis and Lipogenesis in 3T3-L1 Preadipocytes and HFD-Induced Obese Rats. |
Q89474658 | A MAFG-lncRNA axis links systemic nutrient abundance to hepatic glucose metabolism |
Q36480874 | A MARCH6 and IDOL E3 Ubiquitin Ligase Circuit Uncouples Cholesterol Synthesis from Lipoprotein Uptake in Hepatocytes |
Q100568447 | A MicroRNA Linking Human Positive Selection and Metabolic Disorders |
Q42366779 | A Novel Link between Plasma MicroRNA-33b Levels and Lipid Disorders in Diabetes Mellitus |
Q58610328 | A Novel Regulatory Role of Apoptosis Antagonizing Transcription Factor in the Pathogenesis of NAFLD and HCC |
Q36204429 | A Systems Biology Approach to Deciphering the Etiology of Steatosis Employing Patient-Derived Dermal Fibroblasts and iPS Cells |
Q47595788 | A bacterial hydrogen-dependent CO2 reductase forms filamentous structures. |
Q28080618 | A century of cholesterol and coronaries: from plaques to genes to statins |
Q64226349 | A chemical biology screen identifies a vulnerability of neuroendocrine cancer cells to SQLE inhibition |
Q37173870 | A comparative analysis of genistein and daidzein in affecting lipid metabolism in rat liver |
Q39451299 | A conserved SREBP-1/phosphatidylcholine feedback circuit regulates lipogenesis in metazoans |
Q41072298 | A distinct function of the retinoblastoma protein in the control of lipid composition identified by lipidomic profiling |
Q42175219 | A fatty acid-dependent hypothalamic-DVC neurocircuitry that regulates hepatic secretion of triglyceride-rich lipoproteins |
Q33842841 | A feed-forward loop amplifies nutritional regulation of PNPLA3 |
Q37759155 | A fresh look at NASH pathogenesis. Part 1: the metabolic movers. |
Q64079567 | A functional interaction between Hippo-YAP signalling and SREBPs mediates hepatic steatosis in diabetic mice |
Q84517434 | A high-amylopectin diet caused hepatic steatosis associated with more lipogenic enzymes and increased serum insulin concentration |
Q48062689 | A large indel mutation of the bovine ADD1/SREBP1c gene and its effects on growth traits in some native cattle breeds from China. |
Q64061115 | A lipid-free and insulin-supplemented medium supports De Novo fatty acid synthesis gene activation in melanoma cells |
Q104142494 | A metastasis map of human cancer cell lines |
Q33648820 | A new role for sterol regulatory element binding protein 1 transcription factors in the regulation of muscle mass and muscle cell differentiation |
Q34417809 | A novel 3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMGCR) splice variant with an alternative exon 1 potentially encoding an extended N-terminus |
Q28513195 | A novel ChREBP isoform in adipose tissue regulates systemic glucose metabolism |
Q34837806 | A novel potent synthetic steroidal liver X receptor agonist lowers plasma cholesterol and triglycerides and reduces atherosclerosis in LDLR(-/-) mice |
Q39004530 | A novel processing system of sterol regulatory element-binding protein-1c regulated by polyunsaturated fatty acid |
Q41551699 | A novel role for CRTC2 in hepatic cholesterol synthesis through SREBP-2. |
Q45057647 | A novel role of astrocyte elevated gene-1 (AEG-1) in regulating nonalcoholic steatohepatitis (NASH). |
Q28543563 | A novel sterol regulatory element-binding protein gene (sreA) identified in penicillium digitatum is required for prochloraz resistance, full virulence and erg11 (cyp51) regulation |
Q36827108 | A regulatory role for microRNA 33* in controlling lipid metabolism gene expression. |
Q38790759 | A relative quantitative positive/negative ion switching method for untargeted lipidomics via high resolution LC-MS/MS from any biological source |
Q42115601 | A role for PPARalpha in the control of SREBP activity and lipid synthesis in the liver |
Q36368258 | A role for protein inhibitor of activated STAT1 (PIAS1) in lipogenic regulation through SUMOylation-independent suppression of liver X receptors. |
Q40508556 | A simple promoter containing two Sp1 sites controls the expression of sterol-regulatory-element-binding protein 1a (SREBP-1a). |
Q35654048 | A spontaneous mutation in Srebf2 leads to cataracts and persistent skin wounds in the lens opacity 13 (lop13) mouse |
Q33640757 | A systems approach to mapping transcriptional networks controlling surfactant homeostasis |
Q28585589 | A targeted apoB38.9 mutation in mice is associated with reduced hepatic cholesterol synthesis and enhanced lipid peroxidation |
Q51795712 | A transcription factor of lipid synthesis, sterol regulatory element-binding protein (SREBP)-1a causes G(1) cell-cycle arrest after accumulation of cyclin-dependent kinase (cdk) inhibitors. |
Q37463266 | ABCD2 is abundant in adipose tissue and opposes the accumulation of dietary erucic acid (C22:1) in fat |
Q90169901 | AIG1 and ADTRP are endogenous hydrolases of fatty acid esters of hydroxy fatty acids (FAHFAs) in mice |
Q39898336 | AMP-activated protein kinase suppresses LXR-dependent sterol regulatory element-binding protein-1c transcription in rat hepatoma McA-RH7777 cells |
Q37401943 | AMPK activators--potential therapeutics for metabolic and other diseases |
Q28591122 | AMPK phosphorylates and inhibits SREBP activity to attenuate hepatic steatosis and atherosclerosis in diet-induced insulin-resistant mice |
Q40042305 | ASAS centennial paper: Lactation biology for the twenty-first century |
Q91105558 | ASPP2 inhibits tumor growth by repressing the mevalonate pathway in hepatocellular carcinoma |
Q33729901 | ATAD3 gene cluster deletions cause cerebellar dysfunction associated with altered mitochondrial DNA and cholesterol metabolism |
Q37260315 | ATF6 modulates SREBP2-mediated lipogenesis. |
Q35062390 | ATP-binding cassette A1 protein and HDL homeostasis |
Q50963304 | Aberrant expression of microRNA induced by high-fructose diet: implications in the pathogenesis of hyperlipidemia and hepatic insulin resistance. |
Q47710637 | Aberrant lipid metabolism in cancer cells - the role of oncolipid-activated signaling |
Q33577124 | Ablation of ARNT/HIF1beta in liver alters gluconeogenesis, lipogenic gene expression, and serum ketones |
Q35612921 | Ablation of Iqgap2 protects from diet-induced hepatic steatosis due to impaired fatty acid uptake |
Q46141813 | Abrogation of hepatic ATP-citrate lyase protects against fatty liver and ameliorates hyperglycemia in leptin receptor-deficient mice |
Q37245689 | Absence of stearoyl-CoA desaturase-1 ameliorates features of the metabolic syndrome in LDLR-deficient mice. |
Q37433454 | Accelerated fatty acid oxidation in muscle averts fasting-induced hepatic steatosis in SJL/J mice |
Q42427951 | Accessibility of cholesterol in endoplasmic reticulum membranes and activation of SREBP-2 switch abruptly at a common cholesterol threshold |
Q64095480 | Accumulation of PNPLA3 on lipid droplets is the basis of associated hepatic steatosis |
Q35159141 | Accumulation of advanced glycation end-products and activation of the SCAP/SREBP Lipogenetic pathway occur in diet-induced obese mouse skeletal muscle |
Q53730590 | Acetyl CoA Carboxylase Inhibition Reduces Hepatic Steatosis but Elevates Plasma Triglycerides in Mice and Humans: A Bedside to Bench Investigation. |
Q54978460 | Acetyl-CoA Carboxylase Inhibition Reverses NAFLD and Hepatic Insulin Resistance but Promotes Hypertriglyceridemia in Rodents. |
Q73198853 | Acetyl-CoA carboxylase and SREBP expression during peripheral nervous system myelination |
Q46483039 | Acrolein increases macrophage atherogenicity in association with gut microbiota remodeling in atherosclerotic mice: protective role for the polyphenol-rich pomegranate juice |
Q38971642 | Actinidia chinensis Planch root extract inhibits cholesterol metabolism in hepatocellular carcinoma through upregulation of PCSK9. |
Q38905777 | Activated α2-macroglobulin binding to human prostate cancer cells triggers insulin-like responses |
Q41764630 | Activating transcription factor 6 plays protective and pathological roles in steatosis due to endoplasmic reticulum stress in zebrafish |
Q34795007 | Activation of sterol regulatory element binding protein and NLRP3 inflammasome in atherosclerotic lesion development in diabetic pigs |
Q33853132 | Activation of sterol regulatory element binding proteins in the absence of Scap in Drosophila melanogaster |
Q38968750 | Activation of sterol regulatory element-binding proteins in mice exposed to perfluorooctanoic acid for 28 days. |
Q46260461 | Acute clozapine exposure in vivo induces lipid accumulation and marked sequential changes in the expression of SREBP, PPAR, and LXR target genes in rat liver |
Q36628034 | Acyl CoA synthetase 5 (ACSL5) ablation in mice increases energy expenditure and insulin sensitivity and delays fat absorption |
Q57147493 | Ad4BP/SF-1 regulates cholesterol synthesis to boost the production of steroids |
Q39425985 | Adaptation of retrovirus producer cells to serum deprivation: Implications in lipid biosynthesis and vector production |
Q34362178 | Adaptive changes of the Insig1/SREBP1/SCD1 set point help adipose tissue to cope with increased storage demands of obesity |
Q37305353 | Adaptive responses by mouse fetus to a maternal HLE diet by downregulating SREBP1: a microarray- and bio-analytic-based study |
Q34546580 | Additive regulation of hepatic gene expression by dwarfism and caloric restriction. |
Q34184654 | Adipocyte-specific protein tyrosine phosphatase 1B deletion increases lipogenesis, adipocyte cell size and is a minor regulator of glucose homeostasis |
Q30487354 | Adipogenic and energy metabolism gene networks in longissimus lumborum during rapid post-weaning growth in Angus and Angus x Simmental cattle fed high-starch or low-starch diets |
Q33799720 | Adipose tissue branched chain amino acid (BCAA) metabolism modulates circulating BCAA levels. |
Q51391222 | Adipose triacylglycerol lipase is a major regulator of hepatic lipid metabolism but not insulin sensitivity in mice. |
Q37527258 | Adropin deficiency is associated with increased adiposity and insulin resistance |
Q45154804 | Adult sterol metabolism is not affected by a positive sterol balance in the neonatal Golden Syrian hamster |
Q28552744 | Advanced Running Performance by Genetic Predisposition in Male Dummerstorf Marathon Mice (DUhTP) Reveals Higher Sterol Regulatory Element-Binding Protein (SREBP) Related mRNA Expression in the Liver and Higher Serum Levels of Progesterone |
Q35580451 | Advances in the Understanding and Treatment of Nonalcoholic Fatty Liver Disease |
Q34952133 | Advances in the targeted therapy of liposarcoma |
Q33826583 | Adverse signaling of scavenger receptor class B1 and PGC1s in alcoholic hepatosteatosis and steatohepatitis and protection by betaine in rat. |
Q33824868 | Age-Related Hypercholesterolemia and HMG-CoA Reductase Dysregulation: Sex Does Matter (A Gender Perspective). |
Q37655440 | Age-associated alterations in cholesterol homeostasis: evidence from a cross-sectional study in a Northern Italy population |
Q28242180 | Akt stimulates hepatic SREBP1c and lipogenesis through parallel mTORC1-dependent and independent pathways |
Q36489844 | Alcohol deranges hepatic lipid metabolism via altered transcriptional regulation. |
Q36135903 | Aldo-Keto Reductases 1B in Endocrinology and Metabolism |
Q42377453 | Aliskiren effect on non-alcoholic steatohepatitis in metabolic syndrome |
Q37759137 | Allied industry approaches to alter intramuscular fat content and composition in beef animals. |
Q43177845 | Alloxan-induced diabetes causes morphological and ultrastructural changes in rat liver that resemble the natural history of chronic fatty liver disease in humans. |
Q38798594 | Allyl isothiocyanate suppresses the proteolytic activation of sterol regulatory element-binding proteins and de novo fatty acid and cholesterol synthesis |
Q45067487 | Altered cholesterologenic and lipogenic transcriptional profile in livers of aging Snell dwarf (Pit1dw/dwJ) mice |
Q34400843 | Altered glucose homeostasis in mice with liver-specific deletion of Src homology phosphatase 2 |
Q28508526 | Altered hepatic cholesterol metabolism compensates for disruption of phosphatidylcholine transfer protein in mice |
Q28392301 | Altered lipid metabolism in the aging kidney identified by three layered omic analysis |
Q46968793 | Altered metabolic responses to intermittent hypoxia in mice with partial deficiency of hypoxia-inducible factor-1alpha |
Q44768336 | Altered triglyceride-rich lipoprotein production in Zucker diabetic fatty rats |
Q91828468 | Ambient particulate matter attenuates Sirtuin1 and augments SREBP1-PIR axis to induce human pulmonary fibroblast inflammation: molecular mechanism of microenvironment associated with COPD |
Q36771307 | Amyloid precursor protein controls cholesterol turnover needed for neuronal activity |
Q50879137 | An Essential Role for the Tumor-Suppressor Merlin in Regulating Fatty Acid Synthesis. |
Q51295066 | An Ester of β-Hydroxybutyrate Regulates Cholesterol Biosynthesis in Rats and a Cholesterol Biomarker in Humans. |
Q38926285 | An LXR agonist promotes glioblastoma cell death through inhibition of an EGFR/AKT/SREBP-1/LDLR-dependent pathway |
Q37641438 | An emerging role of mTOR in lipid biosynthesis. |
Q37573880 | An essential requirement for the SCAP/SREBP signaling axis to protect cancer cells from lipotoxicity |
Q59360448 | An important role of SREBP-1 in HBV and HCV co-replication inhibition by PTEN |
Q33186139 | An integrated functional genomics screening program reveals a role for BMP-9 in glucose homeostasis |
Q92565970 | Anabolic androgenic steroids exert a selective remodeling of the plasma lipidome that mirrors the decrease of the de novo lipogenesis in the liver |
Q36302794 | Analysis of bioactive oxysterols in newborn mouse brain by LC/MS. |
Q37280748 | Androgen synthesis in adrenarche |
Q90662016 | Angiotensinogen in hepatocytes contributes to Western diet-induced liver steatosis |
Q28507013 | Ankyrin repeat domain protein 2 and inhibitor of DNA binding 3 cooperatively inhibit myoblast differentiation by physical interaction |
Q40578390 | Anlaysis of complementary expression profiles following WT1 induction versus repression reveals the cholesterol/fatty acid synthetic pathways as a possible major target of WT1. |
Q27653836 | Antagonism of Secreted PCSK9 Increases Low Density Lipoprotein Receptor Expression in HepG2 Cells |
Q58101515 | Anti-Hyperlipidemic Effects of Synthetic Analogs of Nordihydroguaiaretic acid (NDGA) in Dyslipidemic Rats |
Q90230220 | Anti-Metabolic Syndrome Effects of Fucoidan from Fucus vesiculosus via Reactive Oxygen Species-Mediated Regulation of JNK, Akt, and AMPK Signaling |
Q91283900 | Anti-cancer effect of doxorubicin is mediated by downregulation of HMG-Co A reductase via inhibition of EGFR/Src pathway |
Q34685423 | Anti-hyperlipidemic effects and potential mechanisms of action of the caffeoylquinic acid-rich Pandanus tectorius fruit extract in hamsters fed a high fat-diet |
Q47286447 | Anti-leptin receptor antibodies strengthen leptin biofunction in growing chickens |
Q47745044 | Anti-obesity effects of zeaxanthin on 3T3-L1 preadipocyte and high fat induced obese mice |
Q53799057 | Anti-steatotic and anti-inflammatory roles of syringic acid in high-fat diet-induced obese mice. |
Q34687592 | Anticancer effects of Chinese red yeast rice versus monacolin K alone on colon cancer cells |
Q37631570 | Antidiabetic, Lipid Normalizing, and Nephroprotective Actions of the Strawberry: A Potent Supplementary Fruit. |
Q38323472 | Antipsychotic drugs activate SREBP-regulated expression of lipid biosynthetic genes in cultured human glioma cells: a novel mechanism of action? |
Q39765346 | Antipsychotic drugs upregulate lipogenic gene expression by disrupting intracellular trafficking of lipoprotein-derived cholesterol. |
Q34776352 | Antisense oligonucleotide reduction of apoB-ameliorated atherosclerosis in LDL receptor-deficient mice. |
Q38293518 | Antisense oligonucleotides, microRNAs, and antibodies. |
Q38579703 | ApoA-I-Directed Therapies for the Management of Atherosclerosis |
Q52879007 | Apolipoprotein E genotype status affects habitual human blood mononuclear cell gene expression and its response to fish oil intervention. |
Q90419651 | Aqueous Extract of Pepino (Solanum muriactum Ait) Leaves Ameliorate Lipid Accumulation and Oxidative Stress in Alcoholic Fatty Liver Disease |
Q91981109 | Arazyme Suppresses Hepatic Steatosis and Steatohepatitis in Diet-Induced Non-Alcoholic Fatty Liver Disease-Like Mouse Model |
Q33946024 | Arginase inhibition ameliorates hepatic metabolic abnormalities in obese mice |
Q38695535 | Artesunate Activates the Intrinsic Apoptosis of HCT116 Cells through the Suppression of Fatty Acid Synthesis and the NF-κB Pathway. |
Q39012780 | Aryl hydrocarbon receptor-deficient mice are protected from high fat diet-induced changes in metabolic rhythms |
Q90219144 | Ascorbate protects liver from metabolic disorder through inhibition of lipogenesis and suppressor of cytokine signaling 3 (SOCS3) |
Q91199402 | Asiatic acid prevents renal fibrosis in UUO rats via promoting the production of 15d-PGJ2, an endogenous ligand of PPAR-γ |
Q33999784 | Aspergillus fumigatus metabolism: clues to mechanisms of in vivo fungal growth and virulence |
Q90019533 | Assimilation and discrimination of hydrogen isotopes in a terrestrial mammal |
Q36732998 | Association Study Between Metabolic Syndrome and rs8066560 Polymorphism in the Promoter Region of Sterol Regulatory Element-binding Transcription Factor 1 Gene in Iranian Children and Adolescents. |
Q41551428 | Association between SREBP-1 gene expression in mammary gland and milk fat yield in Sarda breed sheep |
Q30241977 | Association between familial hypobetalipoproteinemia and the risk of diabetes. Is this the other side of the cholesterol-diabetes connection? A systematic review of literature |
Q50466501 | Association between single nucleotide polymorphisms of sterol regulatory element binding protein-2 and liver X receptor α gene and risk of polycystic ovary syndrome in a Chinese Han population. |
Q34402269 | Association between single nucleotide polymorphisms of sterol regulatory element binding protein-2 gene and risk of knee osteoarthritis in a Chinese Han population |
Q28264722 | Association between the insulin-induced gene 2 (INSIG2) and weight gain in a German sample of antipsychotic-treated schizophrenic patients: perturbation of SREBP-controlled lipogenesis in drug-related metabolic adverse effects? |
Q57316294 | Associations between Polymorphisms in Genes Involved in Fatty Acid Metabolism and Dietary Fat Intakes |
Q45261580 | Associations of the SREBP-1c gene polymorphism with gender-specific changes in serum lipids induced by a high-carbohydrate diet in healthy Chinese youth |
Q24303810 | Atypical angiopoietin-like protein that regulates ANGPTL3 |
Q53443229 | Atypical antipsychotic drugs perturb AMPK-dependent regulation of hepatic lipid metabolism. |
Q36658341 | Atypical antipsychotics alter cholesterol and fatty acid metabolism in vitro |
Q33770360 | Autophagy deficiency by hepatic FIP200 deletion uncouples steatosis from liver injury in NAFLD. |
Q37677015 | Autophagy in Diabetic Retinopathy |
Q37239685 | Açai (Euterpe oleracea Mart.) Upregulates Paraoxonase 1 Gene Expression and Activity with Concomitant Reduction of Hepatic Steatosis in High-Fat Diet-Fed Rats. |
Q47419246 | Aβ inhibits SREBP-2 activation through Akt inhibition |
Q38769556 | Aβ-Induced Insulin Resistance and the Effects of Insulin on the Cholesterol Synthesis Pathway and Aβ Secretion in Neural Cells |
Q55436860 | BHLHE40, a third transcription factor required for insulin induction of SREBP-1c mRNA in rodent liver. |
Q55073612 | Balanced mTORC1 activity in oligodendrocytes is required for accurate CNS myelination. |
Q37843766 | Bariatric surgery and renal function |
Q30377409 | Beneficial Effect of Synbiotic Supplementation on Hepatic Steatosis and Anthropometric Parameters, But Not on Gut Permeability in a Population with Nonalcoholic Steatohepatitis. |
Q99555726 | Beneficial Effects of Newly Isolated Akkermansia muciniphila Strains from the Human Gut on Obesity and Metabolic Dysregulation |
Q92733664 | Beneficial Effects of SREBP Decoy Oligodeoxynucleotide in an Animal Model of Hyperlipidemia |
Q97524395 | Beneficial effects of Chinese herbs in the treatment of fatty liver diseases |
Q36803841 | Beneficial effects of flaxseed oil and fish oil diet are through modulation of different hepatic genes involved in lipid metabolism in streptozotocin-nicotinamide induced diabetic rats |
Q37465547 | Berberine Alleviates Olanzapine-Induced Adipogenesis via the AMPKα-SREBP Pathway in 3T3-L1 Cells. |
Q36560010 | Berberine prevents progression from hepatic steatosis to steatohepatitis and fibrosis by reducing endoplasmic reticulum stress. |
Q35022545 | Berberine regulated Gck, G6pc, Pck1 and Srebp-1c expression and activated AMP-activated protein kinase in primary rat hepatocytes |
Q42678983 | Betaine attenuates chronic alcohol‑induced fatty liver by broadly regulating hepatic lipid metabolism |
Q37199135 | Bezafibrate at clinically relevant doses decreases serum/liver triglycerides via down-regulation of sterol regulatory element-binding protein-1c in mice: a novel peroxisome proliferator-activated receptor alpha-independent mechanism |
Q33734679 | Bifurcation of insulin signaling pathway in rat liver: mTORC1 required for stimulation of lipogenesis, but not inhibition of gluconeogenesis |
Q27002873 | Bile acid metabolism and signaling |
Q57128781 | Bile acid receptors link nutrient sensing to metabolic regulation |
Q28244875 | Bile acid signaling in metabolic disease and drug therapy |
Q28027885 | Bile acid transporters: structure, function, regulation and pathophysiological implications |
Q36237907 | Bile acids and sphingosine-1-phosphate receptor 2 in hepatic lipid metabolism |
Q37297846 | Bile acids as regulatory molecules |
Q33785270 | Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c |
Q37487196 | Binding between the Niemann-Pick C1 protein and a photoactivatable cholesterol analog requires a functional sterol-sensing domain |
Q44366212 | Binding of polyunsaturated fatty acids to LXRα and modulation of SREBP-1 interaction with a specific SCD1 promoter element. |
Q47703395 | Biochemical and cellular properties of insulin receptor signalling |
Q44265890 | Biomedicine. Lowering LDL--not only how low, but how long? |
Q36303323 | Biosynthesis of conjugated linoleic acid in ruminants and humans |
Q37160039 | Bisphenol A Exposure May Induce Hepatic Lipid Accumulation via Reprogramming the DNA Methylation Patterns of Genes Involved in Lipid Metabolism |
Q90061747 | Black Raspberry (Rubus coreanus Miquel) Promotes Browning of Preadipocytes and Inguinal White Adipose Tissue in Cold-Induced Mice |
Q36053138 | Blockade of MCH1 receptor signalling ameliorates obesity and related hepatic steatosis in ovariectomized mice |
Q36020286 | Blockade of cholesterol absorption by ezetimibe reveals a complex homeostatic network in enterocytes |
Q90596865 | Blocking FSH inhibits hepatic cholesterol biosynthesis and reduces serum cholesterol |
Q36124825 | Body Mass Index and Metastatic Renal Cell Carcinoma: Clinical and Biological Correlations |
Q31130773 | Bovine mammary gene expression profiling during the onset of lactation |
Q96155759 | Brahma Related Gene 1 (Brg1) Regulates Cellular Cholesterol Synthesis by Acting as a Co-factor for SREBP2 |
Q30477204 | Brain cholesterol turnover required for geranylgeraniol production and learning in mice |
Q48288318 | Brain glucose metabolism controls the hepatic secretion of triglyceride-rich lipoproteins |
Q38189850 | Brain microRNAs and insights into biological functions and therapeutic potential of brain enriched miRNA-128. |
Q54315353 | Branched-Chain Amino Acid-Rich Supplements Containing Microelements Have Antioxidant Effects on Nonalcoholic Steatohepatitis in Mice. |
Q33827812 | CIDE gene expression in adipose tissue, liver, and skeletal muscle from obese and lean pigs |
Q98944866 | COVID-19-activated SREBP2 disturbs cholesterol biosynthesis and leads to cytokine storm |
Q24338672 | CREB4, a transmembrane bZip transcription factor and potential new substrate for regulation and cleavage by S1P. |
Q37005595 | CREBH-FGF21 axis improves hepatic steatosis by suppressing adipose tissue lipolysis |
Q59351846 | CVB3 Nonstructural 2A Protein Modulates SREBP1a Signaling via the MEK/ERK Pathway |
Q34049446 | Caffeine attenuates lipid accumulation via activation of AMP-activated protein kinase signaling pathway in HepG2 cells |
Q64062072 | Caffeine-free hawk tea lowers cholesterol by reducing free cholesterol uptake and the production of very-low-density lipoprotein |
Q90438674 | Calorie-Restriction-Induced Insulin Sensitivity Is Mediated by Adipose mTORC2 and Not Required for Lifespan Extension |
Q93015092 | Camellia (Camellia oleifera Abel.) seed oil promotes milk fat and protein synthesis-related gene expression in bovine mammary epithelial cells |
Q35897695 | Camphene, a Plant Derived Monoterpene, Exerts Its Hypolipidemic Action by Affecting SREBP-1 and MTP Expression |
Q39179689 | Can LDL cholesterol be too low? Possible risks of extremely low levels |
Q43134504 | Can tetracycline antibiotics duplicate the ability of azithromycin to stimulate human meibomian gland epithelial cell differentiation? |
Q38044956 | Cannabinoid 1 receptor in fatty liver |
Q39267584 | Canonical microRNAs Enable Differentiation, Protect Against DNA Damage, and Promote Cholesterol Biosynthesis in Neural Stem Cells. |
Q64080416 | Capsaicin Targets Lipogenesis in HepG2 Cells Through AMPK Activation, AKT Inhibition and PPARs Regulation |
Q54977465 | Capsaicinoids improve consequences of physical activity. |
Q37244695 | Carbohydrate response element binding protein gene expression is positively regulated by thyroid hormone |
Q45558516 | Carbohydrate-response-element-binding protein (ChREBP) and not the liver X receptor α (LXRα) mediates elevated hepatic lipogenic gene expression in a mouse model of glycogen storage disease type 1 |
Q35861635 | Carbon source metabolism and its regulation in cancer cells |
Q28591917 | Carcinoembryonic antigen-related cell adhesion molecule 1: a link between insulin and lipid metabolism |
Q28513543 | Carcinoembryonic antigen-related cell adhesion molecule 2 controls energy balance and peripheral insulin action in mice |
Q59136837 | Carvacrol reduces adipogenic differentiation by modulating autophagy and ChREBP expression |
Q37536508 | Casein kinase 1 regulates sterol regulatory element-binding protein (SREBP) to control sterol homeostasis |
Q40361392 | Caspase-2, a novel lipid sensor under the control of sterol regulatory element binding protein 2. |
Q95265626 | Catalpol Attenuates Hepatic Steatosis by Regulating Lipid Metabolism via AMP-Activated Protein Kinase Activation |
Q97643589 | Caught in the genetic network: a novel regulator of lipid metabolism |
Q28511396 | Cdc2-like kinase 2 is an insulin-regulated suppressor of hepatic gluconeogenesis |
Q35889110 | Cell and molecular mechanisms of insulin-induced angiogenesis |
Q36645721 | Cell type-dependent pro- and anti-inflammatory role of signal transducer and activator of transcription 3 in alcoholic liver injury |
Q34464888 | Cellular and molecular effect of MEHP Involving LXRα in human fetal testis and ovary. |
Q37092913 | Cellular fatty acid metabolism and cancer |
Q34732190 | Central nervous system: cholesterol turnover, brain development and neurodegeneration |
Q37388544 | Central role for liver X receptor in insulin-mediated activation of Srebp-1c transcription and stimulation of fatty acid synthesis in liver. |
Q34290846 | Central role of SREBP-2 in the pathogenesis of osteoarthritis |
Q24564225 | Central role of suppressors of cytokine signaling proteins in hepatic steatosis, insulin resistance, and the metabolic syndrome in the mouse |
Q37395843 | ChREBP regulates fructose-induced glucose production independently of insulin signaling |
Q39156264 | Changes in cholesterol homeostasis modify the response of F1B hamsters to dietary very long chain n-3 and n-6 polyunsaturated fatty acids |
Q37085056 | Characteristics of oxysterol binding proteins. |
Q24305155 | Characterization of mouse short-chain aldehyde reductase (SCALD), an enzyme regulated by sterol regulatory element-binding proteins |
Q24598294 | Characterization of the human insulin-induced gene 2 (INSIG2) promoter: the role of Ets-binding motifs |
Q39695623 | Chemical combinations elucidate pathway interactions and regulation relevant to Hepatitis C replication |
Q63246525 | Chewing the Fat: The Conserved Ability of DNA Viruses to Hijack Cellular Lipid Metabolism |
Q51258146 | Chicoric acid attenuate a nonalcoholic steatohepatitis by inhibiting key regulators of lipid metabolism, fibrosis, oxidation, and inflammation in mice with methionine and choline deficiency. |
Q49951009 | Chinese olive extract ameliorates hepatic lipid accumulation in vitro and in vivo by regulating lipid metabolism |
Q64242985 | Cholesterol Metabolism: A Potential Therapeutic Target in Glioblastoma |
Q64948306 | Cholesterol Trafficking: An Emerging Therapeutic Target for Angiogenesis and Cancer. |
Q45081451 | Cholesterol and 25-hydroxycholesterol inhibit activation of SREBPs by different mechanisms, both involving SCAP and Insigs |
Q37722680 | Cholesterol as a causative factor in Alzheimer's disease: a debatable hypothesis |
Q38718368 | Cholesterol auxotrophy and intolerance to ezetimibe in mice with SREBP-2 deficiency in the intestine |
Q64266714 | Cholesterol enrichment in liver mitochondria impairs oxidative phosphorylation and disrupts the assembly of respiratory supercomplexes |
Q24652984 | Cholesterol feedback: from Schoenheimer's bottle to Scap's MELADL |
Q34809782 | Cholesterol in health and disease |
Q35941122 | Cholesterol metabolism and its implications for therapeutic interventions in patients with hypercholesterolaemia |
Q26738307 | Cholesterol metabolism in cholestatic liver disease and liver transplantation: From molecular mechanisms to clinical implications |
Q58553192 | Cholesterol metabolism in innate and adaptive response |
Q89935777 | Cholesterol metabolism regulation mediated by SREBP-2, LXRα and miR-33a in rainbow trout (Oncorhynchus mykiss) both in vivo and in vitro |
Q64965319 | Cholesterol metabolism-physiological regulation and pathophysiological deregulation by the endoplasmic reticulum. |
Q34377251 | Cholesterol modulates human intestinal sodium-dependent bile acid transporter |
Q88618152 | Cholesterol negatively regulates IL-9-producing CD8+ T cell differentiation and antitumor activity |
Q61454738 | Cholesterol pathway the Achilles heel in prostate cancer metastasis |
Q35607325 | Cholesterol synthesis is associated with hepatic lipid content and dependent on fructose/glucose intake in healthy humans |
Q42257091 | Cholesterol-Independent SREBP-1 Maturation Is Linked to ARF1 Inactivation |
Q33417684 | Cholesterol-dependent anaplasma phagocytophilum exploits the low-density lipoprotein uptake pathway |
Q24685842 | Cholesterol-induced conformational change in SCAP enhanced by Insig proteins and mimicked by cationic amphiphiles |
Q36086300 | Cholesterol-lowering Action of BNA-based Antisense Oligonucleotides Targeting PCSK9 in Atherogenic Diet-induced Hypercholesterolemic Mice |
Q36776696 | Cholesterol: from feeding to gene regulation |
Q28504868 | Chromatin remodeling complex interacts with ADD1/SREBP1c to mediate insulin-dependent regulation of gene expression |
Q89658772 | Chronic Microcystin-LR Exposure Induces Abnormal Lipid Metabolism via Endoplasmic Reticulum Stress in Male Zebrafish |
Q45928058 | Chronic Rhodiola rosea extract supplementation enforces exhaustive swimming tolerance. |
Q34904117 | Chronic administration of proanthocyanidins or docosahexaenoic acid reverses the increase of miR-33a and miR-122 in dyslipidemic obese rats. |
Q45261151 | Chronic ethanol feeding and folate deficiency activate hepatic endoplasmic reticulum stress pathway in micropigs |
Q36514288 | Chronic exposure to low-dose arsenic modulates lipogenic gene expression in mice |
Q38323357 | Chronic intermittent hypoxia upregulates genes of lipid biosynthesis in obese mice |
Q34559843 | Chronic social defeat stress disrupts regulation of lipid synthesis |
Q64101969 | Cideb controls sterol-regulated ER export of SREBP/SCAP by promoting cargo loading at ER exit sites |
Q37726319 | Cinnamon Polyphenol Extract Inhibits Hyperlipidemia and Inflammation by Modulation of Transcription Factors in High-Fat Diet-Fed Rats |
Q42800723 | Cinnamyl Alcohol, the Bioactive Component of Chestnut Flower Absolute, Inhibits Adipocyte Differentiation in 3T3-L1 Cells by Downregulating Adipogenic Transcription Factors |
Q92882095 | Circadian lipid synthesis in brown fat maintains murine body temperature during chronic cold |
Q101226470 | Circulating expression of Hsa_circRNA_102893 contributes to early gestational diabetes mellitus detection |
Q58611996 | Circulating miRNA measurements are reflective of cholesterol-based changes in rainbow trout (Oncorhynchus mykiss) |
Q39094141 | Cirsium brevicaule A. GRAY leaf inhibits adipogenesis in 3T3-L1 cells and C57BL/6 mice |
Q34668864 | Citrus flavonoids repress the mRNA for stearoyl-CoA desaturase, a key enzyme in lipid synthesis and obesity control, in rat primary hepatocytes |
Q37420502 | Clinical Significance of Determining Plasma MicroRNA33b in Type 2 Diabetic Patients with Dyslipidemia |
Q38549782 | Clinically Relevant Mechanisms of Lipid Synthesis, Transport, and Storage |
Q35111476 | Clinically used selective oestrogen receptor modulators increase LDL receptor activity in primary human lymphocytes. |
Q30319871 | Clofibrate causes an upregulation of PPAR-{alpha} target genes but does not alter expression of SREBP target genes in liver and adipose tissue of pigs |
Q46510270 | Cloning and Characterization of Lxr and Srebp1, and Their Potential Roles in Regulation of LC-PUFA Biosynthesis in Rabbitfish Siganus canaliculatus |
Q42685997 | Cloning, comparative characterization of porcine SCAP gene, and identification of its two splice variants |
Q40260041 | Closely related colon cancer cell lines display different sensitivity to polyunsaturated fatty acids, accumulate different lipid classes and downregulate sterol regulatory element-binding protein 1. |
Q33267280 | Clues to neuro-degeneration in Niemann-Pick type C disease from global gene expression profiling |
Q89810232 | Collaborative interactions of heterogenous ribonucleoproteins contribute to transcriptional regulation of sterol metabolism in mice |
Q36503263 | Combination of deep sea water and Sesamum indicum leaf extract prevents high-fat diet-induced obesity through AMPK activation in visceral adipose tissue |
Q24683425 | Combined analysis of oligonucleotide microarray data from transgenic and knockout mice identifies direct SREBP target genes |
Q84509552 | Combined effect of sesamin and α-lipoic acid on hepatic fatty acid metabolism in rats |
Q64108612 | Combined effects of ambient particulate matter exposure and a high-fat diet on oxidative stress and steatohepatitis in mice |
Q25255682 | Combined expression trait correlations and expression quantitative trait locus mapping |
Q38619155 | Combined transcriptome and metabolome analyses of metformin effects reveal novel links between metabolic networks in steroidogenic systems. |
Q92267409 | Comparative RNA-sequencing profiled the differential gene expression of liver in response to acetyl-CoA carboxylase inhibitor GS-0976 in a mouse model of NASH |
Q34600814 | Comparative analysis of sesame lignans (sesamin and sesamolin) in affecting hepatic fatty acid metabolism in rats |
Q33464797 | Comparison of electrospray ionization and atmospheric chemical ionization coupled with the liquid chromatography-tandem mass spectrometry for the analysis of cholesteryl esters |
Q37087635 | Comparison of in vivo effects of insulin on SREBP-1c activation and INSIG-1/2 in rat liver and human and rat adipose tissue |
Q28508811 | Compensatory increase in fatty acid synthesis in adipose tissue of mice with conditional deficiency of SCAP in liver |
Q37325136 | Complex assembly on the human CYP17 promoter |
Q37400096 | Complex structure of the fission yeast SREBP-SCAP binding domains reveals an oligomeric organization |
Q33591054 | Comprehensive analyses of DNA repair pathways, smoking and bladder cancer risk in Los Angeles and Shanghai |
Q37496600 | Conjugated and free sterols from black bean (Phaseolus vulgaris L.) seed coats as cholesterol micelle disruptors and their effect on lipid metabolism and cholesterol transport in rat primary hepatocytes. |
Q30855130 | Connecting gene expression data from connectivity map and in silico target predictions for small molecule mechanism-of-action analysis. |
Q34949033 | Consequences of cellular cholesterol accumulation: basic concepts and physiological implications |
Q34472170 | Consequences of exchanging carbohydrates for proteins in the cholesterol metabolism of mice fed a high-fat diet |
Q33953637 | Conserved role of SIRT1 orthologs in fasting-dependent inhibition of the lipid/cholesterol regulator SREBP. |
Q36289207 | Construction and evaluation of an adenoviral vector for the liver-specific expression of the serine/arginine-rich splicing factor, SRSF3. |
Q37034365 | Contribution of Accelerated Degradation to Feedback Regulation of 3-Hydroxy-3-methylglutaryl Coenzyme A Reductase and Cholesterol Metabolism in the Liver |
Q37486355 | Contributions of hyperhomocysteinemia to atherosclerosis: Causal relationship and potential mechanisms |
Q91673069 | Control of LDL Uptake in Human Cells by Targeting the LDLR Regulatory Long Non-coding RNA BM450697 |
Q49211331 | Control of Muscle Metabolism by the Mediator Complex |
Q34119006 | Control of cholesterol synthesis through regulated ER-associated degradation of HMG CoA reductase |
Q36650322 | Convergent Signaling Pathways Controlled by LRP1 (Receptor-related Protein 1) Cytoplasmic and Extracellular Domains Limit Cellular Cholesterol Accumulation |
Q35857084 | Cooperative interaction between hepatocyte nuclear factor 4 alpha and GATA transcription factors regulates ATP-binding cassette sterol transporters ABCG5 and ABCG8. |
Q34191246 | Coordinate Transcriptomic and Metabolomic Effects of the Insulin Sensitizer Rosiglitazone on Fundamental Metabolic Pathways in Liver, Soleus Muscle, and Adipose Tissue in Diabetic db/db Mice |
Q44512717 | Copper induces the expression of cholesterogenic genes in human macrophages |
Q33727315 | Coronary Artery Disease-Associated LIPA Coding Variant rs1051338 Reduces Lysosomal Acid Lipase Levels and Activity in Lysosomes. |
Q92059085 | Corticosterone-mediated physiological stress modulates hepatic lipid metabolism, metabolite profiles, and systemic responses in chickens |
Q33874248 | Cross-talk between hypoxia and insulin signaling through Phd3 regulates hepatic glucose and lipid metabolism and ameliorates diabetes |
Q93161614 | CtBP promotes metastasis of breast cancer through repressing cholesterol and activating TGF-β signaling |
Q88064814 | Curcumin and dietary polyphenol research: beyond drug discovery |
Q38840947 | Curcumin attenuates ethanol-induced hepatic steatosis through modulating Nrf2/FXR signaling in hepatocytes |
Q37482957 | Curcumin inhibits srebp-2 expression in activated hepatic stellate cells in vitro by reducing the activity of specificity protein-1 |
Q41919315 | Curcumin suppresses expression of low-density lipoprotein (LDL) receptor, leading to the inhibition of LDL-induced activation of hepatic stellate cells |
Q97526776 | Current Evidences and Future Perspectives for AMPK in the Regulation of Milk Production and Mammary Gland Biology |
Q26749224 | Current trends in oxysterol research |
Q35688145 | Cyclin Y Is Involved in the Regulation of Adipogenesis and Lipid Production |
Q36911423 | Cytochrome P450--physiological key factor against cholesterol accumulation and the atherosclerotic vascular process |
Q24320231 | DC-STAMP interacts with ER-resident transcription factor LUMAN which becomes activated during DC maturation |
Q97525815 | Deciphering Macrophage Phenotypes upon Lipid Uptake and Atherosclerosis |
Q34626518 | Deciphering the nuclear bile acid receptor FXR paradigm |
Q36063700 | Deciphering the roles of the constitutive androstane receptor in energy metabolism |
Q34510189 | Deciphering the transcriptional-regulatory network of flocculation in Schizosaccharomyces pombe |
Q92398568 | Decoding inflammation, its causes, genomic responses, and emerging countermeasures |
Q28588292 | Decreased plasma cholesterol and hypersensitivity to statins in mice lacking Pcsk9 |
Q93000058 | Deep transcriptome analysis using RNA-Seq suggests novel insights into molecular aspects of fat-tail metabolism in sheep |
Q43215288 | Deepure Tea Improves High Fat Diet-Induced Insulin Resistance and Nonalcoholic Fatty Liver Disease |
Q35027768 | Deficiency in Nrf2 transcription factor decreases adipose tissue mass and hepatic lipid accumulation in leptin-deficient mice |
Q33706071 | Deficiency of the transcriptional repressor B cell lymphoma 6 (Bcl6) is accompanied by dysregulated lipid metabolism |
Q47875169 | Degradation of PHLPP2 by KCTD17, via a Glucagon-Dependent Pathway, Promotes Hepatic Steatosis |
Q37089101 | Deletion of ELOVL5 leads to fatty liver through activation of SREBP-1c in mice |
Q34565290 | Deletion of ELOVL6 blocks the synthesis of oleic acid but does not prevent the development of fatty liver or insulin resistance |
Q50978081 | Deletion of HNF1α in hepatocytes results in fatty liver-related hepatocellular carcinoma in mice. |
Q37081953 | Deletion of Scap in alveolar type II cells influences lung lipid homeostasis and identifies a compensatory role for pulmonary lipofibroblasts. |
Q46755385 | Demonstration of diet-induced decoupling of fatty acid and cholesterol synthesis by combining gene expression array and 2H2O quantification |
Q33695928 | Desalinated underground seawater of Jeju Island (Korea) improves lipid metabolism in mice fed diets containing high fat and increases antioxidant potential in t-BHP treated HepG2 cells |
Q39877327 | Desmosterol can replace cholesterol in sustaining cell proliferation and regulating the SREBP pathway in a sterol-Delta24-reductase-deficient cell line |
Q46699493 | Determinants of variable response to simvastatin treatment: the role of common variants of SCAP, SREBF-1a and SREBF-2 genes |
Q36744605 | Deubiquitylase Inhibition Reveals Liver X Receptor-independent Transcriptional Regulation of the E3 Ubiquitin Ligase IDOL and Lipoprotein Uptake |
Q90282381 | Development and Application of FASA, a Model for Quantifying Fatty Acid Metabolism Using Stable Isotope Labeling |
Q37444112 | Development of nonalcoholic steatohepatitis in insulin-resistant liver-specific S503A carcinoembryonic antigen-related cell adhesion molecule 1 mutant mice |
Q38653024 | Developmental and extrahepatic physiological functions of SREBP pathway genes in mice |
Q35499561 | Diabetes and Insulin in Regulation of Brain Cholesterol Metabolism |
Q38105993 | Diagnosis and management of familial dyslipoproteinemias |
Q35800445 | Diet as a risk factor for cholesterol gallstone disease. |
Q36125408 | Diet high in fat and sucrose induces rapid onset of obesity-related metabolic syndrome partly through rapid response of genes involved in lipogenesis, insulin signalling and inflammation in mice |
Q90596855 | Diet-Induced Circadian Enhancer Remodeling Synchronizes Opposing Hepatic Lipid Metabolic Processes |
Q43481512 | Diet-induced dyslipidemia impairs reverse cholesterol transport in hamsters |
Q47956509 | Dietary Fatty Acid Composition Modulates Obesity and Interacts with Obesity-Related Genes |
Q92662926 | Dietary Silk Peptide Prevents High-Fat Diet-Induced Obesity and Promotes Adipose Browning by Activating AMP-Activated Protein Kinase in Mice |
Q34076091 | Dietary cholesterol promotes adipocyte hypertrophy and adipose tissue inflammation in visceral, but not in subcutaneous, fat in monkeys |
Q33999048 | Dietary cholesterol reduces plasma triacylglycerol in apolipoprotein E-null mice: suppression of lipin-1 and -2 in the glycerol-3-phosphate pathway |
Q50677335 | Dietary cholesterol supplementation to a plant-based diet suppresses the complete pathway of cholesterol synthesis and induces bile acid production in Atlantic salmon (Salmo salar L.). |
Q34661688 | Dietary fat content and fiber type modulate hind gut microbial community and metabolic markers in the pig. |
Q35992718 | Dietary fat intake promotes the development of hepatic steatosis independently from excess caloric consumption in a murine model. |
Q36221625 | Dietary fiber prevents obesity-related liver lipotoxicity by modulating sterol-regulatory element binding protein pathway in C57BL/6J mice fed a high-fat/cholesterol diet |
Q28569638 | Dietary lipoic acid-dependent changes in the activity and mRNA levels of hepatic lipogenic enzymes in rats |
Q40987059 | Dietary restriction, caloric value and the accumulation of hepatic fat. |
Q33758991 | Dietary saponins of sea cucumber alleviate orotic acid-induced fatty liver in rats via PPARalpha and SREBP-1c signaling |
Q36335120 | Dietary sea cucumber cerebroside alleviates orotic acid-induced excess hepatic adipopexis in rats |
Q39450746 | Dietary ɛ-Polylysine Decreased Serum and Liver Lipid Contents by Enhancing Fecal Lipid Excretion Irrespective of Increased Hepatic Fatty Acid Biosynthesis-Related Enzymes Activities in Rats |
Q35048444 | Diets containing sea cucumber (Isostichopus badionotus) meals are hypocholesterolemic in young rats |
Q41888201 | Differential Regulation of Gene Expression by Cholesterol Biosynthesis Inhibitors That Reduce (Pravastatin) or Enhance (Squalestatin 1) Nonsterol Isoprenoid Levels in Primary Cultured Mouse and Rat Hepatocytes |
Q89954501 | Differential effects of Chinese high-fat dietary habits on lipid metabolism: mechanisms and health implications |
Q44619259 | Differential effects of polyunsaturated fatty acids on sterol synthesis rates in adult and fetal tissues of the hamster: consequence of altered sterol balance |
Q30492215 | Differential expression and function of ABCG1 and ABCG4 during development and aging |
Q36769335 | Differential expression of hepatic genes involved in cholesterol homeostasis in high- and low-responding strains of laboratory opossums |
Q84763447 | Differential expression of lipid metabolism related genes in porcine muscle tissue leading to different intramuscular fat deposition |
Q36198324 | Differential mRNA expression of seven genes involved in cholesterol metabolism and transport in the liver of atherosclerosis-susceptible and -resistant Japanese quail strains. |
Q30412216 | Differential regulation of gene expression by LXRs in response to macrophage cholesterol loading |
Q28743462 | Differential roles of hyperglycemia and hypoinsulinemia in diabetes induced retinal cell death: evidence for retinal insulin resistance |
Q28085501 | Diosgenin, 4-hydroxyisoleucine, and fiber from fenugreek: mechanisms of actions and potential effects on metabolic syndrome |
Q37066522 | Direct Demonstration That Loop1 of Scap Binds to Loop7: A CRUCIAL EVENT IN CHOLESTEROL HOMEOSTASIS. |
Q37008856 | Direct Hepatocyte Insulin Signaling Is Required for Lipogenesis but Is Dispensable for the Suppression of Glucose Production |
Q39848785 | Dislocation of HMG-CoA reductase and Insig-1, two polytopic endoplasmic reticulum proteins, en route to proteasomal degradation |
Q37511111 | Disruption of cholesterol homeostasis by plant sterols |
Q36196777 | Disruption of ldlr causes increased LDL-c and vascular lipid accumulation in a zebrafish model of hypercholesterolemia |
Q34536893 | Disruption of the acyl-CoA-binding protein gene delays hepatic adaptation to metabolic changes at weaning |
Q36867631 | Disruption of the cereblon gene enhances hepatic AMPK activity and prevents high-fat diet-induced obesity and insulin resistance in mice. |
Q37472798 | Dissecting the role of insulin resistance in the metabolic syndrome |
Q28506866 | Distinct C/EBPalpha motifs regulate lipogenic and gluconeogenic gene expression in vivo |
Q55197599 | Distinct correlations between lipogenic gene expression and fatty acid composition of subcutaneous fat among cattle breeds. |
Q28513775 | Distinct roles of insulin and liver X receptor in the induction and cleavage of sterol regulatory element-binding protein-1c |
Q28586335 | Disturbed cholesterol homeostasis in a peroxisome-deficient PEX2 knockout mouse model |
Q47708428 | Divergent effects of glucose and fructose on hepatic lipogenesis and insulin signaling |
Q34190312 | Diversity, topographic differentiation, and positional memory in human fibroblasts |
Q24553299 | Do oxysterols control cholesterol homeostasis? |
Q36725271 | Docosahexaenoic acid (DHA) and hepatic gene transcription |
Q38352477 | Docosahexaenoic acid activates some SREBP-2 targets independent of cholesterol and ER stress in SW620 colon cancer cells |
Q28576771 | Docosahexaneoic acid (22:6,n-3) regulates rat hepatocyte SREBP-1 nuclear abundance by Erk- and 26S proteasome-dependent pathways |
Q47923241 | Does Sirt2 Regulate Cholesterol Biosynthesis During Oligodendroglial Differentiation In Vitro and In Vivo? |
Q37659358 | Dose-dependent effects of siRNA-mediated inhibition of SCAP on PCSK9, LDLR, and plasma lipids in mouse and rhesus monkey |
Q37155389 | Down-regulation of hepatic HNF4alpha gene expression during hyperinsulinemia via SREBPs |
Q49959094 | Downregulation of SREBP inhibits tumor growth and initiation by altering cellular metabolism in colon cancer |
Q36300675 | Drosophila TRF2 and TAF9 regulate lipid droplet size and phospholipid fatty acid composition |
Q33260941 | Drug-induced activation of SREBP-controlled lipogenic gene expression in CNS-related cell lines: marked differences between various antipsychotic drugs |
Q26866577 | Dual functions of Insig proteins in cholesterol homeostasis |
Q28540472 | Dual mode action of mangiferin in mouse liver under high fat diet |
Q90466739 | Dynamic MTORC1-TFEB feedback signaling regulates hepatic autophagy, steatosis and liver injury in long-term nutrient oversupply |
Q64113157 | Dynamic repression by BCL6 controls the genome-wide liver response to fasting and steatosis |
Q45298923 | Dysfunction of the cholesterol biosynthetic pathway in Huntington's disease. |
Q37135525 | Dyslipidemia and atherosclerosis induced by chronic intermittent hypoxia are attenuated by deficiency of stearoyl coenzyme A desaturase |
Q37076334 | Dysregulated signaling hubs of liver lipid metabolism reveal hepatocellular carcinoma pathogenesis |
Q59340519 | Dysregulation of cardiac lipid parameters in high-fat high-cholesterol diet-induced rat model |
Q33746400 | Dysregulation of sterol regulatory element binding protein-1c in livers of morbidly obese women is associated with altered suppressor of cytokine signaling-3 and signal transducer and activator of transcription-1 signaling |
Q36727852 | Dysregulation of the Low-Density Lipoprotein Receptor Pathway Is Involved in Lipid Disorder-Mediated Organ Injury |
Q37033133 | E4BP4 is an insulin-induced stabilizer of nuclear SREBP-1c and promotes SREBP-1c-mediated lipogenesis. |
Q34296575 | EGFR signaling through an Akt-SREBP-1-dependent, rapamycin-resistant pathway sensitizes glioblastomas to antilipogenic therapy |
Q33396126 | ELT-2 is the predominant transcription factor controlling differentiation and function of the C. elegans intestine, from embryo to adult. |
Q61444249 | ENOblock inhibits the pathology of diet-induced obesity |
Q37685967 | ENOblock, a unique small molecule inhibitor of the non-glycolytic functions of enolase, alleviates the symptoms of type 2 diabetes. |
Q33620277 | ER stress and hepatic lipid metabolism |
Q42088790 | ERp57 modulates STAT3 signaling from the lumen of the endoplasmic reticulum |
Q35313420 | Early growth response 1 (Egr1) regulates cholesterol biosynthetic gene expression |
Q50959095 | Early inflammation-associated factors blunt sterol regulatory element-binding proteins-1-mediated lipogenesis in high-fat diet-fed APPSWE /PSEN1dE9 mouse model of Alzheimer's disease. |
Q34221799 | Early steps in steroidogenesis: intracellular cholesterol trafficking |
Q53270887 | Effect and mechanism of waterborne prolonged Zn exposure influencing hepatic lipid metabolism in javelin goby Synechogobius hasta. |
Q33494969 | Effect of CAR activation on selected metabolic pathways in normal and hyperlipidemic mouse livers |
Q35783538 | Effect of Creosote Bush-Derived NDGA on Expression of Genes Involved in Lipid Metabolism in Liver of High-Fructose Fed Rats: Relevance to NDGA Amelioration of Hypertriglyceridemia and Hepatic Steatosis |
Q41064729 | Effect of Ganoderma lucidum spores intervention on glucose and lipid metabolism gene expression profiles in type 2 diabetic rats. |
Q99246655 | Effect of INSIG1 on the milk fat synthesis of buffalo mammary epithelial cells |
Q41006475 | Effect of anti-hyperlipidemia drugs on the alpha-tocopherol concentration and their potential for murine malaria infection |
Q42995318 | Effect of bezafibrate on hepatic oxidative stress: comparison between conventional experimental doses and clinically-relevant doses in mice |
Q49923423 | Effect of brimonidine, an α2 adrenergic agonist, on human meibomian gland epithelial cells. |
Q28588503 | Effect of deficiency in SREBP cleavage-activating protein on lipid metabolism during intermittent hypoxia |
Q41498850 | Effect of dietary conjugated linoleic acid isomers on lipid metabolism in hamsters fed high-carbohydrate and high-fat diets |
Q99578828 | Effect of dietary oils from various sources on carbohydrate and fat metabolism in mice |
Q33804734 | Effect of ezetimibe on hepatic fat, inflammatory markers, and apolipoprotein B-100 kinetics in insulin-resistant obese subjects on a weight loss diet |
Q50108375 | Effect of genetic polymorphisms in SREBF-SCAP pathway on therapeutic response to rosuvastatin in Saudi metabolic syndrome patients. |
Q36951041 | Effect of high-intensity exercise and high-fat diet on lipid metabolism in the liver of rats |
Q35122536 | Effect of sofosbuvir and ribavirin treatment on peripheral and hepatic lipid metabolism in chronic hepatitis C virus, genotype 1-infected patients |
Q30986308 | Effect of the feeding system on the fatty acid composition, expression of the Delta9-desaturase, Peroxisome Proliferator-Activated Receptor Alpha, Gamma, and Sterol Regulatory Element Binding Protein 1 genes in the semitendinous muscle of light [...] |
Q55132113 | Effects of Dietary Intake of Japanese Mushrooms on Visceral Fat Accumulation and Gut Microbiota in Mice. |
Q91656920 | Effects of Gelidium elegans on Weight and Fat Mass Reduction and Obesity Biomarkers in Overweight or Obese Adults: A Randomized Double-Blinded Study |
Q35053466 | Effects of HIV protease inhibitor therapy on lipid metabolism |
Q34987299 | Effects of Long-Term Supplementation of Blue-Green Algae on Lipid Metabolism in C57BL/6J mice. |
Q92082401 | Effects of Paramylon Extracted from Euglena gracilis EOD-1 on Parameters Related to Metabolic Syndrome in Diet-Induced Obese Mice |
Q33959600 | Effects of SREBF-1a and SCAP polymorphisms on plasma levels of lipids, severity, progression and regression of coronary atherosclerosis and response to therapy with fluvastatin |
Q34955169 | Effects of adiposity on plasma lipid response to reductions in dietary saturated fatty acids and cholesterol |
Q34776347 | Effects of antisense-mediated inhibition of 11β-hydroxysteroid dehydrogenase type 1 on hepatic lipid metabolism |
Q38289690 | Effects of atherogenic diet and atorvastatin treatment on gene expression profiles in the C57BL/6J mouse liver |
Q39474573 | Effects of atorvastatin metabolites on induction of drug-metabolizing enzymes and membrane transporters through human pregnane X receptor |
Q27312061 | Effects of dietary pantothenic acid on growth, intestinal function, anti-oxidative status and fatty acids synthesis of juvenile blunt snout bream Megalobrama amblycephala |
Q48638860 | Effects of dietary sea cucumber saponin on the gene expression rhythm involved in circadian clock and lipid metabolism in mice during nighttime-feeding |
Q46097289 | Effects of elevated fatty acid and glucose concentrations on pancreatic islet function in vitro |
Q64249304 | Effects of feeding ethanol on growth performances, carcass characteristics, and lipid metabolism of finishing Korean cattle (Hanwoo) steers |
Q30319689 | Effects of fish oil and conjugated linoleic acids on expression of target genes of PPAR alpha and sterol regulatory element-binding proteins in the liver of laying hens |
Q35609581 | Effects of hypolipidemic agent nordihydroguaiaretic acid on lipid droplets and hepatitis C virus |
Q42367387 | Effects of ingredients of Korean brown rice cookies on attenuation of cholesterol level and oxidative stress in high-fat diet-fed mice |
Q35349492 | Effects of miR-33a-5P on ABCA1/G1-mediated cholesterol efflux under inflammatory stress in THP-1 macrophages |
Q44783076 | Effects of phenotypic residual feed intake on response to a glucose tolerance test and gene expression in the insulin signaling pathway in longissimus dorsi in beef cattle |
Q43515242 | Effects of simvaglyzin and atorvaglyzin on the expression of 3-hydroxy-3-methyl-glutaryl-CoA reductase in rat liver. |
Q51320999 | Effects of soyabean meal- or whey-based diets on lipid metabolism in weaned piglets. |
Q35834373 | Effects of sterol regulatory element-binding protein (SREBP) in chickens |
Q51063528 | Effects of trans-fatty acids on liver lipid metabolism in mice fed on diets showing different fatty acid composition. |
Q46984001 | Effects of treatment with hydrogen sulfide on methionine-choline deficient diet-induced non-alcoholic steatohepatitis in rats |
Q48226610 | Effects of vitamin D on insulin resistance and myosteatosis in diet-induced obese mice. |
Q93079612 | Egg white hydrolysate enhances insulin sensitivity in high-fat diet-induced insulin-resistant rats via Akt activation |
Q93251378 | Eicosapentaenoic acid in combination with EPHA2 inhibition shows efficacy in preclinical models of triple-negative breast cancer by disrupting cellular cholesterol efflux |
Q37640920 | Elevated hepatic 11β-hydroxysteroid dehydrogenase type 1 induces insulin resistance in uremia. |
Q36727408 | Elevated hepatic fatty acid elongase-5 activity affects multiple pathways controlling hepatic lipid and carbohydrate composition |
Q39233176 | Elevated lipogenesis in epithelial stem-like cell confers survival advantage in ductal carcinoma in situ of breast cancer |
Q41377073 | Emerging roles of SIRT1 in fatty liver diseases |
Q37287593 | Endocrine and paracrine role of bile acids |
Q34545426 | Endocrine functions of bile acids |
Q38742656 | Endoplasmic Reticulum Stress Protein GRP78 Modulates Lipid Metabolism to Control Drug Sensitivity and Antitumor Immunity in Breast Cancer |
Q40445739 | Endoplasmic Reticulum Stress and Ca2+ Depletion Differentially Modulate the Sterol Regulatory Protein PCSK9 to Control Lipid Metabolism. |
Q38863830 | Endoplasmic Reticulum-Associated Degradation and Lipid Homeostasis |
Q37250797 | Endoplasmic reticulum factor ERLIN2 regulates cytosolic lipid content in cancer cells |
Q38557011 | Endoplasmic reticulum stress and Oxidative stress in the pathogenesis of Non-alcoholic fatty liver disease |
Q37834712 | Endoplasmic reticulum stress and lipid dysregulation |
Q47449487 | Endoplasmic reticulum stress inhibits expression of genes involved in thyroid hormone synthesis and their key transcriptional regulators in FRTL-5 thyrocytes. |
Q39148101 | Endoplasmic reticulum stress leads to lipid accumulation through upregulation of SREBP-1c in normal hepatic and hepatoma cells |
Q88031578 | Endosomal-Lysosomal Cholesterol Sequestration by U18666A Differentially Regulates Amyloid Precursor Protein (APP) Metabolism in Normal and APP-Overexpressing Cells |
Q26996783 | Energy metabolism in the liver |
Q35022447 | Enhanced SCAP glycosylation by inflammation induces macrophage foam cell formation |
Q37724743 | Enhanced circulating PCSK9 concentration by berberine through SREBP-2 pathway in high fat diet-fed rats |
Q64098523 | Enhanced early-life nutrition upregulates cholesterol biosynthetic gene expression and Sertoli cell maturation in testes of pre-pubertal Holstein bulls |
Q35646093 | Enhanced fatty acid flux triggered by adiponectin overexpression |
Q54373460 | Epidemiology: Chronic disease, cancer, and exercise - a common link. |
Q64234550 | Epidermal growth factor receptor inhibition attenuates non-alcoholic fatty liver disease in diet-induced obese mice |
Q33577973 | Epithelial SCAP/INSIG/SREBP signaling regulates multiple biological processes during perinatal lung maturation |
Q24339552 | Erlins restrict SREBP activation in the ER and regulate cellular cholesterol homeostasis |
Q86847327 | Estrogen receptor ligands ameliorate fatty liver through a nonclassical estrogen receptor/Liver X receptor pathway in mice |
Q52599636 | Ethanol extract of Allium fistulosum inhibits development of non-alcoholic fatty liver disease. |
Q57687713 | European Obesity Summit (EOS) - Joint Congress of EASOand IFSO-EC, Gothenburg, Sweden, June 1 - 4, 2016: Abstracts |
Q90503839 | Even Cancer Cells Watch Their Cholesterol! |
Q28756853 | Evidence for positive selection in the C-terminal domain of the cholesterol metabolism gene PCSK9 based on phylogenetic analysis in 14 primate species |
Q37426801 | Evolutionary conservation and adaptation in the mechanism that regulates SREBP action: what a long, strange tRIP it's been |
Q93052749 | Excessive BCAA regulates fat metabolism partially through the modification of m6A RNA methylation in weanling piglets |
Q87756489 | Exenatide Prevents Diet-induced Hepatocellular Injury in A CEACAM1-Dependent Mechanism |
Q54941250 | Exenatide induces carcinoembryonic antigen-related cell adhesion molecule 1 expression to prevent hepatic steatosis. |
Q28294805 | Exercise training and calorie restriction increase SREBP-1 expression and intramuscular triglyceride in skeletal muscle |
Q37561703 | Experimental rat models to study the metabolic syndrome |
Q37986051 | Exploitation of lipid components by viral and host proteins for hepatitis C virus infection |
Q35827127 | Exploration of the Hypothalamic-Pituitary-Adrenal Axis to Improve Animal Welfare by Means of Genetic Selection: Lessons from the South African Merino |
Q24815022 | Exploring hepatic hormone actions using a compilation of gene expression profiles |
Q40494469 | Expression and regulation of sterol 27-hydroxylase (CYP27A1) in human macrophages: a role for RXR and PPARgamma ligands |
Q40646962 | Expression of Liver X Receptor Target Genes Decreases Cellular Amyloid β Peptide Secretion |
Q39271419 | Expression of R132H mutational IDH1 in human U87 glioblastoma cells affects the SREBP1a pathway and induces cellular proliferation |
Q37696792 | Expression of SREBP-1c Requires SREBP-2-mediated Generation of a Sterol Ligand for LXR in Livers of Mice. |
Q90494043 | Expression of SREBP2 and cholesterol metabolism related genes in TCGA glioma cohorts |
Q33962008 | Expression of fatty acid synthase in nonalcoholic fatty liver disease. |
Q35120129 | Expression of miR-33 from an SREBF2 intron targets the FTO gene in the chicken |
Q34231924 | Expression of miR-33 from an SREBP2 intron inhibits cholesterol export and fatty acid oxidation |
Q36877761 | Expression profiling of hepatic genes associated with lipid metabolism in nephrotic rats |
Q34138315 | Ezetimibe suppresses cholesterol accumulation in lipid-loaded vascular smooth muscle cells in vitro via MAPK signaling |
Q51737577 | FXR Activation by Obeticholic Acid or Non-Steroidal Agonists Induces a Human-Like Lipoprotein Cholesterol Change in Mice with Humanized Chimeric Liver. |
Q45068059 | Factors affecting adipose tissue development in chickens: A review |
Q58555382 | Familial Hypercholesterolemia: The Most Frequent Cholesterol Metabolism Disorder Caused Disease |
Q41779360 | Familial hypercholesterolaemia |
Q57818471 | Farnesoid X Receptor Activation by Obeticholic Acid Elevates Liver Low-Density Lipoprotein Receptor Expression by mRNA Stabilization and Reduces Plasma Low-Density Lipoprotein Cholesterol in Mice |
Q37508029 | Farnesoid X receptor-Acting through bile acids to treat metabolic disorders. |
Q35921709 | Fasting-dependent glucose and lipid metabolic response through hepatic sirtuin 1 |
Q40690647 | Fatostatin blocks ER exit of SCAP but inhibits cell growth in a SCAP-independent manner. |
Q33856101 | Fatostatin displays high antitumor activity in prostate cancer by blocking SREBP-regulated metabolic pathways and androgen receptor signaling |
Q97527055 | Fatty Acid Composition and Regulatory Gene Expression in Late-Term Embryos of ACRB and COBB Broilers |
Q57373134 | Fatty Acid Regulation of Gene Transcription |
Q35139141 | Fatty acid signaling: the new function of intracellular lipases |
Q51795557 | Fatty acid supplied as triglyceride regulates SRE-mediated gene expression as efficiently as free fatty acids. |
Q49960728 | Fatty acid synthase mediates EGFR palmitoylation in EGFR mutated non-small cell lung cancer |
Q35343063 | Fatty acid synthase-positive hepatocytes and subsequent steatosis in rat livers by irinotecan. |
Q37613511 | Fatty acid-regulated transcription factors in the liver |
Q47846781 | Fatty acids promote fatty liver disease via the dysregulation of 3-mercaptopyruvate sulfurtransferase/hydrogen sulfide pathway. |
Q38678326 | Fatty liver and FGF21 physiology |
Q91551847 | Fatty liver diseases, mechanisms, and potential therapeutic plant medicines |
Q92614731 | Fatty liver formation in fulminant type 1 diabetes |
Q92759389 | Feature Article: Transplantation of neuregulin 4-overexpressing adipose-derived mesenchymal stem cells ameliorates insulin resistance by attenuating hepatic steatosis |
Q37168356 | Feedback Loop Regulation of SCAP/SREBP-1 by miR-29 Modulates EGFR Signaling-Driven Glioblastoma Growth. |
Q28512190 | Feedback modulation of cholesterol metabolism by the lipid-responsive non-coding RNA LeXis |
Q37173755 | Feedback regulation of cholesterol synthesis: sterol-accelerated ubiquitination and degradation of HMG CoA reductase |
Q43293545 | Feeding pregnant rats a low-protein diet alters the hepatic expression of SREBP-1c in their offspring via a glucocorticoid-related mechanism |
Q55036636 | Fenugreek (Trigonella Foenum-Graecum) Seed Flour and Diosgenin Preserve Endothelium-Dependent Arterial Relaxation in a Rat Model of Early-Stage Metabolic Syndrome. |
Q35092731 | Fermentation of soy milk via Lactobacillus plantarum improves dysregulated lipid metabolism in rats on a high cholesterol diet |
Q36184925 | Fermented rice bran supplementation mitigates metabolic syndrome in stroke-prone spontaneously hypertensive rats. |
Q47970720 | Ferulic acid improves lipid and glucose homeostasis in high-fat diet-induced obese mice |
Q26766528 | Fibroblast Growth Factor 21 Protects against Atherosclerosis via Fine-Tuning the Multiorgan Crosstalk |
Q58107270 | Fibroblast Growth Factor Binding Protein 3 (FGFBP3) impacts carbohydrate and lipid metabolism |
Q42359780 | Fibroblast growth factor 21 potentially inhibits microRNA-33 expression to affect macrophage actions |
Q35338937 | Flavin-containing monooxygenase 3 as a potential player in diabetes-associated atherosclerosis |
Q41815877 | Flavonoid-Rich Extract of Paulownia fortunei Flowers Attenuates Diet-Induced Hyperlipidemia, Hepatic Steatosis and Insulin Resistance in Obesity Mice by AMPK Pathway |
Q38023567 | Flavonoids and metabolic syndrome |
Q57149857 | Flavonoids and saponins extracted from black bean (Phaseolus vulgaris L.) seed coats modulate lipid metabolism and biliary cholesterol secretion in C57BL/6 mice |
Q47997031 | Flavonoids extracted from Linaria vulgaris protect against hyperlipidemia and hepatic steatosis induced by western-type diet in mice |
Q35769202 | Flaxseed Oil Containing α -Linolenic Acid Ester of Plant Sterol Improved Atherosclerosis in ApoE Deficient Mice |
Q85394276 | Fluoxetine induces hepatic lipid accumulation via both promotion of the SREBP1c-related lipogenesis and reduction of lipolysis in primary mouse hepatocytes |
Q91167055 | Fluoxetine induces lipid metabolism abnormalities by acting on the liver in patients and mice with depression |
Q33777071 | Formation of 7-dehydrocholesterol-containing membrane rafts in vitro and in vivo, with relevance to the Smith-Lemli-Opitz syndrome |
Q35451879 | Forward genetic screening for regulators involved in cholesterol synthesis using validation-based insertional mutagenesis |
Q36016844 | FoxO1 inhibits sterol regulatory element-binding protein-1c (SREBP-1c) gene expression via transcription factors Sp1 and SREBP-1c |
Q26997647 | From evolution to revolution: miRNAs as pharmacological targets for modulating cholesterol efflux and reverse cholesterol transport |
Q37126009 | From fatty streak to fatty liver: 33 years of joint publications in the JCI |
Q35078197 | From gallstones to genes: two hundred years of sterol research. A tribute to George J. Schroepfer Jr. |
Q37596560 | From sugar to fat: How the transcription factor XBP1 regulates hepatic lipogenesis |
Q26801099 | Fructose Metabolism and Relation to Atherosclerosis, Type 2 Diabetes, and Obesity |
Q47340121 | Fructose and glucose regulate mammalian target of rapamycin complex 1 and can activate lipogenic gene expression via distinct pathways |
Q34117313 | Fructose consumption: potential mechanisms for its effects to increase visceral adiposity and induce dyslipidemia and insulin resistance |
Q93127569 | Function and Transcriptional Regulation of Bovine TORC2 Gene in Adipocytes: Roles of C/EBP, XBP1, INSM1 and ZNF263 |
Q34359084 | Function of SREBP1 in the milk fat synthesis of dairy cow mammary epithelial cells |
Q90640539 | Functional Comparison of High and Low Molecular Weight Chitosan on Lipid Metabolism and Signals in High-Fat Diet-Fed Rats |
Q33720216 | Functional characterization and differential nutritional regulation of putative Elovl5 and Elovl4 elongases in large yellow croaker (Larimichthys crocea). |
Q44770240 | Functional development of the mammary gland: use of expression profiling and trajectory clustering to reveal changes in gene expression during pregnancy, lactation, and involution |
Q26744062 | Fundamentals of cancer metabolism |
Q37625838 | GLUT4 glucose transporter deficiency increases hepatic lipid production and peripheral lipid utilization. |
Q28834044 | GPR40 agonist ameliorates liver X receptor-induced lipid accumulation in liver by activating AMPK pathway |
Q36173755 | GRP78 rescues the ABCG5 ABCG8 sterol transporter in db/db mice |
Q92508950 | GRP94 Is Involved in the Lipid Phenotype of Brain Metastatic Cells |
Q42237860 | GSK-3-mediated phosphorylation couples ER-Golgi transport and nuclear stabilization of the CREB-H transcription factor to mediate apolipoprotein secretion |
Q38303031 | GW4064, a farnesoid X receptor agonist, upregulates adipokine expression in preadipocytes and HepG2 cells |
Q33616651 | Gelidium elegans Regulates the AMPK-PRDM16-UCP-1 Pathway and Has a Synergistic Effect with Orlistat on Obesity-Associated Features in Mice Fed a High-Fat Diet |
Q91831481 | Gene expression and DNA methylation as mechanisms of disturbed metabolism in offspring after exposure to a prenatal HF diet |
Q33309487 | Gene expression and biological processes influenced by deletion of Stat3 in pulmonary type II epithelial cells |
Q33356782 | Gene networks driving bovine milk fat synthesis during the lactation cycle |
Q28190497 | Gene switching by metabolic enzymes--how did you get on the invitation list? |
Q47140917 | Generation of patient specific human neural stem cells from Niemann-Pick disease type C patient-derived fibroblasts |
Q50422447 | Genetic Ablation of miR-33 Increases Food Intake, Enhances Adipose Tissue Expansion, and Promotes Obesity and Insulin Resistance |
Q43291536 | Genetic Dissection of the Impact of miR-33a and miR-33b during the Progression of Atherosclerosis |
Q35617057 | Genetic alterations affecting cholesterol metabolism and human fertility |
Q40473012 | Genetic and chemical correction of cholesterol accumulation and impaired autophagy in hepatic and neural cells derived from Niemann-Pick Type C patient-specific iPS cells. |
Q33867059 | Genetic control of de novo lipogenesis: role in diet-induced obesity |
Q37411799 | Genetic evidence for a role of adiponutrin in the metabolism of apolipoprotein B-containing lipoproteins |
Q47690946 | Genetic variation in the MITF promoter affects skin colour and transcriptional activity in black-boned chickens |
Q43299076 | Genetic variations in regulatory pathways of fatty acid and glucose metabolism are associated with obesity phenotypes: a population-based cohort study |
Q34281148 | Genetic, anatomic, and clinical determinants of human serum sterol and vitamin D levels |
Q36924747 | Genistein upregulates LDLR levels via JNK-mediated activation of SREBP-2 |
Q24299109 | Genome-wide RNAi screen identifies the Parkinson disease GWAS risk locus SREBF1 as a regulator of mitophagy |
Q37310596 | Genome-wide analysis of SREBP-1 binding in mouse liver chromatin reveals a preference for promoter proximal binding to a new motif. |
Q42324809 | Genome-wide localization and expression profiling establish Sp2 as a sequence-specific transcription factor regulating vitally important genes |
Q38502786 | Genome-wide localization of SREBP-2 in hepatic chromatin predicts a role in autophagy |
Q33354965 | Genome-wide occupancy of SREBP1 and its partners NFY and SP1 reveals novel functional roles and combinatorial regulation of distinct classes of genes |
Q42793008 | Gentiana manshurica Kitagawa Reverses Acute Alcohol-Induced Liver Steatosis through Blocking Sterol Regulatory Element-Binding Protein-1 Maturation |
Q39659977 | Ginkgo biloba extract enhances glucose tolerance in hyperinsulinism-induced hepatic cells |
Q36057216 | Ginsenoside Rg3 reduces lipid accumulation with AMP-Activated Protein Kinase (AMPK) activation in HepG2 cells |
Q38300652 | Glia-induced neuronal differentiation by transcriptional regulation |
Q34458474 | Glial lipid droplets and ROS induced by mitochondrial defects promote neurodegeneration |
Q34008340 | Global metabolic effects of glycerol kinase overexpression in rat hepatoma cells |
Q40990999 | Glucagon regulates hepatic lipid metabolism via cAMP and Insig-2 signaling: implication for the pathogenesis of hypertriglyceridemia and hepatic steatosis |
Q34244209 | Glucagonocentric restructuring of diabetes: a pathophysiologic and therapeutic makeover |
Q36275975 | Glucose-Mediated N-glycosylation of SCAP Is Essential for SREBP-1 Activation and Tumor Growth |
Q30318687 | Glutathione deficiency down-regulates hepatic lipogenesis in rats |
Q37189493 | Glycerol-3-phosphate acyltransferase (GPAT)-1, but not GPAT4, incorporates newly synthesized fatty acids into triacylglycerol and diminishes fatty acid oxidation |
Q27687782 | Glycerolipid and cholesterol ester analyses in biological samples by mass spectrometry |
Q37410185 | Glycogen Synthase Kinase 3 Inactivation Induces Cell Senescence through Sterol Regulatory Element Binding Protein 1-Mediated Lipogenesis in Chang Cells |
Q36478902 | Glycogen synthase kinase-3-mediated phosphorylation of serine 73 targets sterol response element binding protein-1c (SREBP-1c) for proteasomal degradation |
Q39004649 | Glycolytic genes are targets of the nuclear receptor Ad4BP/SF-1. |
Q38834993 | Golgi Associated HIF1a Serves as a Reserve in Melanoma Cells |
Q35314103 | Gonadotropin-regulated testicular RNA helicase (GRTH/DDX25), a negative regulator of luteinizing/chorionic gonadotropin hormone-induced steroidogenesis in Leydig cells: central role of steroidogenic acute regulatory protein (StAR). |
Q41255108 | Green tea polyphenol treatment attenuates atherosclerosis in high-fat diet-fed apolipoprotein E-knockout mice via alleviating dyslipidemia and up-regulating autophagy. |
Q42829572 | Group IIE secretory phospholipase A2 regulates lipolysis in adipocytes |
Q41100060 | HBx truncation mutants differentially modulate SREBP-1a and -1c transcription and HBV replication |
Q42149934 | HCBP6 Modulates Triglyceride Homeostasis in Hepatocytes Via the SREBP1c/FASN Pathway |
Q92715714 | HCMV-encoded IE2 promotes NAFLD progression by up-regulation of SREBP1c expression in UL122 genetically modified mice |
Q38293471 | HDLs, diabetes, and metabolic syndrome |
Q44922052 | HIV protease inhibitors activate the unfolded protein response and disrupt lipid metabolism in primary hepatocytes. |
Q34617496 | HIV protease inhibitors in gut barrier dysfunction and liver injury |
Q35184027 | HIV-1 Nef is transferred from expressing T cells to hepatocytic cells through conduits and enhances HCV replication |
Q39100782 | HNRNPA1 regulates HMGCR alternative splicing and modulates cellular cholesterol metabolism |
Q24624413 | Hair growth defects in Insig-deficient mice caused by cholesterol precursor accumulation and reversed by simvastatin |
Q47153617 | Haploid Mammalian Genetic Screen Identifies UBXD8 as a Key Determinant of HMGCR Degradation and Cholesterol Biosynthesis |
Q89947617 | Haploid genetic screens identify SPRING/C12ORF49 as a determinant of SREBP signaling and cholesterol metabolism |
Q38733740 | Heat-Killed Lactobacillus salivarius and Lactobacillus johnsonii Reduce Liver Injury Induced by Alcohol In Vitro and In Vivo. |
Q36765180 | Hedgehog signaling and steroidogenesis |
Q38001336 | Hepatic ABC transporters and triglyceride metabolism. |
Q35737630 | Hepatic ABCA1 and VLDL triglyceride production |
Q40631328 | Hepatic CEACAM1 Over-Expression Protects Against Diet-Induced Fibrosis and Inflammation in White Adipose Tissue |
Q52594706 | Hepatic CREBZF Couples Insulin to Lipogenesis by Inhibiting Insig activity and Contributes to Hepatic Steatosis in Diet-Induced Insulin-Resistant Mice. |
Q39141580 | Hepatic Expression of Adenovirus 36 E4ORF1 Improves Glycemic Control and Promotes Glucose Metabolism Through AKT Activation |
Q34094336 | Hepatic FoxO1 ablation exacerbates lipid abnormalities during hyperglycemia |
Q34442922 | Hepatic FoxO1 integrates glucose utilization and lipid synthesis through regulation of Chrebp O-glycosylation |
Q84008571 | Hepatic PTP1B Deficiency: The Promise of a Treatment for Metabolic Syndrome? |
Q37163041 | Hepatic SREBP-2 and cholesterol biosynthesis are regulated by FoxO3 and Sirt6 |
Q64096707 | Hepatic Sdf2l1 controls feeding-induced ER stress and regulates metabolism |
Q90227054 | Hepatic Transcriptomics Reveals that Lipogenesis Is a Key Signaling Pathway in Isocitrate Dehydrogenase 2 Deficient Mice |
Q33840844 | Hepatic deletion of Smad7 in mouse leads to spontaneous liver dysfunction and aggravates alcoholic liver injury |
Q37130242 | Hepatic effects of a methionine-choline-deficient diet in hepatocyte RXRalpha-null mice |
Q28581281 | Hepatic farnesyl diphosphate synthase expression is suppressed by polyunsaturated fatty acids |
Q40404141 | Hepatic fatty acid biosynthesis is more responsive to protein than carbohydrate in rainbow trout during acute stimulations |
Q37665444 | Hepatic insulin receptor deficiency impairs the SREBP-2 response to feeding and statins |
Q34609585 | Hepatic insulin resistance is sufficient to produce dyslipidemia and susceptibility to atherosclerosis |
Q42947256 | Hepatic iron loading in mice increases cholesterol biosynthesis. |
Q41208609 | Hepatic isoprenoid metabolism in a rat model of Smith-Lemli-Opitz Syndrome |
Q58596261 | Hepatic lesions induced by feeding Western diets to Zucker fatty rats, an insulin-resistant model |
Q93064624 | Hepatic lipid homeostasis by peroxisome proliferator-activated receptor gamma 2 |
Q35104088 | Hepatic oxidative stress promotes insulin-STAT-5 signaling and obesity by inactivating protein tyrosine phosphatase N2 |
Q38009669 | Hepatic steatosis in type 1 diabetes |
Q91062570 | Hepatic triglyceride accumulation via endoplasmic reticulum stress-induced SREBP-1 activation is regulated by ceramide synthases |
Q42009283 | Hepatic very-low-density lipoprotein and apolipoprotein B production are increased following in vivo induction of betaine-homocysteine S-methyltransferase |
Q45952314 | Hepatic-specific activation of peroxisome proliferator-activated receptor γ coactivator-1β protects against steatohepatitis. |
Q27481013 | Hepatitis C Virus Induces Proteolytic Cleavage of Sterol Regulatory Element Binding Proteins and Stimulates Their Phosphorylation via Oxidative Stress |
Q27488294 | Hepatitis C Virus Nonstructural 4B Protein Modulates Sterol Regulatory Element-binding Protein Signaling via the AKT Pathway |
Q27490446 | Hepatitis C Virus Proteins Induce Lipogenesis and Defective Triglyceride Secretion in Transgenic Mice |
Q29620653 | Hepatitis C virus RNA replication is regulated by host geranylgeranylation and fatty acids |
Q24652319 | Hepatitis C virus hijacks host lipid metabolism |
Q36913366 | Hepatitis C virus infection activates an innate pathway involving IKK-α in lipogenesis and viral assembly |
Q37527686 | Hepatitis C virus-host interactions: Etiopathogenesis and therapeutic strategies |
Q52583858 | Hepatocellular Carcinoma-associated Protein TD26 Interacts and Enhances SREBP1 Activity to Promote Tumor Cell Proliferation and Growth. |
Q90142977 | Hepatocyte ELOVL Fatty Acid Elongase 6 Determines Ceramide Acyl-Chain Length and Hepatic Insulin Sensitivity in Mice |
Q24652495 | Hepatocyte nuclear factor 1alpha plays a critical role in PCSK9 gene transcription and regulation by the natural hypocholesterolemic compound berberine |
Q33613991 | Hepatocyte nuclear factor 4alpha coordinates a transcription factor network regulating hepatic fatty acid metabolism. |
Q47428749 | Hepatocyte-specific deletion of BAP31 promotes SREBP1C activation, promotes hepatic lipid accumulation, and worsens IR in mice |
Q39377977 | Hepatokines: linking nonalcoholic fatty liver disease and insulin resistance |
Q34675761 | Hepatoprotective Effect and Synergism of Bisdemethoycurcumin against MCD Diet-Induced Nonalcoholic Fatty Liver Disease in Mice |
Q26752622 | Hepatoprotective Effects of Chinese Medicinal Herbs: A Focus on Anti-Inflammatory and Anti-Oxidative Activities |
Q41899072 | Hepatoprotective Potential of Prosopis farcta Beans Extracts against Acetaminophen-induced Hepatotoxicity in Wister Rats |
Q53134487 | Herbal Formula HT048 Attenuates Diet-Induced Obesity by Improving Hepatic Lipid Metabolism and Insulin Resistance in Obese Rats. |
Q35691565 | Herbal SGR Formula Prevents Acute Ethanol-Induced Liver Steatosis via Inhibition of Lipogenesis and Enhancement Fatty Acid Oxidation in Mice |
Q92068346 | Heterozygous Disruption of Beclin 1 Alleviates Zinc Oxide Nanoparticles-Induced Disturbance of Cholesterol Biosynthesis in Mouse Liver |
Q37050327 | Hexavalent chromium-induced alteration of proteomic landscape in human skin fibroblast cells |
Q90384304 | High Energy Intake Induced Overexpression of Transcription Factors and Its Regulatory Genes Involved in Acceleration of Hepatic Lipogenesis: A Rat Model for Type 2 Diabetes |
Q44084511 | High levels of dietary phytosterols affect lipid metabolism and increase liver and plasma TAG in Atlantic salmon (Salmo salar L.). |
Q52585959 | High-content screen for modifiers of Niemann-Pick Type C disease in patient cells. |
Q51763141 | High-dose supplemental selenite to male Syrian hamsters fed hypercholesterolaemic diets alters Ldlr, Abcg8 and Npc1l1 mRNA expression and lowers plasma cholesterol concentrations. |
Q34799099 | High-flux mitochondrial cholesterol trafficking, a specialized function of the adrenal cortex |
Q43215242 | High-starch diets induce precocious adipogenic gene network up-regulation in longissimus lumborum of early-weaned Angus cattle |
Q35231302 | Higher protein kinase C ζ in fatty rat liver and its effect on insulin actions in primary hepatocytes |
Q28484950 | Histone deacetylase inhibition decreases cholesterol levels in neuronal cells by modulating key genes in cholesterol synthesis, uptake and efflux |
Q30440164 | Hormonal regulation of testicular steroid and cholesterol homeostasis |
Q64067571 | How Viral and Intracellular Bacterial Pathogens Reprogram the Metabolism of Host Cells to Allow Their Intracellular Replication |
Q24606762 | Human SREBP1c expression in liver is directly regulated by peroxisome proliferator-activated receptor alpha (PPARalpha) |
Q36322128 | Human Subtilisin Kexin Isozyme-1 (SKI-1)/Site-1 Protease (S1P) regulates cytoplasmic lipid droplet abundance: A potential target for indirect-acting anti-dengue virus agents |
Q35588477 | Human fatty liver disease: old questions and new insights |
Q36314748 | Human low-density lipoprotein receptor gene and its regulation |
Q27004438 | Hydrogen peroxide sensing, signaling and regulation of transcription factors |
Q64078914 | Hydrogen sulfide inhibits PCSK9 expression through the PI3K/Akt‑SREBP‑2 signaling pathway to influence lipid metabolism in HepG2 cells |
Q36629792 | Hypercholesterolemia with consumption of PFOA-laced Western diets is dependent on strain and sex of mice |
Q97652933 | Hyperglycemia-stimulating diet induces liver steatosis in sheep |
Q45219986 | Hyperhomocysteinemia induces hepatic cholesterol biosynthesis and lipid accumulation via activation of transcription factors |
Q35905331 | Hyperinsulinemia Enhances Hepatic Expression of the Fatty Acid Transporter Cd36 and Provokes Hepatosteatosis and Hepatic Insulin Resistance |
Q36953661 | Hyperlipidemia-associated gene variations and expression patterns revealed by whole-genome and transcriptome sequencing of rabbit models. |
Q33920062 | Hyperphosphorylation regulates the activity of SREBP1 during mitosis |
Q46526262 | Hypolipidaemic effect of maize starch with different amylose content in ovariectomized rats depends on intake amount of resistant starch |
Q30319539 | Hypolipidaemic effects of potato protein and fish protein in pigs |
Q38347242 | Hypolipidemic effect of dietary pea proteins: Impact on genes regulating hepatic lipid metabolism. |
Q39277489 | Hypomorphic sialidase expression decreases serum cholesterol by downregulation of VLDL production in mice |
Q38765909 | Hypothalamic Insulin Resistance in Obesity: Effects on Glucose Homeostasis |
Q64941088 | Hypothalamic gene transfer of BDNF promotes healthy aging in mice. |
Q43260810 | Hypoxia aggravates non-alcoholic steatohepatitis in mice lacking hepatocellular PTEN. |
Q90351515 | Hypoxia: A breath of fresh air for the meibomian gland |
Q37376114 | IL-33 treatment attenuated diet-induced hepatic steatosis but aggravated hepatic fibrosis |
Q48171842 | IL-36/LXR axis modulates cholesterol metabolism and immune defense to Mycobacterium tuberculosis |
Q37949664 | IL-6/IL-6 receptor system and its role in physiological and pathological conditions |
Q33728329 | INSIG1 influences obesity-related hypertriglyceridemia in humans. |
Q36790115 | INSIG2 variants, dietary patterns and metabolic risk in Samoa |
Q30432659 | Id3 is a novel atheroprotective factor containing a functionally significant single-nucleotide polymorphism associated with intima-media thickness in humans |
Q34212011 | Identification by whole-genome resequencing of gene defect responsible for severe hypercholesterolemia |
Q36479650 | Identification of NPC1 as the target of U18666A, an inhibitor of lysosomal cholesterol export and Ebola infection |
Q64375311 | Identification of a novel function of hepatic long-chain acyl-CoA synthetase-1 (ACSL1) in bile acid synthesis and its regulation by bile acid-activated farnesoid X receptor |
Q37726237 | Identification of a novel human long non-coding RNA that regulates hepatic lipid metabolism by inhibiting SREBP-1c |
Q37352148 | Identification of adropin as a secreted factor linking dietary macronutrient intake with energy homeostasis and lipid metabolism. |
Q34519267 | Identification of genes whose expression is altered by obesity throughout the arterial tree. |
Q31035638 | Identification of high-copper-responsive target pathways in Atp7b knockout mouse liver by GSEA on microarray data sets |
Q35036420 | Identification of inflammatory gene modules based on variations of human endothelial cell responses to oxidized lipids |
Q34979050 | Identification of luminal Loop 1 of Scap protein as the sterol sensor that maintains cholesterol homeostasis |
Q33432792 | Identification of novel genes and pathways regulating SREBP transcriptional activity |
Q36288686 | Identification of the ER-resident E3 ubiquitin ligase RNF145 as a novel LXR-regulated gene |
Q36836017 | Identification of twenty-three mutations in fission yeast Scap that constitutively activate SREBP. |
Q34544753 | Identifying gene-gene interactions that are highly associated with four quantitative lipid traits across multiple cohorts |
Q37682496 | Immunologic, metabolic and genetic factors in hepatitis C virus infection |
Q91945216 | Immunometabolism and natural killer cell responses |
Q26749628 | Impact of ACTH Signaling on Transcriptional Regulation of Steroidogenic Genes |
Q36017816 | Impact of SCP-2/SCP-x gene ablation and dietary cholesterol on hepatic lipid accumulation |
Q37183381 | Impact of genetic polymorphisms on the efficacy of HMG-CoA reductase inhibitors. |
Q46839764 | Impact of maternal circulating cholesterol and gestational diabetes mellitus on lipid metabolism in human term placenta |
Q34735669 | Impact of oxLDL on Cholesterol-Rich Membrane Rafts |
Q91905927 | Impact of psychiatric comorbidity on the severity, short-term functional outcome, and psychiatric complications after acute stroke |
Q54979827 | Impact of silencing hepatic SREBP-1 on insulin signaling. |
Q37610670 | Impaired SUMOylation of nuclear receptor LRH-1 promotes nonalcoholic fatty liver disease |
Q34378904 | Impaired adipogenic response to thiazolidinediones in mice expressing human apolipoproteinE4 |
Q92890070 | Impaired lipid biosynthesis hinders anti-tumor efficacy of intratumoral iNKT cells |
Q43236613 | Impairment of fat oxidation under high- vs. low-glycemic index diet occurs before the development of an obese phenotype. |
Q64928861 | Implementation of environmental enrichment after middle age promotes healthy aging. |
Q89697924 | In Steatotic Cells, ATP-Citrate Lyase mRNA Is Efficiently Translated through a Cap-Independent Mechanism, Contributing to the Stimulation of De Novo Lipogenesis |
Q36217591 | In ovo leptin administration affects hepatic lipid metabolism and microRNA expression in newly hatched broiler chickens |
Q39089992 | In vitro exposure to copper influences lipid metabolism in hepatocytes from grass carp (Ctenopharyngodon idellus). |
Q44297509 | In vivo hyperpolarized carbon-13 magnetic resonance spectroscopy reveals increased pyruvate carboxylase flux in an insulin-resistant mouse model |
Q37264829 | Inability to fully suppress sterol synthesis rates with exogenous sterol in embryonic and extraembyronic fetal tissues |
Q52690273 | Inactivation of SREBP-1a Phosphorylation Prevents Fatty Liver Disease in Mice: Identification of Related Signaling Pathways by Gene Expression Profiles in Liver and Proteomes of Peroxisomes. |
Q34089899 | Inactivation of hepatic Foxo1 by insulin signaling is required for adaptive nutrient homeostasis and endocrine growth regulation |
Q46253871 | Increased 27-hydroxycholesterol production during luteolysis may mediate the progressive decline in progesterone secretion |
Q42396896 | Increased cellular free cholesterol in macrophage-specific Abca1 knock-out mice enhances pro-inflammatory response of macrophages |
Q40068676 | Increased expression of CD14 in macrophages after inhibition of the cholesterol biosynthetic pathway by lovastatin |
Q54977313 | Increased intracellular iron in mouse primary hepatocytes in vitro causes activation of the Akt pathway but decreases its response to insulin. |
Q34672477 | Increased lipogenesis, induced by AKT-mTORC1-RPS6 signaling, promotes development of human hepatocellular carcinoma. |
Q38289418 | Increased renal collagen cross-linking and lipid accumulation in nephropathy of Zucker diabetic fatty rats |
Q35186665 | Increased very low density lipoprotein (VLDL) secretion, hepatic steatosis, and insulin resistance. |
Q47271342 | Individual co-variation between viral RNA load and gene expression reveals novel host factors during early dengue virus infection of the Aedes aegypti midgut |
Q28510700 | Induced polymerization of mammalian acetyl-CoA carboxylase by MIG12 provides a tertiary level of regulation of fatty acid synthesis |
Q97519188 | Induction of autophagy by Beclin-1 in granulosa cells contributes to follicular progesterone elevation in ovarian endometriosis: BECN1 and P4 elevation in endometriosis |
Q33842597 | Induction of fatty acid synthesis is a key requirement for phagocytic differentiation of human monocytes |
Q92052851 | Industrial Trans Fatty Acids Stimulate SREBP2-Mediated Cholesterogenesis and Promote Non-Alcoholic Fatty Liver Disease |
Q37299994 | Influence of genotype on the modulation of gene and protein expression by n-3 LC-PUFA in rats |
Q37194960 | Influence of the cystic fibrosis transmembrane conductance regulator on expression of lipid metabolism-related genes in dendritic cells |
Q54223483 | Influence of virgin coconut oil-enriched diet on the transcriptional regulation of fatty acid synthesis and oxidation in rats - a comparative study. |
Q64069791 | Influences of sterol regulatory element binding protein-1c silencing on glucose production in HepG2 cells treated with free fatty acid |
Q90169703 | Inhibition of HSP90β Improves Lipid Disorders by Promoting Mature SREBPs Degradation via the Ubiquitin-proteasome System |
Q33612522 | Inhibition of NAMPT aggravates high fat diet-induced hepatic steatosis in mice through regulating Sirt1/AMPKα/SREBP1 signaling pathway |
Q40630837 | Inhibition of Net HepG2 Cell Apolipoprotein B Secretion by the Citrus Flavonoid Naringenin Involves Activation of Phosphatidylinositol 3-Kinase, Independent of Insulin Receptor Substrate-1 Phosphorylation |
Q34205103 | Inhibition of Notch signaling ameliorates insulin resistance in a FoxO1-dependent manner |
Q42684428 | Inhibition of SOAT1 Suppresses Glioblastoma Growth via Blocking SREBP-1-Mediated Lipogenesis |
Q92885348 | Inhibition of SREBP Improves Cardiac Lipidopathy, Improves Endoplasmic Reticulum Stress, and Modulates Chronic Chagas Cardiomyopathy |
Q42631278 | Inhibition of cholesterol biosynthesis through RNF145-dependent ubiquitination of SCAP. |
Q48127350 | Inhibition of exendin-4-induced steatosis by protein kinase A in cultured HepG2 human hepatoma cells |
Q28729212 | Inhibition of intestinal bile acid transporter Slc10a2 improves triglyceride metabolism and normalizes elevated plasma glucose levels in mice |
Q64927546 | Inhibition of low-density lipoprotein receptor degradation with a cyclic peptide that disrupts the homodimerization of IDOL E3 ubiquitin ligase. |
Q36189861 | Inhibition of mTOR complex 2 induces GSK3/FBXW7-dependent degradation of sterol regulatory element-binding protein 1 (SREBP1) and suppresses lipogenesis in cancer cells |
Q35606800 | Inhibition of miR-33a/b in non-human primates raises plasma HDL and lowers VLDL triglycerides. |
Q39568148 | Inhibition of microRNA-24 expression in liver prevents hepatic lipid accumulation and hyperlipidemia |
Q34103753 | Inhibition of obesity-induced hepatic ER stress by early insulin therapy in obese diabetic rats |
Q39531917 | Inhibitory effect of schisandrin B on free fatty acid-induced steatosis in L-02 cells. |
Q37511728 | Insig proteins mediate feedback inhibition of cholesterol synthesis in the intestine |
Q24681212 | Insig-1 "brakes" lipogenesis in adipocytes and inhibits differentiation of preadipocytes |
Q24307390 | Insig-2, a second endoplasmic reticulum protein that binds SCAP and blocks export of sterol regulatory element-binding proteins |
Q40753400 | Insig: a significant integrator of nutrient and hormonal signals |
Q36466124 | Insulin Dissociates the Effects of Liver X Receptor on Lipogenesis, Endoplasmic Reticulum Stress, and Inflammation. |
Q28581484 | Insulin enhances post-translational processing of nascent SREBP-1c by promoting its phosphorylation and association with COPII vesicles |
Q37126710 | Insulin induction of SREBP-1c in rodent liver requires LXRα-C/EBPβ complex |
Q38663211 | Insulin induction of glucokinase and fatty acid synthase in hepatocytes: analysis of the roles of sterol-regulatory-element-binding protein-1c and liver X receptor |
Q35049218 | Insulin regulation of cholesterol 7alpha-hydroxylase expression in human hepatocytes: roles of forkhead box O1 and sterol regulatory element-binding protein 1c. |
Q34467208 | Insulin resistance and liver steatosis in chronic hepatitis C infection genotype 3. |
Q35561045 | Insulin resistance induces posttranslational hepatic sortilin 1 degradation in mice |
Q44839519 | Insulin resistance, serum adipokines and risk of fibrosis progression in patients transplanted for hepatitis C. |
Q42206112 | Insulin sensitivity regulates cholesterol metabolism to a greater extent than obesity: lessons from the METSIM Study |
Q37785391 | Insulin signaling in fatty acid and fat synthesis: a transcriptional perspective |
Q36342908 | Insulin stimulation of SREBP-1c processing in transgenic rat hepatocytes requires p70 S6-kinase |
Q34212126 | Insulin- and leptin-regulated fatty acid uptake plays a key causal role in hepatic steatosis in mice with intact leptin signaling but not in ob/ob or db/db mice |
Q35037837 | Insulin-independent regulation of hepatic triglyceride synthesis by fatty acids. |
Q38358901 | Insulin-like growth factor-1 coordinately induces the expression of fatty acid and cholesterol biosynthetic genes in murine C2C12 myoblasts |
Q33952316 | Insulin-regulated Srebp-1c and Pck1 mRNA expression in primary hepatocytes from zucker fatty but not lean rats is affected by feeding conditions |
Q61136557 | Insulin/Snail1 axis ameliorates fatty liver disease by epigenetically suppressing lipogenesis |
Q55040220 | Intake of 3 Eggs per Day When Compared to a Choline Bitartrate Supplement, Downregulates Cholesterol Synthesis without Changing the LDL/HDL Ratio. |
Q90359982 | Integrated Analys of High-Fat Challenge-Induced Changes in Blood Cell Whole-Genome Gene Expression |
Q41885229 | Integrative Transcriptome Analyses of Metabolic Responses in Mice Define Pivotal LncRNA Metabolic Regulators. |
Q37983638 | Interaction networks of hepatitis C virus NS4B: implications for antiviral therapy |
Q37788976 | Interaction of the hepatitis C virus (HCV) core with cellular genes in the development of HCV-induced steatosis. |
Q52724160 | Interlink between cholesterol & cell cycle in prostate carcinoma. |
Q47553435 | Interplay between ChREBP and SREBP-1c Coordinates Postprandial Glycolysis and Lipogenesis in Livers of Mice |
Q83523156 | Interrelated effects of dihomo-γ-linolenic and arachidonic acids, and sesamin on hepatic fatty acid synthesis and oxidation in rats |
Q34985745 | Intersection of the unfolded protein response and hepatic lipid metabolism |
Q38234847 | Intestinal nuclear receptors in HDL cholesterol metabolism |
Q42008733 | Intracellular delivery strategies for microRNAs and potential therapies for human cardiovascular diseases |
Q37463283 | Intramembrane glycine mediates multimerization of Insig-2, a requirement for sterol regulation in Chinese hamster ovary cells |
Q24658154 | Intramembrane processing by signal peptide peptidase regulates the membrane localization of hepatitis C virus core protein and viral propagation |
Q44574966 | Intramyocitic lipid accumulation and SREBP-1c expression are related to insulin resistance and cardiovascular risk in morbid obesity |
Q35171937 | Investigation of de novo cholesterol synthetic capacity in the gonads of goldfish (Carassius auratus) exposed to the phytosterol beta-sitosterol |
Q33642067 | Involvement of 4E-BP1 in the protection induced by HDLs on pancreatic beta-cells |
Q42216601 | Involvement of insulin resistance in the protective effect of metformin against alcoholic liver injury |
Q30559384 | Ion-current-based proteomic profiling of the retina in a rat model of Smith-Lemli-Opitz syndrome. |
Q100406084 | Iron chaperone PCBP1 protects murine liver from lipid peroxidation and steatosis |
Q91666114 | Iron overload reduces synthesis and elimination of bile acids in rat liver |
Q28075486 | Is REDD1 a Metabolic Éminence Grise? |
Q33911138 | Is alcohol beneficial or harmful for cardioprotection? |
Q38357914 | Isolation stress for 30 days alters hepatic gene expression profiles, especially with reference to lipid metabolism in mice |
Q60947803 | Isoquercetin Improves Hepatic Lipid Accumulation by Activating AMPK Pathway and Suppressing TGF-β Signaling on an HFD-Induced Nonalcoholic Fatty Liver Disease Rat Model |
Q91173877 | Isorhamnetin Alleviates Steatosis and Fibrosis in Mice with Nonalcoholic Steatohepatitis |
Q37231144 | Keap1 knockdown increases markers of metabolic syndrome after long-term high fat diet feeding |
Q28580518 | Keratinocyte growth factor and the transcription factors C/EBP alpha, C/EBP delta, and SREBP-1c regulate fatty acid synthesis in alveolar type II cells |
Q37098581 | Keratinocyte growth factor induces lipogenesis in alveolar type II cells through a sterol regulatory element binding protein-1c-dependent pathway |
Q37590276 | Key intestinal genes involved in lipoprotein metabolism are downregulated in dyslipidemic men with insulin resistance. |
Q58765163 | Key regulators of lipid metabolism drive endocrine resistance in invasive lobular breast cancer |
Q102053746 | Key role for lipids in cognitive symptoms of schizophrenia |
Q35749416 | Key stages in mammary gland development. Secretory activation in the mammary gland: it's not just about milk protein synthesis! |
Q41240626 | Kmt5a Controls Hepatic Metabolic Pathways by Facilitating RNA Pol II Release from Promoter-Proximal Regions. |
Q36319877 | Knockout of SOD1 alters murine hepatic glycolysis, gluconeogenesis, and lipogenesis |
Q90092009 | Knockout of Stat5 in T cells ameliorates high cholesterol and high fat diet-induced hypercholesterolemia by influencing cholesterol metabolism in the liver |
Q37002627 | Knockout of mouse Cyp3a gene enhances synthesis of cholesterol and bile acid in the liver |
Q28506083 | Kr-pok increases FASN expression by modulating the DNA binding of SREBP-1c and Sp1 at the proximal promoter |
Q90213130 | LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring |
Q35758221 | LDL and cAMP cooperate to regulate the functional expression of the LRP in rat ovarian granulosa cells |
Q54945090 | LXRɑ participates in the mTOR/S6K1/SREBP-1c signaling pathway during sodium palmitate-induced lipogenesis in HepG2 cells. |
Q98241464 | Lack of Augmenter of Liver Regeneration Disrupts Cholesterol Homeostasis of Liver in Mice by Inhibiting the AMPK Pathway |
Q37215867 | Lack of association between SREBF-1c gene polymorphisms and risk of non-alcoholic fatty liver disease in a Chinese Han population |
Q30425020 | Large-scale gene-centric meta-analysis across 39 studies identifies type 2 diabetes loci |
Q35834429 | Lean gene and the clock machine |
Q47237304 | Leonurus japonicus Houtt Attenuates Nonalcoholic Fatty Liver Disease in Free Fatty Acid-Induced HepG2 Cells and Mice Fed a High-Fat Diet |
Q37474320 | Leptin engages a hypothalamic neurocircuitry to permit survival in the absence of insulin |
Q33602487 | Leptin revisited: its mechanism of action and potential for treating diabetes |
Q42009740 | Levels of Hepatic Activating Transcription Factor 6 and Caspase-3 Are Downregulated in Mice after Excessive Training |
Q50987394 | Lifelong exposure to dietary isoflavones reduces risk of obesity in ovariectomized Wistar rats. |
Q43088910 | Lignophenols decrease oleate-induced apolipoprotein-B secretion in HepG2 cells |
Q38810328 | Limiting Cholesterol Biosynthetic Flux Spontaneously Engages Type I IFN Signaling |
Q42729920 | Linking lipid metabolism to the innate immune response in macrophages through sterol regulatory element binding protein-1a. |
Q47754576 | Lipid Metabolism and Lipid Droplets in Pancreatic Cancer and Stellate Cells. |
Q39253589 | Lipid droplets and liver disease: from basic biology to clinical implications. |
Q58077805 | Lipid mediators of liver injury in nonalcoholic fatty liver disease |
Q30684049 | Lipid metabolism emerges as a promising target for malignant glioma therapy |
Q44835133 | Lipid metabolism fattens up hedgehog signaling |
Q88761261 | Lipid metabolism reprogramming and its potential targets in cancer |
Q37731005 | Lipid metabolism-related gene expression pattern of Atlantic bluefin tuna (Thunnus thynnus L.) larvae fed on live prey |
Q36323141 | Lipid quantification by Raman microspectroscopy as a potential biomarker in prostate cancer |
Q34131027 | Lipid regulation in lipodystrophy versus the obesity-associated metabolic syndrome: the dissociation of HDL-C and triglycerides |
Q46890519 | Lipid synthesis in lactation: diet and the fatty acid switch |
Q40366577 | Lipid synthetic transcription factor SREBP-1a activates p21WAF1/CIP1, a universal cyclin-dependent kinase inhibitor |
Q108685161 | Lipid-based therapies against SARS-CoV-2 infection |
Q34506022 | Lipid-lowering effects of tetradecylthioacetic acid in antipsychotic-exposed, female rats: challenges with long-term treatment |
Q35961350 | Lipid-regulating effect of traditional chinese medicine: mechanisms of actions |
Q37339704 | Lipidomic Profiling of Lung Pleural Effusion Identifies Unique Metabotype for EGFR Mutants in Non-Small Cell Lung Cancer |
Q40033380 | Lipidomics: a new window to biomedical frontiers. |
Q37524335 | Lipids rule: resetting lipid metabolism restores T cell function in systemic lupus erythematosus |
Q35515576 | Lipocalin 13 protein protects against hepatic steatosis by both inhibiting lipogenesis and stimulating fatty acid β-oxidation. |
Q37039775 | Lipodystrophy and severe metabolic dysfunction in mice with adipose tissue-specific insulin receptor ablation |
Q41661616 | Lipogenic transcription factor ChREBP mediates fructose-induced metabolic adaptations to prevent hepatotoxicity. |
Q41853980 | Lipopolysaccharides accelerate hepatic steatosis in the development of nonalcoholic fatty liver disease in Zucker rats |
Q34990605 | Lipoprotein heterogeneity: diagnostic and therapeutic implications |
Q35754362 | Lipoprotein kinetics in the metabolic syndrome: pathophysiological and therapeutic lessons from stable isotope studies |
Q37705810 | Lipoprotein metabolism, dyslipidemia, and nonalcoholic fatty liver disease |
Q27332377 | Lipoproteins in Drosophila melanogaster--assembly, function, and influence on tissue lipid composition |
Q37544267 | Lipoproteins, cholesterol homeostasis and cardiac health |
Q81127015 | Lipotoxicity, an imbalance between lipogenesis de novo and fatty acid oxidation |
Q35876818 | Liraglutide prevents hypoadiponectinemia-induced insulin resistance and alterations of gene expression involved in glucose and lipid metabolism |
Q36898227 | Liver MicroRNA-291b-3p Promotes Hepatic Lipogenesis through Negative Regulation of Adenosine 5'-Monophosphate (AMP)-activated Protein Kinase α1. |
Q46861751 | Liver X receptor agonist TO-901317 upregulates SCD1 expression in renal proximal straight tubule |
Q80695266 | Liver X receptor antagonist reduces lipid formation and increases glucose metabolism in myotubes from lean, obese and type 2 diabetic individuals |
Q46442905 | Liver X receptor in cooperation with SREBP-1c is a major lipid synthesis regulator in nonalcoholic fatty liver disease. |
Q34205850 | Liver X receptor regulation of thyrotropin-releasing hormone transcription in mouse hypothalamus is dependent on thyroid status |
Q36411128 | Liver X receptors as integrators of metabolic and inflammatory signaling |
Q38462005 | Liver X receptors as regulators of metabolism. |
Q27010631 | Liver steatosis in hepatitis C patients |
Q42954995 | Liver x receptor: a novel therapeutic target |
Q37105304 | Liver-specific deletion of protein-tyrosine phosphatase 1B (PTP1B) improves metabolic syndrome and attenuates diet-induced endoplasmic reticulum stress |
Q34835012 | Liver-specific disruption of PPARgamma in leptin-deficient mice improves fatty liver but aggravates diabetic phenotypes |
Q34171384 | Liver-specific expression of transcriptionally active SREBP-1c is associated with fatty liver and increased visceral fat mass |
Q24554492 | Liver-specific mRNA for Insig-2 down-regulated by insulin: implications for fatty acid synthesis |
Q97643839 | Lnc-ing microRNA activity to atheroprotection |
Q28510849 | Local regulation of fat metabolism in peripheral nerves |
Q64961324 | Long non‑coding RNA HR1 participates in the expression of SREBP‑1c through phosphorylation of the PDK1/AKT/FoxO1 pathway. |
Q64099274 | Long-Term Feeding of Soy Protein Attenuates Choline Deficient-Induced Adverse Effects in Wild Type Mice and Prohibitin 1 Deficient Mice Response More Sensitively |
Q37014966 | Long-term exposure to abnormal glucose levels alters drug metabolism pathways and insulin sensitivity in primary human hepatocytes |
Q35208528 | Long-term hyperphagia and caloric restriction caused by low- or high-density husbandry have differential effects on zebrafish postembryonic development, somatic growth, fat accumulation and reproduction |
Q50930149 | Long-term oral administration of osteocalcin induces insulin resistance in male mice fed a high-fat, high-sucrose diet. |
Q34342477 | Long-term therapeutic silencing of miR-33 increases circulating triglyceride levels and hepatic lipid accumulation in mice |
Q33918846 | Loss of Calreticulin Uncovers a Critical Role for Calcium in Regulating Cellular Lipid Homeostasis. |
Q36847534 | Loss of Fas apoptosis inhibitory molecule leads to spontaneous obesity and hepatosteatosis |
Q90410097 | Loss of HNF1α Function Contributes to Hepatocyte Proliferation and Abnormal Cholesterol Metabolism via Downregulating miR-122: A Novel Mechanism of MODY3 |
Q39128964 | Loss of Hepatic CEACAM1: A Unifying Mechanism Linking Insulin Resistance to Obesity and Non-Alcoholic Fatty Liver Disease |
Q30443685 | Loss of Nocturnin, a circadian deadenylase, confers resistance to hepatic steatosis and diet-induced obesity |
Q57794656 | Loss of progesterone receptor membrane component 1 promotes hepatic steatosis via the induced de novo lipogenesis |
Q40646911 | Low-temperature effect on the sterol-dependent processing of SREBPs and transcription of related genes in HepG2 cells |
Q47132548 | Lunasin functionally enhances LDL uptake via inhibiting PCSK9 and enhancing LDLR expression in vitro and in vivo |
Q89985629 | Lung cancer cells survive epidermal growth factor receptor tyrosine kinase inhibitor exposure through upregulation of cholesterol synthesis |
Q30319047 | Lupin protein acts hypocholesterolemic and increases milk fat content in lactating rats by influencing the expression of genes involved in cholesterol homeostasis and triglyceride synthesis |
Q30319037 | Lupin protein compared to casein lowers the LDL cholesterol:HDL cholesterol-ratio of hypercholesterolemic adults |
Q30319700 | Lupin protein influences the expression of hepatic genes involved in fatty acid synthesis and triacylglycerol hydrolysis of adult rats |
Q38995005 | Luteolin alleviates alcoholic liver disease induced by chronic and binge ethanol feeding in mice |
Q92862044 | Lysosomal acid lipase deficiency - early diagnosis is the key |
Q39371640 | Lysosomal acid lipase deficiency: a form of non-obese fatty liver disease (NOFLD). |
Q36057629 | MARCKS-dependent mucin clearance and lipid metabolism in ependymal cells are required for maintenance of forebrain homeostasis during aging |
Q50934689 | MTTP polymorphisms and susceptibility to non-alcoholic fatty liver disease in a Han Chinese population. |
Q37130478 | MUC1-induced alterations in a lipid metabolic gene network predict response of human breast cancers to tamoxifen treatment |
Q28609710 | Maintaining cholesterol homeostasis: sterol regulatory element-binding proteins |
Q28790189 | Malformation syndromes due to inborn errors of cholesterol synthesis |
Q39136059 | Managing Cardiovascular Risk in Lysosomal Acid Lipase Deficiency |
Q30244206 | Mangiferin modulation of metabolism and metabolic syndrome |
Q37163024 | Map4k4 suppresses Srebp-1 and adipocyte lipogenesis independent of JNK signaling |
Q50053108 | Maraviroc improves hepatic triglyceride content but not inflammation in a murine nonalcoholic fatty liver disease model induced by a chronic exposure to high-fat diet. |
Q59791398 | Maternal Protein Restriction Induces Alterations in Hepatic Unfolded Protein Response-Related Molecules in Adult Rat Offspring |
Q45075424 | Maternal dietary iron restriction modulates hepatic lipid metabolism in the fetuses. |
Q90124248 | Maternal folic acid supplementation does not counteract the deleterious impact of prenatal exposure to environmental pollutants on lipid homeostasis in male rat descendants |
Q36951291 | Maternal hypercholesterolemia leads to activation of endogenous cholesterol synthesis in the offspring |
Q34129747 | Maternal magnesium deficiency in mice leads to maternal metabolic dysfunction and altered lipid metabolism with fetal growth restriction |
Q41682399 | Maternal resveratrol intake during lactation attenuates hepatic triglyceride and fatty acid synthesis in adult male rat offspring |
Q34482862 | Maturation and activity of sterol regulatory element binding protein 1 is inhibited by acyl-CoA binding domain containing 3. |
Q37530120 | MeCP2 co-ordinates liver lipid metabolism with the NCoR1/HDAC3 corepressor complex |
Q27321213 | Meal time shift disturbs circadian rhythmicity along with metabolic and behavioral alterations in mice |
Q35022533 | Mechanism of AMPK suppression of LXR-dependent Srebp-1c transcription |
Q28567638 | Mechanism underlying long-term regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase during L6 myoblast differentiation |
Q92059973 | Mechanisms and regulation of cholesterol homeostasis |
Q90685522 | Mechanisms of Insulin Action and Insulin Resistance |
Q37785293 | Mechanisms of LDL oxidation |
Q33898945 | Mechanisms of Liver Injury in Non-Alcoholic Steatohepatitis |
Q36956040 | Mechanisms of antidiabetogenic and body weight-lowering effects of estrogen in high-fat diet-fed mice |
Q36558384 | Mechanisms of hepatic steatosis in mice fed a lipogenic methionine choline-deficient diet |
Q36788344 | Mechanisms of hepatic triglyceride accumulation in non-alcoholic fatty liver disease |
Q36052468 | Mechanisms of regulation of gene expression by fatty acids |
Q38770951 | Mechanistic insight into nuclear receptor-mediated regulation of bile acid metabolism and lipid homeostasis by grape seed procyanidin extract (GSPE). |
Q37097833 | Mediating lipid biosynthesis: implications for cardiovascular disease |
Q34116726 | Medicine. HDL miR-ed down by SREBP introns |
Q30248650 | Mediterranean diet and nonalcoholic fatty liver disease: molecular mechanisms of protection. |
Q53189763 | Melissa officinalis essential oil reduces plasma triglycerides in human apolipoprotein E2 transgenic mice by inhibiting sterol regulatory element-binding protein-1c-dependent fatty acid synthesis. |
Q90607848 | Mesencephalic astrocyte-derived neurotrophic factor ameliorates steatosis in HepG2 cells by regulating hepatic lipid metabolism |
Q104136828 | Metabolic Network Analysis Reveals Altered Bile Acid Synthesis and Metabolism in Alzheimer's Disease |
Q33769884 | Metabolic and transcriptomic responses of weaned pigs induced by different dietary amylose and amylopectin ratio |
Q38662384 | Metabolic changes associated with tumor metastasis, part 2: Mitochondria, lipid and amino acid metabolism |
Q97643603 | Metabolic coessentiality mapping identifies C12orf49 as a regulator of SREBP processing and cholesterol metabolism |
Q52768568 | Metabolic control of YAP and TAZ by the mevalonate pathway. |
Q92664771 | Metabolic influence on macrophage polarization and pathogenesis |
Q48491781 | Metabolic programming of sirtuin 1 (SIRT1) expression by moderate energy restriction during gestation in rats may be related to obesity susceptibility in later life |
Q26798088 | Metabolic regulation of T cell differentiation and function |
Q89646829 | Metabolic regulation of hepatic PNPLA3 expression and severity of liver fibrosis in patients with NASH |
Q99207689 | Metabolic rivalry: circadian homeostasis and tumorigenesis |
Q36461906 | Metabolic syndrome: focus on dyslipidemia |
Q33594722 | Metabolism dysregulation induces a specific lipid signature of nonalcoholic steatohepatitis in patients |
Q35938856 | Metabolism of lipids in human white adipocyte |
Q35031827 | Metabolite and transcriptome analysis during fasting suggest a role for the p53-Ddit4 axis in major metabolic tissues |
Q41195887 | Metabolomics study of the therapeutic mechanism of Schisandra Chinensis lignans in diet-induced hyperlipidemia mice |
Q36262595 | Metformin inhibits hepatocellular glucose, lipid and cholesterol biosynthetic pathways by transcriptionally suppressing steroid receptor coactivator 2 (SRC-2). |
Q61812025 | Mg-supplementation attenuated lipogenic and oxidative/nitrosative gene expression caused by Combination Antiretroviral Therapy (cART) in HIV-1-transgenic rats |
Q39704194 | MiR-33 contributes to the regulation of cholesterol homeostasis. |
Q28504875 | Mice lacking ANGPTL8 (Betatrophin) manifest disrupted triglyceride metabolism without impaired glucose homeostasis |
Q37650114 | Micro-RNAs and High-Density Lipoprotein Metabolism. |
Q37036352 | MicroRNA 33 regulates glucose metabolism. |
Q27026071 | MicroRNA modulation of cholesterol homeostasis |
Q38823315 | MicroRNA regulation of macrophages in human pathologies |
Q37413876 | MicroRNA-124 promotes hepatic triglyceride accumulation through targeting tribbles homolog 3. |
Q34750679 | MicroRNA-185 regulates expression of lipid metabolism genes and improves insulin sensitivity in mice with non-alcoholic fatty liver disease |
Q38297030 | MicroRNA-21 is a potential link between non-alcoholic fatty liver disease and hepatocellular carcinoma via modulation of the HBP1-p53-Srebp1c pathway |
Q37130421 | MicroRNA-26a/b and their host genes synergistically regulate triacylglycerol synthesis by targeting the INSIG1 gene |
Q28509140 | MicroRNA-33 and the SREBP host genes cooperate to control cholesterol homeostasis |
Q37394060 | MicroRNA-33 regulates sterol regulatory element-binding protein 1 expression in mice. |
Q36910037 | MicroRNA-33a mediates the regulation of high mobility group AT-hook 2 gene (HMGA2) by thyroid transcription factor 1 (TTF-1/NKX2-1) |
Q33760162 | MicroRNA-33b knock-in mice for an intron of sterol regulatory element-binding factor 1 (Srebf1) exhibit reduced HDL-C in vivo |
Q39195873 | MicroRNAs and lipid metabolism. |
Q26852606 | MicroRNAs as controlled systems and controllers in non-alcoholic fatty liver disease |
Q46822603 | MicroRNAs in brain cholesterol metabolism and their implications for Alzheimer's disease |
Q24633633 | MicroRNAs in lipid metabolism |
Q41850658 | MicroRNAs in metabolism and metabolic diseases |
Q33612997 | MicroRNAs in metabolism and metabolic disorders |
Q60675346 | MicroRNAs regulating lipid metabolism in atherogenesis |
Q37294679 | Microarray analysis of gene expression in liver, adipose tissue and skeletal muscle in response to chronic dietary administration of NDGA to high-fructose fed dyslipidemic rats |
Q37200642 | Microarray analysis of hepatic gene expression identifies new genes involved in steatotic liver |
Q50099274 | Milk lipid regulation at the maternal-offspring interface |
Q36064668 | Mimp/Mtch2, an Obesity Susceptibility Gene, Induces Alteration of Fatty Acid Metabolism in Transgenic Mice. |
Q82824351 | Mineralocorticoid hypertension |
Q89386524 | Minor lipid metabolic perturbations in the liver of Atlantic salmon (Salmo salar L.) caused by suboptimal dietary content of nutrients from fish oil |
Q36478196 | Misregulation of PPAR Functioning and Its Pathogenic Consequences Associated with Nonalcoholic Fatty Liver Disease in Human Obesity |
Q37339912 | Mitochondrial cholesterol loading exacerbates amyloid beta peptide-induced inflammation and neurotoxicity |
Q38126549 | Mitochondrial dysfunction in non-alcoholic fatty liver disease and insulin resistance: cause or consequence? |
Q24306617 | Modulation of 3-hydroxy-3-methylglutaryl-CoA reductase gene expression by CuZn superoxide dismutase in human fibroblasts and HepG2 cells |
Q89944024 | Modulation of Fatty Acid-Related Genes in the Response of H9c2 Cardiac Cells to Palmitate and n-3 Polyunsaturated Fatty Acids |
Q36978947 | Modulation of hepatitis C virus genome encapsidation by nonstructural protein 4B |
Q38309085 | Modulation of human Niemann-Pick C1-like 1 gene expression by sterol: Role of sterol regulatory element binding protein 2. |
Q46388639 | Modulation of intestinal cholesterol absorption by high glucose levels: impact on cholesterol transporters, regulatory enzymes, and transcription factors. |
Q53387154 | Modulation of the murine microbiome with a concomitant anti-obesity effect by Lactobacillus rhamnosus GG and Lactobacillus sakei NR28. |
Q35947974 | Molecular Cloning, Functional Characterization and Nutritional Regulation of the Putative Elongase Elovl5 in the Orange-Spotted Grouper (Epinephelus coioides) |
Q28609443 | Molecular and Cell Biology of Phosphatidylserine and Phosphatidylethanolamine Metabolism |
Q36089092 | Molecular characterization of HLH-17, a C. elegans bHLH protein required for normal larval development |
Q39925312 | Molecular consequences of altered neuronal cholesterol biosynthesis. |
Q97643554 | Molecular logic of mTORC1 signalling as a metabolic rheostat |
Q37437295 | Molecular mechanisms involved in NAFLD progression |
Q38569945 | Molecular mechanisms of fatty liver in obesity |
Q29616709 | Molecular mediators of hepatic steatosis and liver injury |
Q37972887 | Molecular pathology of familial hypercholesterolemia, related dyslipidemias and therapies beyond the statins |
Q33890230 | Molecular pathways in non-alcoholic fatty liver disease. |
Q57807657 | Molecular pathways of nonalcoholic fatty liver disease development and progression |
Q40414527 | Molecular regulation of LHCGR expression by miR-122 during follicle growth in the rat ovary |
Q35723508 | Molecular regulation of SREBP function: the Insig-SCAP connection and isoform-specific modulation of lipid synthesis |
Q39259280 | Mollugin inhibits proliferation and induces apoptosis by suppressing fatty acid synthase in HER2-overexpressing cancer cells |
Q24803714 | Monomethyl branched-chain fatty acids play an essential role in Caenorhabditis elegans development |
Q35043691 | Mouse models as tools for dissecting disorders of lipoprotein metabolism |
Q43804565 | Mouse patatin-like phospholipase domain-containing 3 influences systemic lipid and glucose homeostasis |
Q64957324 | Multi-dimensional Transcriptional Remodeling by Physiological Insulin In Vivo. |
Q34501727 | Multi-tissue, selective PPARγ modulation of insulin sensitivity and metabolic pathways in obese rats |
Q26767396 | Mutant p53 Drives Cancer by Subverting Multiple Tumor Suppression Pathways |
Q30354662 | Mutant p53 Protein and the Hippo Transducers YAP and TAZ: A Critical Oncogenic Node in Human Cancers. |
Q24302433 | Mutant p53 disrupts mammary tissue architecture via the mevalonate pathway |
Q34972521 | Mutations in LMNA modulate the lamin A--Nesprin-2 interaction and cause LINC complex alterations |
Q37156302 | N-3 polyunsaturated fatty acid regulation of hepatic gene transcription |
Q94517849 | NAD(P)-dependent steroid dehydrogenase-like is involved in breast cancer cell growth and metastasis |
Q35159321 | NAFLD, Estrogens, and Physical Exercise: The Animal Model |
Q36099612 | NOX4 pathway as a source of selective insulin resistance and responsiveness |
Q33908866 | Nef induces multiple genes involved in cholesterol synthesis and uptake in human immunodeficiency virus type 1-infected T cells |
Q47569103 | Nelfinavir inhibits regulated intramembrane proteolysis of sterol regulatory element binding protein-1 and activating transcription factor 6 in castration-resistant prostate cancer. |
Q36337964 | Neuregulin-activated ERBB4 induces the SREBP-2 cholesterol biosynthetic pathway and increases low-density lipoprotein uptake |
Q48909259 | Neuronal Activity-Induced Sterol Regulatory Element Binding Protein-1 (SREBP1) is Disrupted in Dysbindin-Null Mice-Potential Link to Cognitive Impairment in Schizophrenia |
Q89654798 | Neuronal modulation of hepatic lipid accumulation induced by binge-like drinking |
Q94547493 | New Insights Into the Role of Phenotypic Plasticity and EMT in Driving Cancer Progression |
Q93052075 | New Insights on the Role of Lipid Metabolism in the Metabolic Reprogramming of Macrophages |
Q37788073 | New insights into S2P signaling cascades: regulation, variation, and conservation. |
Q35521069 | New insights into the mechanism of low high-density lipoprotein cholesterol in obesity |
Q37374183 | New insights into the molecular mechanisms underlying effects of estrogen on cholesterol gallstone formation. |
Q58145237 | New mechanisms contributing to hepatic steatosis: glucose, insulin, and lipid signaling |
Q39974401 | New mutations in C1GALT1C1 in individuals with Tn positive phenotype |
Q24628724 | Next-generation mTOR inhibitors in clinical oncology: how pathway complexity informs therapeutic strategy |
Q37662878 | Niemann-Pick C1-Like 1 (NPC1L1) Protein in Intestinal and Hepatic Cholesterol Transport |
Q34187966 | Niemann-Pick C1-Like 1 deletion in mice prevents high-fat diet-induced fatty liver by reducing lipogenesis. |
Q47904028 | Nischarin inhibition alters energy metabolism by activating AMP-activated protein kinase |
Q54420633 | Nlrp3 is a key modulator of diet-induced nephropathy and renal cholesterol accumulation. |
Q42151368 | Nobiletin attenuates VLDL overproduction, dyslipidemia, and atherosclerosis in mice with diet-induced insulin resistance |
Q37970350 | Non-alcoholic Fatty liver disease: the bile Acid-activated farnesoid x receptor as an emerging treatment target |
Q38197690 | Non-alcoholic fatty liver disease: the role of nuclear receptors and circadian rhythmicity. |
Q61806959 | Non-antibody Approaches to Proprotein Convertase Subtilisin Kexin 9 Inhibition: siRNA, Antisense Oligonucleotides, Adnectins, Vaccination, and New Attempts at Small-Molecule Inhibitors Based on New Discoveries |
Q89179213 | Non-coding RNAs in lipid metabolism |
Q33580031 | Nonalcoholic Fatty liver disease/non-alcoholic steatohepatitis in childhood: endocrine-metabolic "mal-programming". |
Q34412650 | Nonalcoholic Fatty liver disease: pathogenesis and therapeutics from a mitochondria-centric perspective |
Q37149405 | Nonalcoholic fatty liver disease: an overview of current insights in pathogenesis, diagnosis and treatment |
Q38859044 | Nonalcoholic fatty liver disease: cause or consequence of type 2 diabetes? |
Q37229854 | Nonalcoholic fatty liver disease: molecular mechanisms for the hepatic steatosis |
Q41640719 | Nonnuclear Estrogen Receptor Activation Improves Hepatic Steatosis in Female Mice. |
Q36527942 | Nordihydroguaiaretic acid improves metabolic dysregulation and aberrant hepatic lipid metabolism in mice by both PPARα-dependent and -independent pathways |
Q42909043 | Nordihydroguaiaretic acid protects against high-fat diet-induced fatty liver by activating AMP-activated protein kinase in obese mice |
Q94672841 | Nostoc sphaeroids Kütz ameliorates hyperlipidemia and maintains the intestinal barrier and gut microbiota composition of high-fat diet mice |
Q92534729 | Nostoc sphaeroids Kütz powder ameliorates diet-induced hyperlipidemia in C57BL/6j mice |
Q90580543 | Novel Lipid Long Intervening Noncoding RNA, Oligodendrocyte Maturation-Associated Long Intergenic Noncoding RNA, Regulates the Liver Steatosis Gene Stearoyl-Coenzyme A Desaturase As an Enhancer RNA |
Q90640730 | Novel Neohesperidin Dihydrochalcone Analogue Inhibits Adipogenic Differentiation of Human Adipose-Derived Stem Cells through the Nrf2 Pathway |
Q28384230 | Novel Role of Soluble Epoxide Hydrolase in Regulating Cholesterol in Mammalian Cells |
Q46030429 | Novel action of 7-O-galloyl-D-sedoheptulose isolated from Corni Fructus as a hypertriglyceridaemic agent. |
Q38355827 | Novel genes in cell cycle control and lipid metabolism with dynamically regulated binding sites for sterol regulatory element-binding protein 1 and RNA polymerase II in HepG2 cells detected by chromatin immunoprecipitation with microarray detection. |
Q36231628 | Novel metabolites and roles for α-tocopherol in humans and mice discovered by mass spectrometry-based metabolomics |
Q85641644 | Novel modulators of hepatosteatosis, inflammation and fibrogenesis |
Q40586604 | Novel role for a sterol response element binding protein in directing spermatogenic cell-specific gene expression |
Q41001877 | Novel role for the CRTC2 in lipid homeostasis |
Q93026449 | Novel role of NLRP3-inflammasome in regulation of lipogenesis in fasting-induced hepatic steatosis |
Q36865812 | Novel transcriptional activities of vitamin E: inhibition of cholesterol biosynthesis |
Q28076525 | Novel treatment options for lysosomal acid lipase deficiency: critical appraisal of sebelipase alfa |
Q34810523 | Nuclear receptor cofactor receptor interacting protein 140 controls hepatic triglyceride metabolism during wasting in mice |
Q35609154 | Nuclear receptors in nonalcoholic Fatty liver disease |
Q36732028 | Nuclear receptors reverse McGarry's vicious cycle to insulin resistance |
Q24306217 | Nutrient deprivation induces α-synuclein aggregation through endoplasmic reticulum stress response and SREBP2 pathway |
Q52324285 | Nutrients and Oxidative Stress: Friend or Foe? |
Q33582787 | Nutrigenomics therapy of hepatisis C virus induced-hepatosteatosis |
Q35012948 | Nutrigenomics: exploiting systems biology in the nutrition and health arena |
Q26770270 | O-GlcNAcylation and the Metabolic Shift in High-Proliferating Cells: All the Evidence Suggests that Sugars Dictate the Flux of Lipid Biogenesis in Tumor Processes |
Q33941203 | OSBP-related protein 8 (ORP8) regulates plasma and liver tissue lipid levels and interacts with the nucleoporin Nup62 |
Q37008626 | Obese diet-induced mouse models of nonalcoholic steatohepatitis-tracking disease by liver biopsy. |
Q37732961 | Obesity, cholesterol, and clear-cell renal cell carcinoma (RCC). |
Q42356833 | Obesity: Rubensian beauty turned into major health problem |
Q24679235 | Occupancy and function of the -150 sterol regulatory element and -65 E-box in nutritional regulation of the fatty acid synthase gene in living animals |
Q35664542 | Oligonol suppresses lipid accumulation and improves insulin resistance in a palmitate-induced in HepG2 hepatocytes as a cellular steatosis model |
Q36387184 | Omega-3 fatty acid supplementation and cardiovascular disease |
Q26825517 | Omega-3 fatty acids for the treatment of non-alcoholic fatty liver disease |
Q38869139 | Oncogenic PI3K and K-Ras stimulate de novo lipid synthesis through mTORC1 and SREBP. |
Q51295693 | Osthole improves glucose and lipid metabolism via modulation of PPARα/γ-mediated target gene expression in liver, adipose tissue, and skeletal muscle in fatty liver rats. |
Q90616240 | Ostreolysin A and anthrolysin O use different mechanisms to control movement of cholesterol from the plasma membrane to the endoplasmic reticulum |
Q34643522 | Other ways to skin a cat: activating SREBP without Scap |
Q36658364 | Ovarian granulosa cells utilize scavenger receptor SR-BI to evade cellular cholesterol homeostatic control for steroid synthesis |
Q41880154 | Overactivation of intestinal SREBP2 in mice increases serum cholesterol |
Q24631468 | Overexpression of Insig-1 in the livers of transgenic mice inhibits SREBP processing and reduces insulin-stimulated lipogenesis |
Q41541889 | Overexpression of Insig-2 inhibits atypical antipsychotic-induced adipogenic differentiation and lipid biosynthesis in adipose-derived stem cells |
Q33836878 | Overexpression of glucose-6-phosphate dehydrogenase is associated with lipid dysregulation and insulin resistance in obesity |
Q38572199 | Overindulgence and metabolic syndrome: is FoxO1 a missing link? |
Q35152219 | Oxidative stress activates endothelial innate immunity via sterol regulatory element binding protein 2 (SREBP2) transactivation of microRNA-92a |
Q37164536 | Oxidative stress-mediated mitochondrial dysfunction contributes to angiotensin II-induced nonalcoholic fatty liver disease in transgenic Ren2 rats |
Q36760237 | Oxysterol-binding protein family I is the target of minor enviroxime-like compounds. |
Q37638753 | Oxysterols in biological systems: the gastrointestinal tract, liver, vascular wall and central nervous system |
Q33917134 | Oxysterols synergize with statins by inhibiting SREBP-2 in ovarian cancer cells |
Q41991413 | PAQR3 modulates cholesterol homeostasis by anchoring Scap/SREBP complex to the Golgi apparatus |
Q42751911 | PAS kinase drives lipogenesis through SREBP-1 maturation. |
Q34433146 | PCSK9 and LDLR degradation: regulatory mechanisms in circulation and in cells |
Q47134612 | PCSK9 signaling pathways and their potential importance in clinical practice |
Q35691132 | PGC-1beta controls mitochondrial metabolism to modulate circadian activity, adaptive thermogenesis, and hepatic steatosis |
Q39474407 | PGC1α promotes tumor growth by inducing gene expression programs supporting lipogenesis. |
Q40923110 | PI3K-Akt signaling pathway upregulates hepatitis C virus RNA translation through the activation of SREBPs |
Q28587145 | PIASy-mediated sumoylation of SREBP1c regulates hepatic lipid metabolism upon fasting signaling |
Q39013884 | PKA/AMPK signaling in relation to adiponectin's antiproliferative effect on multiple myeloma cells |
Q28582308 | PKClambda in liver mediates insulin-induced SREBP-1c expression and determines both hepatic lipid content and overall insulin sensitivity |
Q34671888 | PKR-like endoplasmic reticulum kinase is necessary for lipogenic activation during HCMV infection |
Q91803007 | PMP22 Regulates Cholesterol Trafficking and ABCA1-Mediated Cholesterol Efflux |
Q80594539 | PPARalpha in the pathogenesis of fatty liver disease |
Q33805104 | PPARalpha: energy combustion, hypolipidemia, inflammation and cancer |
Q34330290 | PPARdelta is a very low-density lipoprotein sensor in macrophages |
Q89640752 | PRMT5 in gene regulation and hematologic malignancies |
Q64075627 | Paeonol Ameliorates Glucose and Lipid Metabolism in Experimental Diabetes by Activating Akt |
Q47676910 | Pak1 mediates the stimulatory effect of insulin and curcumin on hepatic ChREBP expression |
Q90656244 | Palmitate-Induced SREBP1 Expression and Activation Underlies the Increased BACE 1 Activity and Amyloid Beta Genesis |
Q46799280 | Palmitic Acid: Physiological Role, Metabolism and Nutritional Implications. |
Q36967762 | Palmiwon attenuates hepatic lipid accumulation and hyperlipidemia in a menopausal rat model |
Q34449857 | Pathogenesis and therapeutic approaches for non-alcoholic fatty liver disease |
Q37537264 | Pathogenesis of alcoholic liver disease: the role of nuclear receptors |
Q90055401 | Pathophysiologic mechanisms of obesity- and chronic inflammation-related genes in etiology of polycystic ovary syndrome |
Q38648556 | Pathophysiological mechanisms and therapeutic potentials of macrophages in non-alcoholic steatohepatitis |
Q38584848 | Pathophysiological mechanisms of increased cardiometabolic risk in people with schizophrenia and other severe mental illnesses |
Q58774678 | Pathophysiology of Diabetic Dyslipidemia |
Q27022707 | Pathophysiology of insulin resistance and steatosis in patients with chronic viral hepatitis |
Q34757496 | Pathways of cholesterol homeostasis in mouse retina responsive to dietary and pharmacologic treatments |
Q24320126 | Pdro, a protein associated with late endosomes and lysosomes and implicated in cellular cholesterol homeostasis |
Q90720156 | Penfluridol as a Candidate of Drug Repurposing for Anticancer Agent |
Q60953856 | Per-Arnt-Sim Kinase (PASK) Deficiency Increases Cellular Respiration on a Standard Diet and Decreases Liver Triglyceride Accumulation on a Western High-Fat High-Sugar Diet |
Q46484710 | Perilipin-2 Deletion Impairs Hepatic Lipid Accumulation by Interfering with Sterol Regulatory Element-binding Protein (SREBP) Activation and Altering the Hepatic Lipidome |
Q43942380 | Peripheral blood mononuclear cells: a potential source of homeostatic imbalance markers associated with obesity development |
Q43167089 | Peroxisome deficiency causes a complex phenotype because of hepatic SREBP/Insig dysregulation associated with endoplasmic reticulum stress. |
Q24623871 | Peroxisome proliferator-activated receptor-gamma coactivator 1alpha (PGC-1alpha) regulates triglyceride metabolism by activation of the nuclear receptor FXR |
Q42792348 | Peroxisome-proliferator-activated receptor gamma coactivator 1 α contributes to dysmyelination in experimental models of Huntington's disease |
Q42936021 | Perturbations of membrane structure by cholesterol and cholesterol derivatives are determined by sterol orientation |
Q49789719 | Pharmacogenomics of chemically distinct classes of Keap1-Nrf2 activators identify common and unique gene, protein, and pathway responses in vivo |
Q37725043 | Pharmacogenomics of sterol synthesis and statin use in schizophrenia subjects treated with antipsychotics |
Q35907138 | Pharmacologic ER stress induces non-alcoholic steatohepatitis in an animal model. |
Q36987335 | Pharmacology of bile acid receptors: Evolution of bile acids from simple detergents to complex signaling molecules |
Q57281714 | Phosphatidylcholine and phosphatidylethanolamine plasmalogens in lipid loaded human macrophages |
Q37284901 | Phosphorylation and protein-protein interactions in PXR-mediated CYP3A repression |
Q37206403 | Phosphorylation and recruitment of BAF60c in chromatin remodeling for lipogenesis in response to insulin |
Q43143155 | Phosphorylation of sterol regulatory element binding protein-1a by protein kinase A (PKA) regulates transcriptional activity |
Q38944183 | Phosphorylation of sterol regulatory element-binding protein (SREBP)-1c by p38 kinases, ERK and JNK influences lipid metabolism and the secretome of human liver cell line HepG2. |
Q49706850 | Physiological Suppression of Lipotoxic Liver Damage by Complementary Actions of HDAC3 and SCAP/SREBP. |
Q42548169 | Physiology. Unfolding lipid metabolism |
Q34581638 | Phytosterols and phytosterolemia: gene-diet interactions |
Q89267034 | Plasma PCSK9 correlates with apoB-48-containing triglyceride-rich lipoprotein production in men with insulin resistance |
Q36662650 | Plasma PCSK9 preferentially reduces liver LDL receptors in mice |
Q28258554 | Plasma cholesterol-lowering and transient liver dysfunction in mice lacking squalene synthase in the liver |
Q36554065 | Plasma proprotein convertase subtilisin/kexin type 9 levels and the risk of first cardiovascular events |
Q39531870 | Pleiotropic effects of a schweinfurthin on isoprenoid homeostasis |
Q38808338 | Pleiotropic effects of antitumour alkylphospholipids on cholesterol transport and metabolism. |
Q38825843 | Pleiotropic effects of statins: new therapeutic targets in drug design |
Q36850216 | Point mutation in luminal loop 7 of Scap protein blocks interaction with loop 1 and abolishes movement to Golgi |
Q46308032 | Polymorphisms in SREBF1 and SREBF2, two antipsychotic-activated transcription factors controlling cellular lipogenesis, are associated with schizophrenia in German and Scandinavian samples |
Q37158095 | Polymorphisms in the gene encoding sterol regulatory element-binding factor-1c are associated with type 2 diabetes |
Q30502199 | Polyomic profiling reveals significant hepatic metabolic alterations in glucagon-receptor (GCGR) knockout mice: implications on anti-glucagon therapies for diabetes. |
Q53222845 | Polyphenol-rich blackcurrant extract exerts hypocholesterolaemic and hypoglycaemic effects in mice fed a diet containing high fat and cholesterol. |
Q47387115 | Post-transcriptional Regulation of De Novo Lipogenesis by mTORC1-S6K1-SRPK2 Signaling. |
Q38666646 | Postprandial hepatic lipid metabolism requires signaling through Akt2 independent of the transcription factors FoxA2, FoxO1, and SREBP1c |
Q46252515 | Posttranscriptional regulation of lipid metabolism by non-coding RNAs and RNA binding proteins |
Q38119865 | Potential mechanisms of atypical antipsychotic-induced hypertriglyceridemia |
Q54426300 | Potential role of branched-chain amino acids in glucose metabolism through the accelerated induction of the glucose-sensing apparatus in the liver. |
Q41510767 | Precise integration of inducible transcriptional elements (PrIITE) enables absolute control of gene expression. |
Q89916588 | Preclinical and Clinical Development of Noncoding RNA Therapeutics for Cardiovascular Disease |
Q35962050 | Pregnane X Receptor-Humanized Mice Recapitulate Gender Differences in Ethanol Metabolism but Not Hepatotoxicity |
Q53023338 | Pregnane X receptor activation and silencing promote steatosis of human hepatic cells by distinct lipogenic mechanisms. |
Q41431281 | Prenatal caloric restriction alters lipid metabolism but not hepatic Fasn gene expression and methylation profiles in rats |
Q35839265 | Prenatal exposure to a low-protein diet programs disordered regulation of lipid metabolism in the aging rat |
Q37389108 | Prenatal exposure to undernutrition and programming of responses to high-fat feeding in the rat. |
Q41839667 | Preventing High Fat Diet-induced Obesity and Improving Insulin Sensitivity through Neuregulin 4 Gene Transfer |
Q34182797 | Preventing phosphorylation of sterol regulatory element-binding protein 1a by MAP-kinases protects mice from fatty liver and visceral obesity |
Q35717888 | Primary cilium suppression by SREBP1c involves distortion of vesicular trafficking by PLA2G3. |
Q35606085 | Primate-specific evolution of an LDLR enhancer |
Q37148306 | Pro-apoptotic miRNA-128-2 modulates ABCA1, ABCG1 and RXRα expression and cholesterol homeostasis |
Q37591701 | Pro-inflammation NF-κB signaling triggers a positive feedback via enhancing cholesterol accumulation in liver cancer cells |
Q26765495 | Progress and prospects of long noncoding RNAs in lipid homeostasis |
Q37064933 | Prolactin regulation of mammary gland development. |
Q42007845 | Promoter analysis of the DHCR24 (3β-hydroxysterol Δ(24)-reductase) gene: characterization of SREBP (sterol-regulatory-element-binding protein)-mediated activation. |
Q33922486 | Prosteatotic genes are associated with unsaturated fat suppression of saturated fat-induced hepatic steatosis in C57BL/6 mice |
Q90167210 | Protection from Endotoxin Shock by Selective Targeting of Proinflammatory Signaling to the Nucleus Mediated by Importin Alpha 5 |
Q46842563 | Protective Effect of Argan and Olive Oils against LPS-Induced Oxidative Stress and Inflammation in Mice Livers |
Q37397907 | Protective Effects of Ecklonia stolonifera Extract on Ethanol-Induced Fatty Liver in Rats. |
Q34098522 | Protective effects of farnesoid X receptor (FXR) on hepatic lipid accumulation are mediated by hepatic FXR and independent of intestinal FGF15 signal |
Q89855474 | Protein arginine methyltransferase 5 promotes cholesterol biosynthesis-mediated Th17 responses and autoimmunity |
Q35838266 | Protein mediators of sterol transport across intestinal brush border membrane |
Q90019833 | Proteolytic Control of Lipid Metabolism |
Q46290614 | Proteostatic Tactics in the Strategy of Sterol Regulation |
Q43154975 | Proto-oncogene FBI-1 (Pokemon) and SREBP-1 synergistically activate transcription of fatty-acid synthase gene (FASN). |
Q54323184 | Puerariae flos alleviates metabolic diseases in Western diet-loaded, spontaneously obese type 2 diabetic model mice. |
Q33543669 | Quantitative proteomics analysis of inborn errors of cholesterol synthesis: identification of altered metabolic pathways in DHCR7 and SC5D deficiency |
Q38464758 | Quercetin up-regulates LDL receptor expression in HepG2 cells |
Q39664968 | Quercetin up-regulates paraoxonase 1 gene expression via sterol regulatory element binding protein 2 that translocates from the endoplasmic reticulum to the nucleus where it specifically interacts with sterol responsive element-like sequence in para |
Q64898416 | RA-XII Suppresses the Development and Growth of Liver Cancer by Inhibition of Lipogenesis via SCAP-dependent SREBP Supression. |
Q42116517 | REPTOR and REPTOR-BP Regulate Organismal Metabolism and Transcription Downstream of TORC1. |
Q34246542 | RETRACTED ARTICLE: A novel polymorphism of the GP78 gene is associated with coronary artery disease in Han population in China |
Q24305480 | RING-dependent tumor suppression and G2/M arrest induced by the TRC8 hereditary kidney cancer gene |
Q91752935 | RNA-Sequencing Analysis of Paternal Low-Protein Diet-Induced Gene Expression Change in Mouse Offspring Adipocytes |
Q39499551 | RNAi-mediated knockdown of HMG CoA reductase enhances gene expression from physiologically regulated low-density lipoprotein receptor therapeutic vectors in vivo |
Q38639202 | RNF20 Suppresses Tumorigenesis by Inhibiting SREBP1c-PTTG1 Axis in Kidney Cancer. |
Q37802722 | RUMINANT NUTRITION SYMPOSIUM: Molecular adaptation of ruminal epithelia to highly fermentable diets1 |
Q33630411 | RXR Partial Agonist CBt-PMN Exerts Therapeutic Effects on Type 2 Diabetes without the Side Effects of RXR Full Agonists. |
Q33578758 | Rab1 in cell signaling, cancer and other diseases |
Q56981583 | Randomized comparison of reduced fat and reduced carbohydrate hypocaloric diets on intrahepatic fat in overweight and obese human subjects |
Q88916888 | Rapid communication: lipid metabolic gene expression and triacylglycerol accumulation in goat mammary epithelial cells are decreased by inhibition of SREBP-1 |
Q43237473 | Rapid method for cholesterol analysis in bovine milk and options for applications |
Q35089365 | Ras pathway signaling on endomembranes |
Q46112159 | Rats selectively bred for low aerobic capacity have reduced hepatic mitochondrial oxidative capacity and susceptibility to hepatic steatosis and injury |
Q34821020 | Recent Advances in Understanding of NASH: MicroRNAs as Both Biochemical Markers and Players |
Q91635371 | Recent Insights Into SREBP as a Direct Mediator of Kidney Fibrosis via Lipid-Independent Pathways |
Q83736486 | Recent advances in the regulation of milk fat synthesis |
Q34303001 | Recent insights into farnesoid X receptor in non-alcoholic fatty liver disease |
Q30252210 | Recent insights into the implications of metabolism in plasmacytoid dendritic cell innate functions: Potential ways to control these functions |
Q28184828 | Reconstitution of sterol-regulated endoplasmic reticulum-to-Golgi transport of SREBP-2 in insect cells by co-expression of mammalian SCAP and Insigs |
Q36409240 | Red clover extract exerts antidiabetic and hypolipidemic effects in db/db mice |
Q24301581 | Reduced hepatic expression of farnesoid X receptor in hereditary cholestasis associated to mutation in ATP8B1 |
Q37392679 | Reduced miR-200b and miR-200c expression contributes to abnormal hepatic lipid accumulation by stimulating JUN expression and activating the transcription of srebp1. |
Q47098397 | Reduced sterol regulatory element-binding protein (SREBP) processing through site-1 protease (S1P) inhibition alters oligodendrocyte differentiation in vitro |
Q37454290 | Regulated endoplasmic reticulum-associated degradation of a polytopic protein: p97 recruits proteasomes to Insig-1 before extraction from membranes |
Q53450573 | Regulation and mechanism of leptin on lipid metabolism in ovarian follicle cells from yellow catfish Pelteobagrus fulvidraco. |
Q41869580 | Regulation of GLUT4 gene expression by SREBP-1c in adipocytes |
Q38293434 | Regulation of HDL genes: transcriptional, posttranscriptional, and posttranslational |
Q39985039 | Regulation of HMG-CoA reductase expression by hypoxia |
Q58282329 | Regulation of INSIG2 by microRNA-96 |
Q38854079 | Regulation of PXR and CAR by protein-protein interaction and signaling crosstalk |
Q37075782 | Regulation of cholesterol and bile acid homeostasis by the cholesterol 7α-hydroxylase/steroid response element-binding protein 2/microRNA-33a axis in mice |
Q37947137 | Regulation of cholesterol homeostasis |
Q39954571 | Regulation of cholesterologenesis by the oxysterol receptor, LXRalpha. |
Q35559626 | Regulation of fatty acid and cholesterol synthesis: co-operation or competition? |
Q89790066 | Regulation of gene expression during the fasting-feeding cycle of the liver displays mouse strain specificity |
Q37996638 | Regulation of gene transcription by fatty acids. |
Q37826168 | Regulation of genes involved in lipid metabolism by dietary oxidized fat |
Q26766488 | Regulation of glucose metabolism from a liver-centric perspective |
Q33816670 | Regulation of hepatic gene expression by saturated fatty acids |
Q28507784 | Regulation of hepatic lipogenesis by the transcription factor XBP1 |
Q37719350 | Regulation of hepatic lipogenesis by the zinc finger protein Zbtb20. |
Q37847726 | Regulation of lipid homeostasis by the bifunctional SREBF2-miR33a locus |
Q27009151 | Regulation of lipid stores and metabolism by lipophagy |
Q34396919 | Regulation of lipogenic gene expression by lysine-specific histone demethylase-1 (LSD1). |
Q34342717 | Regulation of mTORC1 and its impact on gene expression at a glance |
Q39842237 | Regulation of steroid 5-alpha reductase type 2 (Srd5a2) by sterol regulatory element binding proteins and statin |
Q33738188 | Regulation of the cholesterol biosynthetic pathway and its integration with fatty acid biosynthesis in the oleaginous microalga Nannochloropsis oceanica |
Q36302755 | Regulation of the human prostacyclin receptor gene by the cholesterol-responsive SREBP1. |
Q57289164 | Regulatory Efficacy of the Polyunsaturated Fatty Acids from Microalgae on Lipid Metabolism and Gut Microbiota in High-Fat Diet Rats |
Q42909202 | Regulatory role for phosphatidylcholine transfer protein/StarD2 in the metabolic response to peroxisome proliferator activated receptor alpha (PPARalpha). |
Q39427104 | Replacement of Marine Fish Oil with de novo Omega-3 Oils from Transgenic Camelina sativa in Feeds for Gilthead Sea Bream (Sparus aurata L.). |
Q38616121 | Reprogramming of glucose, fatty acid and amino acid metabolism for cancer progression |
Q28393663 | Reprogramming of lysosomal gene expression by interleukin-4 and Stat6 |
Q64916831 | Resolving the Paradox of Hepatic Insulin Resistance. |
Q40567001 | Restoration of sterol-regulatory-element-binding protein-1c gene expression in HepG2 cells by peroxisome-proliferator-activated receptor-gamma co-activator-1alpha |
Q53162831 | Restriction of dietary protein does not promote hepatic lipogenesis in lean or fatty pigs. |
Q35783084 | Resveratrol and SRT1720 Elicit Differential Effects in Metabolic Organs and Modulate Systemic Parameters Independently of Skeletal Muscle Peroxisome Proliferator-activated Receptor γ Co-activator 1α (PGC-1α) |
Q36291200 | Resveratrol as a calorie restriction mimetic: therapeutic implications |
Q46317478 | Resveratrol improves high-fat diet induced fatty liver and insulin resistance by concomitantly inhibiting proteolytic cleavage of sterol regulatory element-binding proteins, free fatty acid oxidation, and intestinal triglyceride absorption |
Q57168983 | Retinal Cholesterol Content is Reduced in Simvastatin-Treated Mice Due to Inhibited Local Biosynthesis Albeit Increased Uptake of Serum Cholesterol |
Q93193771 | Retinal Vascular Abnormalities and Microglia Activation in Mice with Deficiency in Cytochrome P450 46A1-Mediated Cholesterol Removal |
Q39214040 | Retinol binding protein 4 stimulates hepatic sterol regulatory element-binding protein 1 and increases lipogenesis through the peroxisome proliferator-activated receptor-γ coactivator 1β-dependent pathway |
Q46069993 | Retracted: Advances in the physiological and pathological implications of cholesterol. |
Q38608332 | Retrospective on Cholesterol Homeostasis: The Central Role of Scap |
Q48526360 | Reversal of metabolic disorders by pharmacological activation of bile acid receptors TGR5 and FXR. |
Q37736580 | Review article: omega-3 fatty acids - a promising novel therapy for non-alcoholic fatty liver disease |
Q38239205 | Revising the high-density lipoprotein targeting strategies - insights from human and preclinical studies |
Q35856201 | Revisiting Human Cholesterol Synthesis and Absorption: The Reciprocity Paradigm and its Key Regulators |
Q49647269 | Ring finger protein 145 (RNF145) is a ubiquitin ligase for sterol-induced degradation of HMG-CoA reductase. |
Q34643735 | Ring finger protein20 regulates hepatic lipid metabolism through protein kinase A-dependent sterol regulatory element binding protein1c degradation |
Q26749020 | Role of BAF60a/BAF60c in chromatin remodeling and hepatic lipid metabolism |
Q41060685 | Role of MSX1 in Osteogenic Differentiation of Human Dental Pulp Stem Cells. |
Q91716127 | Role of MicroRNAs in Pathophysiology of Non-alcoholic Fatty Liver Disease and Non-alcoholic Steatohepatitis |
Q34377243 | Role of Mitochondria in Alcoholic Liver Disease |
Q39153946 | Role of Phospholipid Flux during Milk Secretion in the Mammary Gland. |
Q92536780 | Role of Podocyte Injury in Glomerulosclerosis |
Q57066893 | Role of SREBPs in Liver Diseases: A Mini-review |
Q44723555 | Role of STAT-3 in regulation of hepatic gluconeogenic genes and carbohydrate metabolism in vivo |
Q46045008 | Role of adenosine monophosphate-activated protein kinase-p70 ribosomal S6 kinase-1 pathway in repression of liver X receptor-alpha-dependent lipogenic gene induction and hepatic steatosis by a novel class of dithiolethiones |
Q26738976 | Role of bile acids in the regulation of the metabolic pathways |
Q36327808 | Role of cholesterol and lipid organization in disease |
Q90481242 | Role of de novo cholesterol synthesis enzymes in cancer |
Q58796821 | Role of hepatoma-derived growth factor in promoting de novo lipogenesis and tumorigenesis in hepatocellular carcinoma |
Q35831223 | Role of hyperhomocysteinemia in endothelial dysfunction and atherothrombotic disease. |
Q33963845 | Role of stearoyl-coenzyme A desaturase in lipid metabolism |
Q38074996 | Role of the constitutive androstane receptor in obesity and type 2 diabetes: a case study of the endobiotic function of a xenobiotic receptor |
Q36020648 | Role of the liver in the control of carbohydrate and lipid homeostasis |
Q38776796 | Role of transgelin-2 in diabetes-associated pancreatic ductal adenocarcinoma |
Q58702898 | Roles for ER:endosome membrane contact sites in ligand-stimulated intraluminal vesicle formation |
Q36962066 | Roles of Vitamin A Metabolism in the Development of Hepatic Insulin Resistance. |
Q37826774 | Roles of sphingolipids in Drosophila development and disease |
Q37980154 | Roles of vitamin A status and retinoids in glucose and fatty acid metabolism |
Q114371367 | Rotavirus exploits SREBP pathway for hyper lipid biogenesis during replication |
Q89895213 | Running Head: Heat Affects Cholesterol and Bile Acid Alterations in Cholesterol and Bile Acids Metabolism in Large White Pigs during Short-Term Heat Exposure |
Q36822549 | S-nitrosylation of ARH is required for LDL uptake by the LDL receptor |
Q38798359 | SAR studies on FXR modulators led to the discovery of the first combined FXR antagonistic/TGR5 agonistic compound. |
Q43593551 | SCAP gene polymorphisms decrease the risk of nonalcoholic fatty liver disease in females with metabolic syndrome |
Q64966841 | SCAP/SREBPs are Central Players in Lipid Metabolism and Novel Metabolic Targets in Cancer Therapy. |
Q42817419 | SIK2 can be activated by deprivation of nutrition and it inhibits expression of lipogenic genes in adipocytes |
Q37619655 | SIRT1 and other sirtuins in metabolism |
Q43173436 | SIRT3 reduces lipid accumulation via AMPK activation in human hepatic cells |
Q30494316 | SLEEP DISORDERED BREATHING AND METABOLIC EFFECTS: EVIDENCE FROM ANIMAL MODELS |
Q93147449 | SREBF1c and SREBF2 gene polymorphisms are associated with acute coronary syndrome and blood lipid levels in Mexican population |
Q83827454 | SREBP activation by antipsychotic- and antidepressant-drugs in cultured human liver cells: relevance for metabolic side-effects? |
Q84453638 | SREBP isoform and SREBP target gene expression during rat primary hepatocyte culture |
Q46455282 | SREBP-1 as a transcriptional integrator of circadian and nutritional cues in the liver |
Q36728656 | SREBP-1c and TFE3, energy transcription factors that regulate hepatic insulin signaling |
Q36709238 | SREBP-1c/MicroRNA 33b Genomic Loci Control Adipocyte Differentiation |
Q36930243 | SREBP-2 regulates gut peptide secretion through intestinal bitter taste receptor signaling in mice |
Q36617459 | SREBP-2-deficient and hypomorphic mice reveal roles for SREBP-2 in embryonic development and SREBP-1c expression |
Q47094029 | SREBP-2-driven transcriptional activation of human SND1 oncogene |
Q37355532 | SREBP-2/PNPLA8 axis improves non-alcoholic fatty liver disease through activation of autophagy |
Q60912768 | SREBP-dependent lipidomic reprogramming as a broad-spectrum antiviral target |
Q91923092 | SREBP-regulated adipocyte lipogenesis is dependent on substrate availability and redox modulation of mTORC1 |
Q47692117 | SREBP-regulated lipid metabolism: convergent physiology - divergent pathophysiology |
Q41501239 | SREBP1 Contributes to Resolution of Pro-inflammatory TLR4 Signaling by Reprogramming Fatty Acid Metabolism |
Q64060396 | SREBP1 drives Keratin-80-dependent cytoskeletal changes and invasive behavior in endocrine-resistant ERα breast cancer |
Q38919899 | SREBP1 regulates tumorigenesis and prognosis of pancreatic cancer through targeting lipid metabolism |
Q91968324 | SREBP1-dependent de novo fatty acid synthesis gene expression is elevated in malignant melanoma and represents a cellular survival trait |
Q50294118 | SREBP1A,1C binds the SCD gene |
Q36650405 | SREBP2 Activation Induces Hepatic Long-chain Acyl-CoA Synthetase 1 (ACSL1) Expression in Vivo and in Vitro through a Sterol Regulatory Element (SRE) Motif of the ACSL1 C-promoter. |
Q64998467 | SREBPs in Lipid Metabolism, Insulin Signaling, and Beyond. |
Q47868873 | SREBPs suppress IRS-2-mediated insulin signalling in the liver |
Q37966406 | SREBPs: metabolic integrators in physiology and metabolism |
Q30274625 | STARD3 mediates endoplasmic reticulum-to-endosome cholesterol transport at membrane contact sites |
Q40032390 | STAT3 regulates ABCA3 expression and influences lamellar body formation in alveolar type II cells |
Q35573397 | Sagunja-Tang Improves Lipid Related Disease in a Postmenopausal Rat Model and HepG2 Cells |
Q41670587 | Salicornia herbacea prevents weight gain and hepatic lipid accumulation in obese ICR mice fed a high-fat diet |
Q28592678 | Salt-inducible kinase regulates hepatic lipogenesis by controlling SREBP-1c phosphorylation |
Q38190465 | Saponin as regulator of biofuel: implication for ethnobotanical management of diabetes. |
Q33856033 | Saturated Fatty Acids and Cardiovascular Disease: Replacements for Saturated Fat to Reduce Cardiovascular Risk. |
Q52715410 | Sauchinone controls hepatic cholesterol homeostasis by the negative regulation of PCSK9 transcriptional network. |
Q35886299 | Scap is required for sterol synthesis and crypt growth in intestinal mucosa |
Q42074184 | Schisandra polysaccharide inhibits hepatic lipid accumulation by downregulating expression of SREBPs in NAFLD mice |
Q28509016 | Schoenheimer effect explained--feedback regulation of cholesterol synthesis in mice mediated by Insig proteins |
Q57057017 | Science, serendipity, and the single degree |
Q34274838 | Scientific side trips: six excursions from the beaten path |
Q42139418 | Sea cucumber cerebrosides and long-chain bases from Acaudina molpadioides protect against high fat diet-induced metabolic disorders in mice |
Q41128622 | Second-hand smoke stimulates lipid accumulation in the liver by modulating AMPK and SREBP-1. |
Q58868066 | Selective Compensatory Induction of Hepatic HMG-CoA Reductase in Response to Inhibition of Cholesterol Absorption |
Q38409173 | Selective targeting of mutant adenomatous polyposis coli (APC) in colorectal cancer |
Q36333338 | Selective targeting of nuclear receptor FXR by avermectin analogues with therapeutic effects on nonalcoholic fatty liver disease |
Q37076798 | Selective versus total insulin resistance: a pathogenic paradox |
Q24630811 | Self-assembling enzymes and the origins of the cytoskeleton |
Q92012498 | Semen Cuscutae Administration Improves Hepatic Lipid Metabolism and Adiposity in High Fat Diet-Induced Obese Mice |
Q38320938 | Sequence analysis and map assignment of pig SREBF2 and ADFP. |
Q28511724 | Severe facial clefting in Insig-deficient mouse embryos caused by sterol accumulation and reversed by lovastatin |
Q53536436 | Severity of non-alcoholic fatty liver disease is associated with high systemic levels of tumor necrosis factor alpha and low serum interleukin 10 in morbidly obese patients. |
Q45968663 | Sex difference in the liver of hepatocyte-specific Pten-deficient mice: A model of nonalcoholic steatohepatitis. |
Q40942950 | Sfrp2 is a transcriptional target of SREBP-1 in mouse chondrogenic cells. |
Q28395865 | Shifting eating to the circadian rest phase misaligns the peripheral clocks with the master SCN clock and leads to a metabolic syndrome |
Q38331700 | Short-term inhibition of SREBP-1c expression reverses diet-induced non-alcoholic fatty liver disease in mice. |
Q30404667 | Side-chain oxysterols: from cells to membranes to molecules |
Q38111226 | Signal integration by mTORC1 coordinates nutrient input with biosynthetic output. |
Q36939995 | Signaling mechanisms in alcoholic liver injury: role of transcription factors, kinases and heat shock proteins |
Q90589491 | Signaling networks in immunometabolism |
Q36485655 | Signalling mechanisms linking hepatic glucose and lipid metabolism |
Q37010826 | Significant association of SREBP-2 genetic polymorphisms with avascular necrosis in the Korean population |
Q35946066 | Simultaneous deletion of the methylcytosine oxidases Tet1 and Tet3 increases transcriptome variability in early embryogenesis |
Q37604358 | Simvastatin promotes NPC1-mediated free cholesterol efflux from lysosomes through CYP7A1/LXRα signalling pathway in oxLDL-loaded macrophages |
Q35927740 | Single dose testosterone increases total cholesterol levels and induces the expression of HMG CoA reductase |
Q35116087 | Single nucleotide polymorphism of SREBF-1 gene associated with an increased risk of endometrial cancer in Chinese women |
Q43116362 | Sirolimus inhibits endogenous cholesterol synthesis induced by inflammatory stress in human vascular smooth muscle cells |
Q26828939 | Sirtuins as regulators of metabolism and healthspan |
Q24548362 | Sirtuins deacetylate and activate mammalian acetyl-CoA synthetases |
Q37976307 | Sirtuins mediate mammalian metabolic responses to nutrient availability |
Q37338987 | Skin-specific deletion of stearoyl-CoA desaturase-1 alters skin lipid composition and protects mice from high fat diet-induced obesity |
Q49201010 | Skin-specific regulation of SREBP processing and lipid biosynthesis by glycerol kinase 5. |
Q51244786 | Social status affects lipid metabolism in rainbow trout, Oncorhynchus mykiss. |
Q80026860 | Some bovine proteins behave as dietary fibres and reduce serum lipids in rats |
Q29619334 | Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease |
Q31157296 | Spatial distribution and function of sterol regulatory element-binding protein 1a and 2 homo- and heterodimers by in vivo two-photon imaging and spectroscopy fluorescence resonance energy transfer |
Q28483866 | Spatial distribution of the pathways of cholesterol homeostasis in human retina |
Q89256466 | Specific Amino Acids Affect Cardiovascular Diseases and Atherogenesis via Protection against Macrophage Foam Cell Formation: Review Article |
Q28302753 | Squalene synthase: a critical enzyme in the cholesterol biosynthesis pathway |
Q47787270 | Srebp-controlled glucose metabolism is essential for NK cell functional responses |
Q35118561 | StAR-related Lipid Transfer (START) Proteins: Mediators of Intracellular Lipid Metabolism |
Q64376813 | Stanniocalcin 2 Ameliorates Hepatosteatosis Through Activation of STAT3 Signaling |
Q37091619 | Statin Effects to Reduce Hepatosteatosis as Measured by Computed Tomography in Patients With Human Immunodeficiency Virus |
Q37704226 | Statin prescribing for people with severe mental illnesses: a staggered cohort study of 'real-world' impacts. |
Q64062792 | Statins and Inflammation: New Therapeutic Opportunities in Psychiatry |
Q80002035 | Statins and hepatic steatosis: perspectives from the Dallas Heart Study |
Q43179430 | Statins and primary prevention: is all the evidence in? |
Q30446668 | Statins in liver disease: a molehill, an iceberg, or neither? |
Q35071237 | Stearoyl-coenzyme A desaturase 1 deficiency protects against hypertriglyceridemia and increases plasma high-density lipoprotein cholesterol induced by liver X receptor activation |
Q45223740 | Steatohepatitis develops rapidly in transgenic mice overexpressing Abcb11 and fed a methionine-choline-deficient diet |
Q33907632 | Steatosis and steatohepatitis: complex disorders |
Q38165140 | Steatosis in the liver. |
Q57072613 | Sterol Metabolism and Transport in Atherosclerosis and Cancer |
Q38761124 | Sterol Regulatory Element Binding Protein Regulates the Expression and Metabolic Functions of Wild-Type and Oncogenic IDH1 |
Q64063164 | Sterol regulatory element binding protein 1 couples mechanical cues and lipid metabolism |
Q28511448 | Sterol regulatory element binding protein 1a regulates hepatic fatty acid partitioning by activating acetyl coenzyme A carboxylase 2 |
Q34425982 | Sterol regulatory element binding protein and dietary lipid regulation of fatty acid synthesis in the mammary epithelium |
Q34519994 | Sterol regulatory element binding protein is a principal regulator of anaerobic gene expression in fission yeast. |
Q47442591 | Sterol regulatory element binding protein-1 (SREBP1) gene expression is similarly increased in polycystic ovary syndrome and endometrial cancer |
Q34121467 | Sterol regulatory element-binding protein (SREBP)-1-mediated lipogenesis is involved in cell senescence |
Q37608436 | Sterol regulatory element-binding protein-1 (SREBP-1) is required to regulate glycogen synthesis and gluconeogenic gene expression in mouse liver |
Q39798905 | Sterol regulatory element-binding protein-1c knockdown protected INS-1E cells from lipotoxicity |
Q36839721 | Sterol regulatory element-binding proteins are essential for the metabolic programming of effector T cells and adaptive immunity |
Q33635793 | Sterol regulatory element-binding proteins are regulators of the NIS gene in thyroid cells |
Q35119794 | Sterol regulatory element-binding proteins are regulators of the rat thyroid peroxidase gene in thyroid cells |
Q37372255 | Sterol-mediated regulation of human lipin 1 gene expression in hepatoblastoma cells |
Q24683936 | Sterol-regulated transport of SREBPs from endoplasmic reticulum to Golgi: oxysterols block transport by binding to Insig |
Q46884435 | Sterol-regulated ubiquitination and degradation of Insig-1 creates a convergent mechanism for feedback control of cholesterol synthesis and uptake |
Q38607566 | Stigmasterol prevents glucolipotoxicity induced defects in glucose-stimulated insulin secretion. |
Q38985926 | Strategies to limit immune-activation in HIV patients. |
Q57064243 | Structural Proteins of HCV and Biological Functions |
Q36845708 | Structure and function of the atypical orphan nuclear receptor small heterodimer partner |
Q35291854 | Structure of the WD40 domain of SCAP from fission yeast reveals the molecular basis for SREBP recognition. |
Q35104849 | Studies of gene variants related to inflammation, oxidative stress, dyslipidemia, and obesity: implications for a nutrigenetic approach |
Q96224669 | Subcellular diversion of cholesterol by gain- and loss-of-function mutations in PMP22 |
Q37125772 | Subverting sterols: rerouting an oxysterol-signaling pathway to promote tumor growth |
Q42703553 | Successful validation of genomic biomarkers for human immunotoxicity in Jurkat T cells in vitro |
Q51042606 | Sulfated polysaccharides from Enteromorpha prolifera suppress SREBP-2 and HMG-CoA reductase expression and attenuate non-alcoholic fatty liver disease induced by a high-fat diet. |
Q34542885 | Sulfation of 25-hydroxycholesterol by SULT2B1b decreases cellular lipids via the LXR/SREBP-1c signaling pathway in human aortic endothelial cells |
Q35077610 | Sulforaphane, a cancer chemopreventive agent, induces pathways associated with membrane biosynthesis in response to tissue damage by aflatoxin B1. |
Q94464349 | Supplemental Clostridium butyricum Modulates Lipid Metabolism Through Shaping Gut Microbiota and Bile Acid Profile of Aged Laying Hens |
Q38752313 | Supplementation with linoleic acid-rich soybean oil stimulates macrophage foam cell formation via increased oxidative stress and diacylglycerol acyltransferase1-mediated triglyceride biosynthesis |
Q34614493 | Supplementation with the reduced form of Coenzyme Q10 decelerates phenotypic characteristics of senescence and induces a peroxisome proliferator-activated receptor-alpha gene expression signature in SAMP1 mice |
Q41180864 | Suppression of PGC-1alpha by Ethanol: Implications of Its Role in Alcohol Induced Liver Injury. |
Q38745464 | Suppressive Effects of the Site 1 Protease (S1P) Inhibitor, PF-429242, on Dengue Virus Propagation |
Q36574008 | Suppressor of Cytokine Signaling-3 (SOCS-3) Induces Proprotein Convertase Subtilisin Kexin Type 9 (PCSK9) Expression in Hepatic HepG2 Cell Line. |
Q55482080 | Sustained SREBP-1-dependent lipogenesis as a key mediator of resistance to BRAF-targeted therapy. |
Q33716026 | Sustained peripheral expression of transgene adiponectin offsets the development of diet-induced obesity in rats |
Q42980095 | Sustained upregulation of stearoyl-CoA desaturase in bovine mammary tissue with contrasting changes in milk fat synthesis and lipogenic gene networks caused by lipid supplements. |
Q97643595 | Systematic mapping of genetic interactions for de novo fatty acid synthesis identifies C12orf49 as a regulator of lipid metabolism |
Q57012097 | Systems Biology in Human Health and Disease |
Q47262709 | Systems Pharmacology Dissection of Cholesterol Regulation Reveals Determinants of Large Pharmacodynamic Variability between Cell Lines |
Q38226358 | Systems biology strategies to study lipidomes in health and disease. |
Q37116046 | TAK1 regulates hepatic lipid homeostasis through SREBP |
Q46835510 | TFE3 transcriptionally activates hepatic IRS-2, participates in insulin signaling and ameliorates diabetes |
Q37549846 | TIFA as a crucial mediator for NLRP3 inflammasome. |
Q38730344 | TIP30 regulates lipid metabolism in hepatocellular carcinoma by regulating SREBP1 through the Akt/mTOR signaling pathway |
Q37656016 | Targeted deletion of C1q/TNF-related protein 9 increases food intake, decreases insulin sensitivity, and promotes hepatic steatosis in mice |
Q39782322 | Targeted depletion of hepatic ACAT2-driven cholesterol esterification reveals a non-biliary route for fecal neutral sterol loss |
Q43105122 | Targeted lipidomic analysis of oxysterols in the embryonic central nervous system |
Q37552285 | Targeting Lipid Metabolic Reprogramming as Anticancer Therapeutics |
Q38121980 | Targeting SREBP-1-driven lipid metabolism to treat cancer |
Q99712026 | Targeting SREBP-2-Regulated Mevalonate Metabolism for Cancer Therapy |
Q36548517 | Targeting arginase-II protects mice from high-fat-diet-induced hepatic steatosis through suppression of macrophage inflammation |
Q27014838 | Targeting autophagy for the treatment of liver diseases |
Q37231731 | Targeting bile-acid signalling for metabolic diseases |
Q92573701 | Targeting extracellular nutrient dependencies of cancer cells |
Q50026335 | Targeting immuno-metabolism to improve anti-cancer therapies |
Q90026856 | Teriparatide Improves Bone and Lipid Metabolism in a Male Rat Model of Type 2 Diabetes Mellitus |
Q30430463 | Tgif1 represses apolipoprotein gene expression in liver |
Q21194859 | The 3-hydroxy-3-methylglutaryl coenzyme-A (HMG-CoA) reductases |
Q34357938 | The A2b adenosine receptor modulates glucose homeostasis and obesity |
Q41995694 | The ATF6-Met[67]Val substitution is associated with increased plasma cholesterol levels |
Q92177891 | The Administration of Chitosan-Tripolyphosphate-DNA Nanoparticles to Express Exogenous SREBP1a Enhances Conversion of Dietary Carbohydrates into Lipids in the Liver of Sparus aurata |
Q57300008 | The Antidiabetic Drug Lobeglitazone Protects Mice From Lipogenesis-Induced Liver Injury via Mechanistic Target of Rapamycin Complex 1 Inhibition |
Q112130067 | The Association between Branched-Chain Amino Acids (BCAAs) and Cardiometabolic Risk Factors in Middle-Aged Caucasian Women Stratified According to Glycemic Status |
Q52661639 | The CREB coactivator CRTC2 controls hepatic lipid metabolism by regulating SREBP1. |
Q42850426 | The Effect of a Mutation in the 3-UTR Region of theHMGCRGene on Cholesterol in Beijing-You Chickens |
Q88210352 | The Endoplasmic Reticulum and the Cellular Reticular Network |
Q35753820 | The Flavone Luteolin Suppresses SREBP-2 Expression and Post-Translational Activation in Hepatic Cells |
Q37821046 | The Golgi apparatus: an organelle with multiple complex functions |
Q36573945 | The Hepatitis C Virus-induced NLRP3 Inflammasome Activates the Sterol Regulatory Element-binding Protein (SREBP) and Regulates Lipid Metabolism |
Q37216964 | The Hippo pathway, p53 and cholesterol |
Q33467104 | The INSIG2 rs7566605 genetic variant does not play a major role in obesity in a sample of 24,722 individuals from four cohorts |
Q36783013 | The LATS2 tumor suppressor inhibits SREBP and suppresses hepatic cholesterol accumulation |
Q24658039 | The LDL receptor |
Q37002668 | The LXR-IDOL axis defines a clathrin-, caveolae-, and dynamin-independent endocytic route for LDLR internalization and lysosomal degradation |
Q36938987 | The Mediator Complex and Lipid Metabolism |
Q42085671 | The MicroRNA Interaction Network of Lipid Diseases. |
Q24613957 | The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders |
Q91106572 | The PI3K-AKT network at the interface of oncogenic signalling and cancer metabolism |
Q60920750 | The Potential of Isoprenoids in Adjuvant Cancer Therapy to Reduce Adverse Effects of Statins |
Q90749894 | The Potential of the FSP1cre-Pparb/d-/- Mouse Model for Studying Juvenile NAFLD |
Q26801471 | The Regulation of Reverse Cholesterol Transport and Cellular Cholesterol Homeostasis by MicroRNAs |
Q90158293 | The Role of Hypoxia-Inducible Factor 1α in the Regulation of Human Meibomian Gland Epithelial Cells |
Q39429872 | The Role of Lipid Bodies in the Microglial Aging Process and Related Diseases |
Q33831711 | The Role of Lipid and Lipoprotein Metabolism in Non-Alcoholic Fatty Liver Disease |
Q28068811 | The Role of miRNAs in Common Inflammatory Arthropathies: Osteoarthritis and Gouty Arthritis |
Q35667292 | The Roles of Vitamin A in the Regulation of Carbohydrate, Lipid, and Protein Metabolism |
Q37723259 | The SCAP/SREBP Pathway: A Mediator of Hepatic Steatosis |
Q37562004 | The SCFβ-TRCP E3 ubiquitin ligase complex targets Lipin1 for ubiquitination and degradation to promote hepatic lipogenesis. |
Q53625244 | The SRE Motif in the Human PNPLA3 Promoter (-97 to -88 bp) Mediates Transactivational Effects of SREBP-1c. |
Q79423649 | The SREBF-1 locus is associated with type 2 diabetes and plasma adiponectin levels in a middle-aged Austrian population |
Q34223258 | The SREBP pathway--insights from Insigs and insects |
Q36869039 | The Scap/SREBP pathway is essential for developing diabetic fatty liver and carbohydrate-induced hypertriglyceridemia in animals |
Q36487390 | The Sterolgene v0 cDNA microarray: a systemic approach to studies of cholesterol homeostasis and drug metabolism. |
Q89862360 | The Surprising Effect of Phenformin on Cutaneous Darkening and Characterization of Its Underlying Mechanism by a Forward Chemical Genetics Approach |
Q24294805 | The TRC8 ubiquitin ligase is sterol regulated and interacts with lipid and protein biosynthetic pathways |
Q92445005 | The Use of High-Throughput Transcriptomics to Identify Pathways with Therapeutic Significance in Podocytes |
Q98177451 | The Vicious Cycle of Renal Lipotoxicity and Mitochondrial Dysfunction |
Q35012730 | The alveolar switch: coordinating the proliferative cues and cell fate decisions that drive the formation of lobuloalveoli from ductal epithelium |
Q35849968 | The anti-obesity effects of a tuna peptide on 3T3-L1 adipocytes are mediated by the inhibition of the expression of lipogenic and adipogenic genes and by the activation of the Wnt/β-catenin signaling pathway |
Q38751170 | The beneficial effects of taurine in preventing metabolic syndrome |
Q24654991 | The blind men 'see' the elephant-the many faces of fatty liver disease |
Q34642326 | The brown fat-enriched secreted factor Nrg4 preserves metabolic homeostasis through attenuation of hepatic lipogenesis |
Q94570622 | The cellular function of SCAP in metabolic signaling |
Q91779435 | The characteristics of glucose homoeostasis in grass carp and Chinese longsnout catfish after oral starch administration: a comparative study between herbivorous and carnivorous species of fish |
Q39970114 | The citrus flavonoids hesperetin and nobiletin differentially regulate low density lipoprotein receptor gene transcription in HepG2 liver cells |
Q34159564 | The combined effect of azithromycin and insulin-like growth factor-1 on cultured human meibomian gland epithelial cells |
Q37132018 | The complexity of thyroid transcription factor 1 with both pro- and anti-oncogenic activities |
Q34860549 | The contribution of endoplasmic reticulum stress to liver diseases |
Q38089090 | The controversy of a wider statin utilization: why? |
Q37684018 | The effect and mechanism of tamoxifen-induced hepatocyte steatosis in vitro |
Q28583355 | The effect of 24S-hydroxycholesterol on cholesterol homeostasis in neurons: quantitative changes to the cortical neuron proteome |
Q46350670 | The effect of fasting on hepatic lipid accumulation and transcriptional regulation of lipid metabolism differs between C57BL/6J and BALB/cA mice fed a high-fat diet |
Q40621928 | The effect of trans-10,cis-12 conjugated linoleic acid on lipogenesis is tissue dependent in hamsters |
Q37196034 | The effects of prenatal metformin on obesogenic diet-induced alterations in maternal and fetal fatty acid metabolism |
Q53817935 | The expression of genes involved in jejunal lipogenesis and lipoprotein synthesis is altered in morbidly obese subjects with insulin resistance. |
Q38096735 | The fat side of prostate cancer |
Q38874423 | The flavone apigenin blocks nuclear translocation of sterol regulatory element-binding protein-2 in the hepatic cells WRL-68. |
Q93164013 | The gluconeogenic enzyme PCK1 phosphorylates INSIG1/2 for lipogenesis |
Q47095631 | The hepatic circadian clock fine-tunes the lipogenic response to feeding through RORα/γ. |
Q47374423 | The hypotriglyceridemic effect of biotin supplementation involves increased levels of cGMP and AMPK activation |
Q37947064 | The importance of the long-chain polyunsaturated fatty acid n-6/n-3 ratio in development of non-alcoholic fatty liver associated with obesity |
Q38125222 | The increasingly complex mechanism of HMG-CoA reductase. |
Q30235314 | The influence of metabolic imbalances and oxidative stress on the outcome of critically ill polytrauma patients: a review. |
Q53090551 | The inhibition of oleic acid induced hepatic lipogenesis and the promotion of lipolysis by caffeic acid via up-regulation of AMP-activated kinase. |
Q28082012 | The interplay of the gut microbiome, bile acids, and volatile organic compounds |
Q49793994 | The liver X receptors and sterol regulatory element binding proteins alter progesterone secretion and are regulated by human chorionic gonadotropin in human luteinized granulosa cells. |
Q35866478 | The liver plays a key role in whole body sterol accretion of the neonatal Golden Syrian hamster |
Q35214901 | The loss of Tm7sf gene accelerates skin papilloma formation in mice |
Q58801216 | The lysolipid transporter Mfsd2a regulates lipogenesis in the developing brain |
Q37867697 | The mechanistic basis for the induction of hepatic steatosis by xenobiotics |
Q37264509 | The miR-33 gene is identified in a marine teleost: a potential role in regulation of LC-PUFA biosynthesis in Siganus canaliculatus |
Q36355502 | The miRNA Interactome in Metabolic Homeostasis |
Q36659049 | The multifaceted role of mTORC1 in the control of lipid metabolism |
Q29694341 | The multifaceted roles of fatty acid synthesis in cancer |
Q35224559 | The nuclear receptor FXR uncouples the actions of miR-33 from SREBP-2 |
Q41546097 | The oxysterol 24(s),25-epoxycholesterol attenuates human smooth muscle-derived foam cell formation via reduced low-density lipoprotein uptake and enhanced cholesterol efflux |
Q57921401 | The peroxisome: an update on mysteries 2.0 |
Q41352872 | The phosphorylation-dependent regulation of nuclear SREBP1 during mitosis links lipid metabolism and cell growth. |
Q36526198 | The plaque "micro" environment: microRNAs control the risk and the development of atherosclerosis. |
Q37272567 | The plasma lipidomic signature of nonalcoholic steatohepatitis |
Q37778758 | The potential of cytokines as safety biomarkers for drug-induced liver injury |
Q36004290 | The role of CREB-H transcription factor in triglyceride metabolism |
Q38656970 | The role of bariatric surgery in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis |
Q24597882 | The role of circadian clocks in metabolic disease |
Q40666587 | The role of cytochrome P450 in the regulation of cholesterol biosynthesis |
Q36954669 | The role of dietary fat in adipose tissue metabolism. |
Q38660769 | The role of insulin resistance in nonalcoholic steatohepatitis and liver disease development--a potential therapeutic target? |
Q38321405 | The role of lipin-1 in the pathogenesis of alcoholic fatty liver |
Q36728983 | The role of microRNAs in cholesterol efflux and hepatic lipid metabolism. |
Q37061247 | The role of muscle insulin resistance in the pathogenesis of atherogenic dyslipidemia and nonalcoholic fatty liver disease associated with the metabolic syndrome. |
Q36947456 | The role of protease inhibitors in the pathogenesis of HIV-associated insulin resistance: cellular mechanisms and clinical implications |
Q24598812 | The role of protease inhibitors in the pathogenesis of HIV-associated lipodystrophy: cellular mechanisms and clinical implications |
Q34273619 | The role of scavenger receptor class B type I (SR-BI) in lipid trafficking. defining the rules for lipid traders |
Q35901803 | The role of skeletal muscle insulin resistance in the pathogenesis of the metabolic syndrome |
Q44237370 | The role of the nuclear receptor CAR as a coordinate regulator of hepatic gene expression in defense against chemical toxicity. |
Q51754944 | The selective peroxisome proliferator-activated receptor-delta agonist seladelpar reverses nonalcoholic steatohepatitis pathology by abrogating lipotoxicity in diabetic obese mice. |
Q28649493 | The small molecule fenpropimorph rapidly converts chloroplast membrane lipids to triacylglycerols in Chlamydomonas reinhardtii |
Q59789027 | The sterol-responsive RNF145 E3 ubiquitin ligase mediates the degradation of HMG-CoA reductase together with gp78 and Hrd1 |
Q37232021 | The structural basis of cholesterol accessibility in membranes |
Q36567141 | The transcription factor STAT-1 couples macrophage synthesis of 25-hydroxycholesterol to the interferon antiviral response |
Q41909224 | The transcription factor cyclic AMP-responsive element-binding protein H regulates triglyceride metabolism |
Q37636344 | The unique role of proprotein convertase subtilisin/kexin 9 in cholesterol homeostasis |
Q48274302 | The utility of noninvasive scores in assessing the prevalence of nonalcoholic fatty liver disease and advanced fibrosis in type 1 diabetic patients |
Q38331528 | Therapeutic effects of ezetimibe for non-alcoholic steatohepatitis in fatty liver shionogi-ob/ob mice |
Q34069183 | Therapeutic potential of cyclodextrins in the treatment of Niemann-Pick type C disease |
Q86315151 | Therapy for lysosomal acid lipase deficiency: replacing a missing link |
Q33861421 | Three pools of plasma membrane cholesterol and their relation to cholesterol homeostasis |
Q93338779 | Thyroid Hormone Signaling and the Liver |
Q33569654 | Thyroid dysfunction associated with follicular cell steatosis in obese male mice and humans |
Q37230659 | Thyroid hormone beta receptor activation has additive cholesterol lowering activity in combination with atorvastatin in rabbits, dogs and monkeys |
Q33653609 | Thyroid hormone responsive protein Spot14 enhances catalysis of fatty acid synthase in lactating mammary epithelium |
Q53638708 | Thyroid hormone responsive protein spot 14 enhances lipogenesis in bovine mammary epithelial cells. |
Q38341562 | Time of day and nutrients in feeding govern daily expression rhythms of the gene for sterol regulatory element-binding protein (SREBP)-1 in the mouse liver |
Q64880869 | Tissue-specific changes in Srebf1 and Srebf2 expression and DNA methylation with perinatal phthalate exposure. |
Q36725247 | Tissue-specific, nutritional, and developmental regulation of rat fatty acid elongases. |
Q33879733 | Topics in transcriptional control of lipid metabolism: from transcription factors to gene-promoter polymorphisms |
Q34255878 | Toward a unifying hypothesis of metabolic syndrome. |
Q58793016 | Trafficking of cholesterol to the ER is required for NLRP3 inflammasome activation |
Q36858185 | Trajectory clustering: a non-parametric method for grouping gene expression time courses, with applications to mammary development |
Q34789643 | Transcription coactivator mediator subunit MED1 is required for the development of fatty liver in the mouse |
Q40553571 | Transcriptional Profiling Reveals a Common Metabolic Program in High-Risk Human Neuroblastoma and Mouse Neuroblastoma Sphere-Forming Cells |
Q50217785 | Transcriptional Regulation of T Cell Metabolism Reprograming |
Q47160173 | Transcriptional Regulation of T-Cell Lipid Metabolism: Implications for Plasma Membrane Lipid Rafts and T-Cell Function |
Q28269939 | Transcriptional and Translational Modulation of myo-Inositol Oxygenase (Miox) by Fatty Acids: IMPLICATIONS IN RENAL TUBULAR INJURY INDUCED IN OBESITY AND DIABETES |
Q43540910 | Transcriptional and post-translational changes in the brain of mice deficient in cholesterol removal mediated by cytochrome P450 46A1 (CYP46A1). |
Q33672543 | Transcriptional control of hepatic lipid metabolism by SREBP and ChREBP. |
Q34721358 | Transcriptional fingerprints of antigen-presenting cell subsets in the human vaginal mucosa and skin reflect tissue-specific immune microenvironments |
Q46811170 | Transcriptional profiling and inhibition of cholesterol biosynthesis in human T lymphocyte cells by the marine toxin azaspiracid |
Q96228328 | Transcriptional regulation mechanism of SREBP on Δ6 Fad in razor clam Sinonovacula constricta |
Q28205169 | Transcriptional regulation of farnesyl pyrophosphate synthase by liver X receptors |
Q24803245 | Transcriptional regulation of lipid metabolism by fatty acids: a key determinant of pancreatic beta-cell function |
Q36100254 | Transcriptome Analysis Reveals Regulation of Gene Expression for Lipid Catabolism in Young Broilers by Butyrate Glycerides |
Q28551174 | Transcriptome Remodeling in Trypanosoma cruzi and Human Cells during Intracellular Infection |
Q41593538 | Transcriptome analysis of the pectoral muscles of local chickens and commercial broilers using Ribo-Zero ribonucleic acid sequencing. |
Q36187924 | Transcriptome profiling identifies p53 as a key player during calreticulin deficiency: Implications in lipid accumulation |
Q36500064 | Transcriptome profiling unveils the role of cholesterol in IL-17A signaling in psoriasis |
Q35350853 | Transcriptomic analysis unveils correlations between regulative apoptotic caspases and genes of cholesterol homeostasis in human brain |
Q41753061 | Transcriptomics expression analysis to unveil the molecular mechanisms underlying the cocoa polyphenol treatment in diet-induced obesity rats. |
Q93051963 | Transforming Growth Factor β Acts as a Regulatory Molecule for Lipogenic Pathways among Hepatitis C Virus Genotype-Specific Infections |
Q37729856 | Transglycosylated Starch Improves Insulin Response and Alters Lipid and Amino Acid Metabolome in a Growing Pig Model |
Q36300178 | Treatment of dyslipidemia in children and adolescents |
Q36360487 | Treatment with PPARα Agonist Clofibrate Inhibits the Transcription and Activation of SREBPs and Reduces Triglyceride and Cholesterol Levels in Liver of Broiler Chickens |
Q47719467 | Triglyceride Metabolism in the Liver. |
Q46597572 | Triglyceridemia and peroxisome proliferator-activated receptor-alpha expression are not connected in fenofibrate-treated pregnant rats |
Q64082852 | Tropomyosin-receptor kinase fused gene (TFG) regulates lipid production in human sebocytes |
Q88984016 | Truncated Adenomatous Polyposis Coli Mutation Induces Asef-Activated Golgi Fragmentation |
Q38984142 | Truths and controversies concerning the role of miRNAs in atherosclerosis and lipid metabolism |
Q38959878 | Trypanosoma cruzi infection results in an increase in intracellular cholesterol |
Q36049513 | Tuberous sclerosis complex 2 loss increases lysophosphatidylcholine synthesis in lymphangioleiomyomatosis. |
Q38161749 | Tumor metabolism of malignant gliomas |
Q30539219 | Tumor-suppressive effects of CDK8 in endometrial cancer cells. |
Q24633793 | Twist2, a novel ADD1/SREBP1c interacting protein, represses the transcriptional activity of ADD1/SREBP1c |
Q36499261 | Txnip balances metabolic and growth signaling via PTEN disulfide reduction |
Q100516145 | USP7 mediates pathological hepatic de novo lipogenesis through promoting stabilization and transcription of ZNF638 |
Q33644530 | Unacylated ghrelin rapidly modulates lipogenic and insulin signaling pathway gene expression in metabolically active tissues of GHSR deleted mice |
Q90975335 | Uncarboxylated osteocalcin ameliorates hepatic glucose and lipid metabolism in KKAy mice via activating insulin signaling pathway |
Q41765603 | Uncoupling hypoxia signaling from oxygen sensing in the liver results in hypoketotic hypoglycemic death. |
Q46381784 | Uncovering Structural Diversity of Unsaturated Fatty Acyls in Cholesteryl Esters via Photochemical Reaction and Tandem Mass Spectrometry. |
Q47436128 | Underlying mechanisms for sterol-induced ubiquitination and ER-associated degradation of HMG CoA reductase. |
Q50147891 | Understanding the diversity of membrane lipid composition. |
Q39246859 | Unraveling the Regulation of Hepatic Metabolism by Insulin |
Q36850798 | Unravelling the mysterious roles of melanocortin-3 receptors in metabolic homeostasis and obesity using mouse genetics |
Q42625301 | Upregulation of fatty acid synthesis and the suppression of hepatic triglyceride lipase as a direct cause of hereditary postprandial hypertriglyceridemia in rabbits |
Q92556677 | Ursodeoxycholic Acid Alters Bile Acid and Fatty Acid Profiles in a Mouse Model of Diet-Induced Obesity |
Q64109856 | Ursodeoxycholic acid ameliorates hepatic lipid metabolism in LO2 cells by regulating the AKT/mTOR/SREBP-1 signaling pathway |
Q21134517 | Ursolic acid increases skeletal muscle and brown fat and decreases diet-induced obesity, glucose intolerance and fatty liver disease |
Q34916798 | Viperin regulates cellular lipid metabolism during human cytomegalovirus infection |
Q64355579 | Visceral Obesity is Associated with High Levels of Serum Squalene* |
Q34719267 | Vitamin D receptor agonist doxercalciferol modulates dietary fat-induced renal disease and renal lipid metabolism |
Q92229282 | WDR76 mediates obesity and hepatic steatosis via HRas destabilization |
Q54992860 | Water-Soluble Fish Protein Intake Led to Lower Serum and Liver Cholesterol Concentrations in Obese Zucker fa/fa Rats. |
Q35689614 | Wedelolactone Regulates Lipid Metabolism and Improves Hepatic Steatosis Partly by AMPK Activation and Up-Regulation of Expression of PPARα/LPL and LDLR |
Q47411211 | Welsh onion extract inhibits PCSK9 expression contributing to the maintenance of the LDLR level under lipid depletion conditions of HepG2 cells. |
Q46355683 | What Is Lipotoxicity? |
Q34040303 | Wild bitter gourd protects against alcoholic fatty liver in mice by attenuating oxidative stress and inflammatory responses. |
Q44011642 | Wild blueberry (Vaccinium angustifolium)-enriched diet improves dyslipidaemia and modulates the expression of genes related to lipid metabolism in obese Zucker rats. |
Q40114088 | Wilms' tumor protein 1: an early target of progestin regulation in T-47D breast cancer cells that modulates proliferation and differentiation |
Q100307286 | Wnt signaling mediates oncogenic synergy between Akt and Dlx5 in T-cell lymphomagenesis by enhancing cholesterol synthesis |
Q38856934 | Xanthohumol Improves Diet-induced Obesity and Fatty Liver by Suppressing Sterol Regulatory Element-binding Protein (SREBP) Activation |
Q92326983 | Yarrow Supercritical Extract Ameliorates the Metabolic Stress in a Model of Obesity Induced by High-Fat Diet |
Q64120997 | Yarrow supercritical extract exerts antitumoral properties by targeting lipid metabolism in pancreatic cancer |
Q28538769 | Zinc finger transcription factors displaced SREBP proteins as the major Sterol regulators during Saccharomycotina evolution |
Q50889958 | Zinc mediates the SREBP-SCD axis to regulate lipid metabolism in Caenorhabditis elegans. |
Q53261375 | [Oxysterols: metabolism, biological role and associated diseases]. |
Q83755659 | [SREBP-1 and fatty liver. Clinical relevance for diabetes, obesity, dyslipidemia and atherosclerosis] |
Q33678751 | alpha(1)-fetoprotein transcription factor (FTF)/liver receptor homolog-1 (LRH-1) is an essential lipogenic regulator |
Q28115537 | cAMP-stimulated transcription of DGKθ requires steroidogenic factor 1 and sterol regulatory element binding protein 1 |
Q33926184 | mTOR Inhibition Subdues Milk Disorder Caused by Maternal VLDLR Loss |
Q90647452 | mTOR and Tumor Cachexia |
Q92643974 | mTOR at the nexus of nutrition, growth, ageing and disease |
Q30425628 | mTOR complex 1 regulates lipin 1 localization to control the SREBP pathway |
Q38209860 | mTOR signaling and transcriptional regulation in T lymphocytes |
Q28252695 | mTOR signaling in tumorigenesis |
Q39363666 | mTORC1 and mTORC2 as regulators of cell metabolism in immunity. |
Q27012468 | mTORC1 signaling activates NRF1 to increase cellular proteasome levels |
Q39256910 | mTORC1 signaling in hepatic lipid metabolism |
Q35970880 | miR-122 Regulates LH Receptor Expression by Activating Sterol Response Element Binding Protein in Rat Ovaries |
Q64377093 | miR-122 Regulates LHR Expression in Rat Granulosa Cells by Targeting Insig1 mRNA |
Q52579260 | miR-203 Inhibits Alcohol-Induced Hepatic Steatosis by Targeting Lipin1. |
Q24627398 | miR-33a/b contribute to the regulation of fatty acid metabolism and insulin signaling |
Q38730644 | miRNAs and High-Density Lipoprotein metabolism |
Q38966905 | miRNAs in non-alcoholic fatty liver disease |
Q37650119 | microRNA regulation of lipoprotein metabolism. |
Q41034686 | microRNA-29 mediates a novel negative feedback loop to regulate SCAP/SREBP-1 and lipid metabolism |
Q34248289 | microRNAs and HDL life cycle. |
Q24634470 | microRNAs and cholesterol metabolism |
Q37709886 | microRNAs in lipoprotein metabolism and cardiometabolic disorders. |
Q35718937 | p38 mitogen-activated protein kinase and liver X receptor-α mediate the leptin effect on sterol regulatory element binding protein-1c expression in hepatic stellate cells |
Q38354871 | p53 Activation in Adipocytes of Obese Mice |
Q90726562 | p53 Represses the Mevalonate Pathway to Mediate Tumor Suppression |
Q38856285 | p54(nrb)/NONO regulates lipid metabolism and breast cancer growth through SREBP-1A. |
Q43846570 | β-amyloid inhibits protein prenylation and induces cholesterol sequestration by impairing SREBP-2 cleavage. |
Search more.